Herbicide-tolerant plants through bypassing metabolic pathway

ABSTRACT

DNA sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are resistant to herbicides. DNA sequence of a gene of hydroxy-phenyl pyruvate dioxygenase; isolation from a bacteria or a plant; utilization for obtaining plants tolerant to herbicides.

[0001] The present invention relates to a novel method for making plants tolerant to herbicides, in particular to HPPD-inhibiting herbicides, to the nucleic acid sequences encoding enzymes which can be used in this method, to the expression cassettes containing them and to the transgenic plants comprising at least one of these expression cassettes.

[0002] Hydroxyphenylpyruvate dioxygenases are enzymes which catalyze the reaction of conversion of para-hydroxyphenylpyruvate (HPP) to homogentisate. This reaction takes place in the presence of iron (Fe²⁺) in the presence of oxygen (N. P. Crouch et al., Tetrahedron, 53, 20, 6993-7010, 1997).

[0003] Certain molecules which inhibit this enzyme are, moreover, known, which attach to the enzyme so as to inhibit the conversion of HPP to homogentisate. Some of these molecules have found a use as herbicides, insofar as inhibition of the reaction in plants leads to a bleaching of the leaves of the treated plants and to the death of said plants (K. E. Pallett et al., 1997 Pestic. Sci. 50 83-84). Such herbicides having HPPD as the target, described in the state of the art, are in particular isoxazoles (EP 418 175, EP 470 856, EP 487 352, EP 527 036, EP 560 482, EP 682,659, U.S. Pat. No. 5,424,276), in particular isoxaflutole, a herbicide selective for maize, diketonitriles (EP 496 630, EP 496 631), in particular 2-cyano-3-cyclopropyl-1-(2-SO₂CH₃-4-CF₃phenyl) propane-1, 3-dione and 2-cyano-3-cyclopropyl-1-(2-SO₂CH₃-4-2, 3-Cl₂phenyl))propane-1,3-dione, triketones (EP 625 505, EP 625 508, U.S. Pat. No. 5,506,195), in particular sulcotrione or mesotrione, or else pyrazolinates.

[0004] Assays to confirm that HPPD is indeed the target for diketonitriles (DKNS) and to demonstrate that HPPD is, at least at certain doses, the only target for diketonitriles, were carried out in the laboratory by germinating Arabidopsis seeds on three types of medium under sterile conditions in vitro:

[0005] 1 Murashige and Skoog medium (T. Murashige and F. Skoog, 1962. A revised medium for a rapid growth and bioassays with tobacco tissue culture. Physiol. Plant. 15, 473-479), control experiment for germination

[0006] 2 MS medium plus DKN at a dose of 1 ppm

[0007] 3 MS medium plus DKN at the same dose+homogentisate at a concentration of 5 mM.

[0008] It is very clear that, on medium 1, germination occurs normally, each plantlet developing two cotyledons which are clearly green. Development then takes place normally. On medium 2, germination occurs, but the plantlet which emerges is white, the two cotyledons exhibiting no pigmentation. The plantlets then die in a few days. On medium 3, germination occurs normally, the cotyledons are clearly green. The plants develop, but very rapidly, the amount of homogentisate in the medium decreasing, the first symptoms of bleaching appear and plant growth stops, they end up dying as in the assay carried out on medium No. 2.

[0009] This makes it possible to confirm that HPPD is clearly the target for DKNs in plants and that it appears to be the only target. This also shows that homogentisate is transported from the culture medium to the cell site where it is necessary for correct functioning of the cell and survival of the plant.

[0010] Three strategies are currently available to make plants tolerant to herbicides, (1) detoxification of the herbicide with an enzyme which converts the herbicide, or its active metabolite, to nontoxic degradation products, such as, for example, the enzymes for tolerance to bromoxynil or to basta (EP 242 236, EP 337 899); (2) mutation of the target enzyme to a functional enzyme less sensitive to the herbicide, or its active metabolite, such as, for example, the enzymes for tolerance to glyphosate (EP 293 356, S. R. Padgette et al., J. Biol. Chem., 266, 33, 1991); or (3) overexpression of the sensitive enzyme, so as to produce in the plant amounts of target enzyme which are sufficient with regard to the kinetic constants of this enzyme with respect to the herbicide in order to have sufficient functional enzyme, despite the presence of its inhibitor.

[0011] This third strategy which has been described for successfully obtaining plants tolerant to HPPD inhibitors (WO 96/38567), it being understood that, for the first time, a strategy of simple overexpression of the sensitive (nonmutated) target enzyme, was used successfully to impart on plants tolerance at an agronomic level to a herbicide. The identification of HPPDs mutated in the C-terminal portion which exhibit improved tolerance to HPPD inhibitors has made it possible to obtain an improvement in the tolerance of plants using the second strategy (WO 99/24585).

[0012] The present invention consists of a novel method for making plants tolerant to a herbicide, which uses a novel or fourth strategy of herbicide tolerance, this novel strategy comprising bypassing the metabolic pathway inhibited by said herbicide. This metabolic bypassing can be summarized as follows:

[0013] for instance a herbicide “H” which is active by inhibiting the activity of an enzyme “E” which converts the, substrate “S” to product “P”, said product P and its metabolites being essential to the life of the plant,

[0014] the metabolic bypassing consists in expressing in the plant at least one novel heterologous enzyme “NE” insensitive to “H” allowing conversion of “S” to an intermediate product “I”, which product is then converted into “P” either via the natural biosynthesis pathways of the plant or via the expression of at least one other heterologous enzyme “OE” also insensitive to “H”,

[0015] the metabolic bypassing also consisting in expressing at least one other heterologous enzyme “OE” insensitive to “H” allowing conversion of “I” to “P”, “I” being an intermediate either naturally produced by the plant or obtained by expressing at least one novel heterologous enzyme “NE” insensitive to “H” allowing conversion of “S” to “I”.

[0016] The present invention relates more particularly to a novel method for making plants tolerant to HPPD inhibitors, said method comprising the metabolic bypassing of HPPD.

[0017] No pathway of metabolic bypassing has been described to date in plants.

[0018] It is known from the literature that the conversion of HPP to homogentisate can be obtained by first carrying out conversion of HPP to ⁴-hydroxyphenylacetic acid (4-HPA) with an enzyme extract exhibiting HPP oxidase activity, followed by conversion of 4-HPA to homogentisate with an enzyme extract exhibiting 4-HPA 1-hydrolase activity (WO 99/34008). This bypassing pathway is represented in FIG. 1.

[0019] A bibliographical study reveals that the enzyme activities required to construct the HPPD bypassing pathway were characterized on crude bacterial extracts in the 1970s. Thus, the HPP oxidase (HPPO, E.C. 1.2.3.-) and 4-HPA 1-hydroxylase (HPAH, E.C. 1.14.13.18) activities were identified respectively in Arthrobacter globiformis (Blakley, 1977) and in Pseudomonas acidovdrans (Hareland et al., 1975). Since then, only HPAH has been purified, by Suemori et al., (1996), but neither the protein sequence nor the nucleic acid, sequence are published. It is therefore necessary to identify the genes encoding these enzyme activities.

[0020] In the bypassing pathway, the conversion of HPP to HGA takes place via 4-HPA. Now, 4-HPA is a compound rarely identified in plants. It is present in Astilbe chinensis (Kindl, 1969), in Plantago sp. (Swiatek, 1977) in dandelion (Taraxacum officinale; Dey & Harborne, 1997), in Artemisia (Swiatek et al., 1998), in the fruit of Forsythia suspensa (Liu et al., 1998) and, finally, in the marine alga Ulva lactuca (Flodin et al., 1999). There is little data regarding origin. It appears to be able to originate from tyrosine, from shikimate, or from tyramine. There is no more information on this regarding what becomes of it or its role in plants. Kindl (1969) has shown its degradation via 3,4-dihydroxyphenylacetic acid, while Flodin et al. (1999) have demonstrated its conversion via 4-hydroxymandelic acid to 2,4,6-tribromophenol, which accumulates in the green alga Ulva lactuca. Gross (1975) suggests that 4-HPA might be a growth regulator in certain higher plants, and Abe et al. (1974) consider it to be an analog of auxin in algae.

[0021] In order to implement the pathway of metabolic bypassing of HPPD, it would have been necessary to identify and isolate beforehand the genes and the nucleic acid sequences encoding the enzyme(s) responsible for the two activities above.

DEFINITIONS ACCORDING TO THE INVENTION

[0022] “Nucleic acid sequence”: a nucleotide or polynucleotide sequence, which can be of the DNA or RNA type, preferably of the DNA type, in particular double stranded. The nucleic acid sequence may be of natural origin, in particular genomic DNA or cDNA, or else a synthetic or semisynthetic sequence, the nucleic acids comprising it having been chosen either to optimize the codons of a coding sequence as a function of the host organism in which it will be expressed, or to introduce or eliminate one or more restriction sites. Methods for preparing synthetic or semisynthetic nucleic acid sequences are well known to those skilled in the art.

[0023] “Sequence capable of selectively hybridizing”: the nucleic acid sequences which hybridize with a reference nucleic acid sequence at a level significantly greater than the background noise. The background noise may be associated with the hybridization of other DNA sequences present, in particular of other cDNAs present in a cDNA library. The level of the signal generated by the interaction between the sequence capable of selectively hybridizing and the sequences defined by the sequence IDs above according to the invention is generally 10 times, preferably 100 times, greater than that of the interaction of the other DNA sequences generating the background noise. The level of interaction can be measured, for example, by labeling the probe with radioactive elements such as ³²P. The selective hybridization is generally obtained by using very severe conditions for the medium (for example 0.03 M NaCl and 0.03 M sodium citrate at approximately 50° C.-60° C.). The hybridization can of course be carried out according to the usual methods of the state of the art (in particular Sambrook et al., 1989. Molecular Cloning: A Laboratory Manual).

[0024] “Homolog of a nucleic acid sequence”: nucleic acid sequence exhibiting one or more sequence modifications compared to a reference nucleic acid sequence. These modifications can be obtained according to the usual techniques of mutation, or else by choosing the synthetic oligonucleotides used in the preparation of said sequence by hybridization. With regard to the multiple combinations of nucleic acids which can result in the expression of the same amino acid, the differences between the reference sequence according to the invention and the corresponding homolog may be considerable. Advantageously, the degree of homology will be at least 60% compared to the reference sequence, preferably at least 70%, more preferentially at least 80%, even more preferentially at least 90%. These modifications are generally and preferably neutral, that is to say that, for a coding sequence, they do not affect the primary sequence of the protein or of the peptide encoded. They may, however, introduce nonsilent modifications, or mutations, which do not affect the function of the nucleic acid sequence compared to the reference sequence. The methods for measuring and identifying the homologies between nucleic acid sequences are well known to those skilled in the art. The PILEUP or BLAST programs (in particular Altschul et al., 1993, J. Mol. Evol. 36:290-300; Altschul et al., 1990, J. Mol. Biol. 215:403-10) can for example be used.

[0025] “Fragments”: fragment of a reference nucleic acid or polypeptide sequence for which portions have been deleted but which conserves the function of said reference sequence.

[0026] “Heterolog”: nucleic acid sequence different from the nucleic acid sequence having the same function in a natural organism. A heterologous sequence may consist of a nucleic acid sequence modified in situ in its natural environment. It may also be a nucleic acid sequence isolated from its natural organism then reintroduced into this same organism. It may also be a nucleic acid sequence which is heterologous with respect to another nucleic acid sequence, i.e. a sequence associated with another sequence, this association not occurring naturally. This is in particular the case of expression cassettes consisting of various nucleic acid sequences which are not generally associated naturally.

[0027] “Homolog of a protein sequence”: protein sequences in which the primary sequence is different from the primary sequence of the reference protein, but which performs the same function as this reference sequence. The methods for measuring and identifying homologies between polypeptides or proteins are also known to those skilled in the art. The UWGCG package and the BESTFITT program can for example be used to calculate the homologies (Deverexu et al., 1984, Nucleic Acid Res. 12, 387-395).

[0028] “Expression cassette”: nucleic acid sequence comprising various functional elements required for the expression of a coding sequence in a host organism. These functional elements comprise, in the direction of transcription, a regulatory promoter sequence, also called promoter, functionally linked to a coding sequence and a regulatory terminator sequence, also called terminator or stop. The expression cassette can also comprise, between the regulatory promoter sequence and the coding sequence, regulatory elements such as transcription activators, or enhancers, and/or introns.

[0029] “Host organism”: according to the invention this is essentially intended to mean plant cells or plants. For the cloning vectors, the host organisms can also be bacteria, fungi or yeasts.

[0030] “Plant cells”: cell which is derived from a plant and which can constitute undifferentiated tissues such as calluses, differentiated tissues such as embryos, parts of plants, plants or seeds.

[0031] “Plant”: differentiated multicellular organism capable of photosynthesis, in particular monocotyledonous or dicotyledonous, more particularly crop plants which may or may not be intended for animal or human food, such as rice, maize, wheat, barley, sugar cane, rapeseed, soybean, beetroot, potato, tobacco, cotton, clover, turf, or ornamental plants such as petunias, or else banana plants, grapevines, raspberries, strawberries, tomatoes, salad plants, etc.

[0032] “Regulatory promoter sequence”: as a regulatory promoter sequence in plants, use may be made of any regulatory promoter sequence of a gene which is naturally expressed in plants, in particular a promoter which is expressed in particular in the leaves of plants, such as, for example, “constitutive” promoters of bacterial, viral or plant origin, or else “light-dependent” promoters such as that of a gene of the plant ribulose-biscarboxylase/oxygenase (RuBisCO) small subunit, or any known suitable promoter which can be used. Among the promoters of plant origin, mention will be made of the histone promoters as described in application EP 0 507 698, or the rice actin promoter (U.S. Pat. No. 5,641,876). Among the promoters of a plant virus gene, mention will be made of that of the cauliflower mosaic virus (CAMV 19S or 35S), or of CsVMV (U.S. Pat. No. ______), or the circovirus promoter (AU 689 311). Use may also be made of a regulatory promoter sequence specific for particular regions or tissues of plants, and more particularly seed-specific promoters ([22] R. Datla et al., Biotechnology Ann. Rev. (1997) 3, 269-296), especially the promoters for napin (EP 255 378), for phaseolin, for glutenin, for heliantinin (WO 92/17580), for albumin (WO 98/45460), for oleosin (WO 98/45461), for ATS1 or for ATS3 (PCT/US98/06978, filed on October 20, 1998, incorporated herein by way of reference). Use may also be made of an inducible promoter advantageously chosen from the, promoters for phenylalanine ammonia lyase (PAL), for HMG-CoA reductase (HMG), for chitinases, for glucanases, for proteinase inhibitors (PI), for PRl family genes, for nopaline synthase (nos) or for the vspB gene (U.S. Pat. No. 5,670,349, Table 3), the. HMG2 promoter (U.S. Pat. No. 5,670,349), the apple beta-galactosidase (ABG1) promoter or the apple aminocyclopropane carboxylate synthase (ACC synthase) promoter (WO 98/45445).

[0033] “Transcription activators (enhancers)”: mention will be made, for example, of the enhancer of the tobacco mosaic virus (TMV) described in application WO 87/07644, or of the tobacco etch virus (TEV) described by Carrington & Freed.

[0034] “Introns”: untranslated nucleic acid sequences. Mention will be made, for example, of intron 1 of the Arabidopsis histone gene as described in patent application WO 97/04114 for expression in dicotyledonous plants, the rice actin first intron described in patent application WO 99/34005, or the maize adhl intron for expression in monocotyledonous plants.

[0035] “Coding sequence”: translated nucleic acid sequence. It comprises a sequence encoding a protein or a peptide of interest, optionally fused in the 5′ or in the 3′ position, with a sequence encoding a signal peptide or a peptide for addressing to a particular cellular compartment.

[0036] “Signal peptide or addressing peptide”: peptides fused to a protein or a peptide of interest in their N- or C-terminal portions, recognized by the cellular machinery for addressing of the protein or of the peptide of interest to a particular cellular compartment. They are in particular chloroplast transit peptides for addressing the protein or the peptide of interest into chloroplasts, or signal peptides to various cellular compartments, for example the vacuole, the mitochondria, the endoplastic reticulum, the golgi apparatus, etc. The role of such protein sequences is in particular described in issue 38 of the review Plant molecular Biology (1998) devoted in large part to the transport of proteins into the various compartments of the plant cell (Sorting of proteins to vacuoles in plant cells pp 127-144; the nuclear pore complex pp 145-162; protein translocation into and across the chloroplastic envelope membranes pp 91-207; multiple pathways for the targeting of thylakoid proteins in chloroplasts pp 209-221; mitochondrial protein import in plants pp 311-338).

[0037] “Chloroplast transit peptide”: the chloroplast transit peptide is encoded by a: nucleic acid sequence positioned 5′ of the nucleic acid sequence encoding a protein or a peptide of interest, so as to allow the expression of a transit peptide/protein (peptide) of interest fusion protein. The transit peptide makes it possible to address the protein or the peptide of interest into plasts, more particularly chloroplasts, the fusion protein being cleaved between the transit peptides and the protein or the peptide of interest as it passes through the plast membrane. The transit peptide may be single, such as an EPSPS transit peptide (U.S. Pat. No. 5,188,642) or a transit peptide from the ribulose-biscarboxylase/oxygenase small subunit (RuBisCO ssu) of a plant, optionally comprising some amino acids of the N-terminal portion of the mature RuBisCO ssu (EP 189 707), or else a multiple transit peptide comprising a first plant transit peptide fused to a portion of the N-terminal sequence of a mature protein located in plastids, fused to a second plant transit peptide as described in patent EP 508 909, and more particularly the optimized transit peptide comprising a transit peptide of sunflower RuBisCO ssu fused to 22 amino acids of the N-terminal end of maize RuBisCO ssu fused to the transit peptide of maize RuBisCO ssu as described with its coding sequence in patent EP 508 909.

[0038] “Signal peptide”: these peptide sequences are in particular described in issue 38 of the review Plant molecular Biology (1998) devoted in large part to the transport of proteins into the various compartments of the plant cell (Sorting of proteins to vacuoles in plant cells pp 127-144; the nuclear pore complex pp 145-162; protein translocation into and across the chloroplastic envelope membranes pp 91-207; multiple pathways for the targeting of thylakoid proteins in chloroplasts pp 209-221; mitochondrial protein import in plants pp 311-338). Peptides for addressing to the vacuole are widely described in the literature (J. M. Neuhaus and J. C. Rogers Sorting of proteins to vacuoles in plant cells Plant molecular Biology 38: 127-144, 1998). Preferably, the vacuole peptide is the vacuole peptide of the protein described in J. M. Ferullo et al. (Plant Molecular Biology 33: 625-15, 633, 1997), fused to the C-terminal portion of the protein or of the peptide of interest.

[0039] “Regulatory terminator sequence”: also comprising the polyadenylation sequences, this is intended to mean any sequence which is functional in plant cells or plants, whether of bacterial origin, such as, for example, the nos terminator of Agrobacterium tumefaciens, of viral origin, such as, for example, the CaMV 35S terminator, or else of plant origin, such as, for example, a histone terminator as described in application EP 0 633 317.

[0040] “Vector”: cloning and/or expression vector for the transformation of a host organism, containing at least one expression cassette. The vector comprises, beside the expression cassette, at least one origin of replication. The vector may consist of a plasmid, a cosmid, a bacteriophage or a virus, transformed by introducing the expression cassette. Such transformation vectors, as a function of the host organism to be transformed, are well known to those skilled in the art and widely described in the literature. For the transformation of plant cells or plants, it will in particular be a virus which can be used to transform developed plants and which also contains its own elements for replication and for expression.

[0041] Preferentially, the vector for transforming plant cells or plants is a plasmid.

[0042] HPP Oxidase

[0043] A first subject of the invention concerns a nucleic acid sequence encoding an HPP oxidase, and the corresponding polypeptide. Preferentially, the HPP oxidase is insensitive to HPPD inhibitors, in particular to isoxazoles such as isoxaflutole and their diketonitriles, in particular those defined above. The HPP oxidase is in particular an HPP oxidase of bacterial origin, for example from Arthrobacter, in particular from Arthrobacter globiformis. The HPP oxidase is advantageously a protein the primary amino acid sequence of which is represented by sequence identifier No. 2 (SEQ ID No. 2) the sequences homologous thereto and the fragments thereof.

[0044] Protein sequences of HPP oxidases homologous to SEQ ID No. 2 are in particular represented by SEQ ID Nos. 4 and 6, the sequences homologous thereto and the fragments thereof.

[0045] The HPP oxidase represented by SEQ ID No. 4 corresponds to the HPP oxidase of SEQ ID No. 2 for which a glycine is replaced with an alanine.

[0046] The present invention also relates to a nucleic acid sequence encoding an HPP oxidase as defined above.

[0047] Preferentially, the sequence encoding the HPP oxidase is a DNA sequence, especially genomic DNA or cDNA, in particular a heterologous or isolated sequence.

[0048] The sequence encoding an HPP oxidase according to the invention is in particular chosen from, the coding sequences of the DNA sequences represented by SEQ ID No. 1, 3, 5 or 15, the sequences homologous thereto, the fragments thereof, and the sequences capable of selectively hybridizing to SEQ ID 1, 3, 5 or 15.

[0049] The coding sequence of SEQ ID No. 5 comprises three mutations at positions 463, 602 and 1511 relative to SEQ ID No. 1, which are silent, i.e. which introduce no modification of the corresponding polypeptide.

[0050] 4-HPA 1-Hydroxylase

[0051] A second subject of the invention concerns the means required for the expression of 4-HPA 1-hydroxylase. Contrary to what was expected from the literature regarding the activity of certain protein extracts, it was noted that the 4-HPA 1-hydroxylase activity in the bacteria, in particular Pseudomonas, resulted from the sum of the activity of two enzymes, hereinafter referred to HPAH and HPAC.

[0052] HPAH

[0053] HPAH allows the conversion of HPA to an intermediate metabolite, hereinafter referred to as metabolite Z, the structure of which remains undetermined. It may be seriously envisaged that HPAH allows hydroxylation of the aromatic ring of HPA, the metabolite Z stabilizing in the form of a ketone. This hypothesis of enzyme activity is represented in FIG. 2.

[0054] A second subject of the invention therefore concerns a nucleic acid sequence encoding an HPAH, and the corresponding polypeptide. Preferentially, the HPAH is insensitive to HPPD inhibitors, in particular to isoxazoles such as isoxaflutole and their diketonitriles, especially those defined above. The HPAH is in particular an HPAH of bacterial origin, for example from Pseudomonas, in particular from Pseudomonas acidovorans. The HPAH is advantageously a protein the primary amino acid sequence of which is represented by sequence identifiers No. 8 and 18 (SEQ ID No. 8 and SEQ ID No. 18), the sequences homologous thereto and the fragments thereof.

[0055] The present invention also relates to a nucleic acid sequence encoding an HPAH as defined above.

[0056] Preferentially, the sequence encoding the HPAH is a DNA sequence, especially genomic DNA or cDNA, in particular a heterologous or isolated sequence.

[0057] The sequence encoding an HPAH according to the invention is in particular chosen from the coding regions of the sequences represented by SEQ ID No. 7 or 17 the sequences homologous thereto, the fragments thereof, and the sequences capable of selectively hybridizing to SEQ ID No. 7 or 17.

[0058] HPAC

[0059] HPAC is the second enzyme which allows conversion of the metabolite Z to homogentisate.

[0060] A third subject of the invention therefore concerns a nucleic acid sequence encoding an HPAC, and the corresponding polypeptide. Preferentially, the HPAC is insensitive to HPPD inhibitors, in particular to isoxazoles such as isoxaflutole and their diketonitriles, especially those defined above. The HPAH is in particular an HPAC of bacterial origin, for example from Pseudomonas, in particular from Pseudomonas acidovorans. The HPAH is advantageously a protein the primary amino acid sequence of which is represented by sequence identifier No. 10 (SEQ ID No. 10), the sequences homologous thereto and the fragments thereof.

[0061] Protein sequences of HPAC homologous to SEQ ID No. 10 are in particular represented by SEQ ID Nos. 12, 14 and 20, the sequences homologous thereto and the fragments thereof.

[0062] The present invention also relates to a nucleic acid sequence encoding an HPAC as defined above.

[0063] Preferentially, the sequence encoding the HPAC is a DNA sequence, especially genomic DNA or cDNA, in particular a heterologous or isolated sequence.

[0064] The sequence encoding an HPAC according to the invention is in particular chosen from the coding regions of the sequences represented by SEQ ID No. 9, 11, 13 or 19, the sequences homologous thereto, the fragments thereof, and the sequences capable of selectively hybridizing to SEQ ID No. 9, 11, 13 or 19.

[0065] Expression Cassettes

[0066] The present invention also relates to an expression cassette the coding sequence of which comprises a nucleic acid sequence selected from the nucleic acid sequences encoding an HGA oxidase, an HGAH or HGAC as defined above.

[0067] The coding sequence can also comprise, in the 5′ or in the 3′ position, a sequence encoding a signal peptide or a transit peptide. Advantageously, the coding sequence comprises, positioned 5′ of the sequence encoding HGA oxidase, an HGAH or an HGAC, and a sequence encoding a transit peptide for chloroplast addressing, in particular a multiple transit peptide, more particularly the optimized transit peptide.

[0068] The present invention therefore also relates to a transit peptide/HGA oxidase, transit peptide/HGAH or transit peptide/HGAC fusion protein, the sequence of the transit peptide being defined above, in particular the sequence of the optimized transit peptide as described in patent application EP 508 909.

[0069] Preferentially, the regulatory promoter sequence is chosen from the regulatory promoter sequences allowing constitutive expression of the coding sequence. These are in particular the sequences of the CaMV 35S, CsVMV, rice actin or histone promoters.

[0070] It is also possible to choose to express the coding sequences according to the invention at a level of expression close to the level of expression of the gene intended to be bypassed. Use may be made, in the expression cassette according to the invention, of a regulatory promoter sequence chosen from the regulatory promoter sequences of plant HPPDs.

[0071] For expression of the three enzymes HPP oxidase, HGAH and HGAC in the same plant, it is possible choose the expression cassettes for the corresponding coding sequences, different regulatory promoter sequences exhibiting different expression profiles, by virtue of their strength and/or their location in the various functional organs of the plant.

[0072] Regulatory promoter sequences allowing a gradient of expression HGAC>HGAH>HPP oxidase, or vice versa, may be chosen.

[0073] For expression of HPP oxidase, of the HGAH and of the HGAC, the regulatory promoter sequence is advantageously chosen from the group comprising the promoters of plant HPPD, of histone H3 or H4, especially from Arabidopsis or from maize, in particular those described in patent application EP 507 698, and of plant RuBisCO SSU, in particular from sunflower or from maize as described in patent application WO 99/25842, the CaMV 35S promoter or the CsVMV promoter, and combinations thereof, in particular the histone/35S hybrid promoters as described in the examples of patent application EP 507 698. For expression in monocotyledonous plants, these regulatory promoter sequences will advantageously be combined with the first intron of rice actin.

[0074] According to one embodiment of the invention, the expression cassette encoding an HPP oxidase comprises a histone promoter, a sequence encoding an HPP oxidase and a histone terminator (FIG. 12; SEQ ID No. 15).

[0075] According to another embodiment of the invention, the expression cassette encoding an HPAH comprises a CaMV 35S promoter, a sequence encoding an HPAH and a NOS terminator (FIG. 11; SEQ ID No. 17).

[0076] According to another embodiment of the invention, the expression cassette encoding an HPAC comprises a CsVMV promoter, a sequence encoding an HPAC and a NOS terminator (FIG. 10; SEQ ID No. 19).

[0077] Vectors:

[0078] The present invention also relates to a cloning and/or expression vector comprising at least one expression cassette according to the invention.

[0079] According to a first embodiment of the invention, the vector comprises just one of the expression cassettes according to the invention, chosen from the cassettes comprising a coding sequence for an HPP oxidase, an HGAH or an HGAC as defined above.

[0080] According to a second embodiment of the invention, the vector comprises two expression cassettes according to the invention, chosen from the cassettes comprising a coding sequence for an HPP oxidasel an HGAH or an HGAC as defined above, combined in pairs in the same vector: HPP oxidase and HGAH, HPP oxidase and HGAC, HGAH and HGAC.

[0081] A vector comprising an expression cassette encoding the HPAH and another encoding the HPAC can comprise the combination of the two expression cassettes defined above (SEQ ID No. 17 and 19). Such an expression cassette is represented in FIG. 13 and SEQ ID No. 21.

[0082] According to a third embodiment of the invention, the vector comprises three expression cassettes according to the invention, a first expression cassette for the HPP oxidase, a second expression cassette for the HGAH and a third expression cassette for the HGAC. Such an expression cassette can comprise, the combination of the three cassettes defined above (SEQ ID Nos. 15, 17 and 19). Such a vector is represented in FIG. 14 and SEQ ID No. 22.

[0083] The vectors according to the invention as defined above can also comprise expression cassettes for other proteins or peptides of interest.

[0084] When the vector comprises several expression cassettes, these cassettes can have various orientations in pairs with respect to one another, colinear, divergent or convergent.

[0085] The expression cassettes for other proteins or peptides of interest comprise a nucleic acid sequence encoding proteins or peptides of interest different than the HPP oxidase, the HGAH and the HGAC defined above.

[0086] There may be sequences of a gene encoding a selectable marker, such as a gene imparting novel agronomic properties to the transformed plant, or a gene which improves the agronomic quality of the transformed plant.

[0087] Selectable Markers

[0088] Among the genes encoding selectable markers, mention may be made of the genes for resistance to antibiotics, the genes for tolerance to herbicides, (bialaphos, glyphosate or isoxazoles), genes encoding readily identifiable reporter enzymes such as the GUS enzyme, genes encoding pigments or enzymes regulating the production of pigments in the transformed cells. Such selectable marker genes are in particular described in patent applications EP 242 236, EP 242 246, GB 2 197 653, WO 91/02071, WO 95/06128, WO 96/38567 or WO 97/04103.

[0089] Genes of Interest

[0090] Among the genes which impart novel agronomic properties to the transformed plants, mention may be made of the genes which impart tolerance to certain herbicides, those which impart resistance to certain insects, those which impart tolerance to certain diseases, etc. Such genes are in particular described in patent applications WO 91/02071 and WO 95/06128.

[0091] Herbicide Tolerance

[0092] The present invention is particularly suitable for the expression of genes which impart tolerance to certain herbicides to the transformed monocotyledonous plants and plant cells. Among the genes imparting tolerance to certain herbicides, mention may be made of the Bar gene imparting tolerance to bialaphos, the gene encoding a suitable EPSPS imparting resistance to herbicides having EPSPS as the target, such as glyphosate and its salts (U.S. Pat. No. 4,535,060, U.S. Pat. No. 4,769,061, U.S. Pat. No. 5,094,945, U.S. Pat. No. 4,940,835, U.S. Pat. No. 5,188,642, U.S. Pat. No. 4,971,908, U.S. Pat. No. 5,145,783, U.S. Pat. No. 5,310,667, U.S. Pat. No. 5,312,910, U.S. Pat. No. 5,627,061, U.S. Pat. No. 5,633,435, FR 2 736 926), the gene encoding glyphosate oxidoreductase (U.S. Pat. No. 5,463,175), or else a gene encoding an HPPD imparting tolerance to herbicides having HPPD as the target, such as isoxazoles, in particular isoxafutole (FR 95 06800, FR 95 13570), diketonitriles (EP 496 630, EP 496 631) or triketones, in particular sulcotrione (EP 625 505, EP 625 508, U.S. Pat. No. 5,506,195). Such genes encoding an HPPD imparting tolerance to herbicides having HPPD as the target are described in patent application WO 96/38567.

[0093] Among the genes encoding a suitable EPSPS imparting resistance to herbicides having EPSPS as the target, mention will be made more particularly of the gene encoding a plant EPSPS, in particular from maize, exhibiting two mutations, 102 and 106, described in patent application FR 2 736 926, referred to below as EPSPS double mutant, or else the gene encoding an EPSPS isolated from Agrobacterium described by sequence ID 2 and ID 3 of U.S. Pat. No. 5,633,435, referred to below as CP4.

[0094] Among the genes encoding an HPPD imparting tolerance to herbicides having HPPD as the target, mention will be made more particularly of the HPPD from Pseudomonas and that from Arabidopsis, described in patent application WO 96/38567.

[0095] In the cases of the genes encoding EPSPS or HPPD, and more particularly encoding the genes above, the sequence encoding these enzymes is advantageously preceded by a sequence encoding a transit peptide, in particular encoding the transit peptide termed “optimized transit peptide” described in U.S. Pat. No. 5,510,471 or 5,633,448.

[0096] Resistance to Insects

[0097] Among the proteins of interest imparting novel properties of resistance to insects, mention will be made more particularly of the Bt proteins widely described in the literature and well known to those skilled in the art. Mention will also be made of the proteins extracted from bacteria such as Photorabdus (WO 97/17432 and WO 98/08932).

[0098] Resistance to Diseases

[0099] Among the proteins or peptides of interest imparting novel properties of resistance to diseases, mention will be made in particular of chitinases, glucanases and oxalate oxidase, all these proteins and their coding sequences being widely described in the literature or else antibacterial and/or antifungal peptides, in particular cysteine-rich peptides of less than 100 amino acids, such as plant thionins or defensins, and more particularly lytic peptides of all origins comprising one or more disulfide bridges between the cysteines and regions comprising basic amino acids, in particular the following lytic peptides: androctonin (WO 97/30082 and PCT/FR98/01814, filed on Aug. 18, 1998) or drosomycin (PCT/FR98/01462, filed on Jul. 8, 1998).

[0100] According to a particular embodiment of the invention, the protein or peptide of interest is chosen from fungal elicital peptides, in particular elicitins (Kamoun et al., 1993; Panabières et al., 1995).

[0101] Modification of the Quality

[0102] Mention may also be made of the genes which modify the constitution of the modified plants, in particular the content and the quality of certain essential fatty acids (EP 666 918) or else the content and the quality of the proteins, in particular in the leaves and/or the seeds of said plants. Mention will in particular be made of the genes encoding proteins enriched in sulfur-containing amino acids (A. A. Korit et al., Eur. J. Biochem. (1991) 195, 329-334; WO 98/20133; WO 97/41239; WO 95/31554; WO 94/20828; WO 92/14822). These proteins enriched in sulfur-containing amino acids will also have the function of trapping and storing excess cysteine and/or methionine, making it possible to avoid possible problems of toxicity associated with overproduction of these sulfur-containing amino acids by trapping them. Mention may also be made of genes encoding peptides rich in sulfur-containing amino acids, and more particularly in cysteines, said peptides also having an antibacterial and/or antifungal activity. Mention will more particularly be made of plant defensins, along with lytic peptides of any origin, and more particularly the following lytic peptides: androctonin (WO 97/30082 and PCT/FR98/01814, filed on Aug. 18, 1998) or drosomycin (PCT/FR98/01462, filed on Jul. 8, 1998).

[0103] Plant Cells and Transgenic Plants

[0104] The present invention also relates to transformed plant cells and plants comprising at least one expression cassette for an HPP oxidase, for an HGAH or for an HGAC as defined above.

[0105] According to a first embodiment of the invention, the plant cells or the plants comprise just one of the expression cassettes according to the invention, chosen from the cassettes comprising a coding sequence for an HPP oxidase, an HGAH or an HGAC as defined above.

[0106] According to a second embodiment of the invention, the plant cells or the plants comprise two expression cassettes according to the invention, chosen from the cassettes comprising a coding sequence for an HPP oxidase, an HGAH or an HGAC as defined above, combined in pairs in the same vector: HPP oxidase and HGAH, HPP oxidase and HGAC, HGAH and HGAC.

[0107] According to a third embodiment of the invention, the plant cells or the plants comprise three expression cassettes according to the invention, a first expression cassette for HPP oxidase, a second expression cassette for. HGAH and a third expression cassette for HGAC.

[0108] The plant cells or the plants according to the invention as defined above can also comprise expression cassettes for other proteins or peptides of interest defined above.

[0109] Preferentially, the expression cassettes are stably integrated into the genome of the plant cells or of the plants. More preferentially, the plants according to the invention are fertile, the expression cassettes according to the invention being transferred to their descendance.

[0110] The present invention also relates to seeds of transgenic plants above, which seeds comprise an expression cassette according to the invention encoding an HPP oxidase, an HGAH or an HGAC.

[0111] The various expression cassettes in the transformed plants according to the invention can originate either from the same transformed parent plant, and in this case, the plant is derived from a single process of transformation/regeneration with the various expression cassettes contained in the same vector or by cotransformation using several vectors. It may also be obtained by crossing parent plants each containing at least one expression cassette according to the invention.

[0112] Transformation of the Plant Cells and of the Plants

[0113] A subject of the invention is also a method of transforming the plant cells and the plants by introducing at least one nucleic acid sequence or an expression cassette according to the invention as defined above, which transformation can be obtained by any suitable known means, widely described in the specialized literature and in particular the references cited in the present application, more particularly with the vector according to the invention.

[0114] A series of methods consists in bombarding cells, protoplasts or tissues with particles to which the DNA sequences are attached. Another series of methods consists in using, as means for transfer into the plant, a chimeric gene inserted into an Agrobacterium tumefaciens Ti plasmid or an Agrobacterium rhizogenes Ri plasmid. Other methods can be used, such as microinjection or electroporation, or else direct precipitation using PEG. Those skilled in the art will choose the appropriate method as a function of the nature of the host organism, in particular of the plant cell or of the plant.

[0115] When the desire is to introduce several nucleic acid sequences or expression cassettes, it can be done using a single vector according to the invention comprising the various expression cassettes. They may also be introduced into the host organism by cotransformation using several vectors, each one comprising at least one expression cassette.

[0116] In general, the transgenic plants according to the invention are obtained by transformation of plant cells and then regeneration of a plant, preferably fertile, from the transformed cell. The regeneration is obtained by any suitable method, which depends on the nature of the species, such as for example described in the references above. For the methods of transforming the plant cells and of regenerating the plants, mention will in particular be made of the following patents and patent applications: U.S. Pat. No. 4,459,355, U.S. Pat. No. 4,536,475, U.S. Pat. No. 5,464,763, U.S. Pat. No. 5,177,010, U.S. Pat. No. 5,187,073, EP 267,159, EP 604 662, EP 672 752, U.S. Pat. No. 4,945,050, U.S. Pat. No. 5,036,006, U.S. Pat. No. 5,100,792, U.S. Pat. No. 5,371,014, U.S. Pat. No. 5,478,744, U.S. Pat. No. 5,179,022, U.S. Pat. No. 5,565,346, U.S. Pat. No. 5,484,956, U.S. Pat. No. 5,508,468, U.S. Pat. No. 5,538,877, U.S. Pat. No. 5,554,798, U.S. Pat. No. 5,489,520, U.S. Pat. No. 5,510,318, U.S. Pat. No. 5,204,253, U.S. Pat. No. 5,405,765, EP 442 174, EP 486 233, EP 486 234, EP 539 563, EP 674 725, WO 91/02071 and WO 95/06128.

[0117] Selective Weeding

[0118] A subject of the invention is also a method for selective weeding of plants, in particular crops, using an HPPD inhibitor, in particular a herbicide defined above, characterized in that this herbicide is applied to transformed plants according to the invention, equally in pre-sowing, in pre-emergence and in post-emergence of the crop.

[0119] The present invention also relates to a method of weed killing in an area of a field comprising seeds or transformed plants according to the invention, which method comprises the application, in said area of the field, of a dose, which is toxic for said weeds, of an HPPD-inhibiting herbicide, without however substantially affecting the seeds or transformed plants according to the invention.

[0120] The present invention also relates to a method of growing the transformed plants according to the invention, which method comprises sowing the seeds of said transformed plants in an area of a field suitable for growing said plants, applying to said area of said field a dose, which is toxic for the weeds, of a herbicide having HPPD as the target, defined above, in the event of weeds being present, without substantially affecting said seeds or said transformed plants, then harvesting the plants grown, when they have reached the desired maturity and, optionally, separating the seeds from the harvested plants.

[0121] According to the invention, the expression “without substantially affecting said seeds or said transformed plants” is intended to mean that the transformed plants according to the invention, subjected to application of a dose of herbicide which is toxic for the weeds, exhibit slight or zero phytotoxicity. According to the invention, the expression “dose which is toxic for the weeds” is intended to mean an applied dose of the herbicide for which the weeds are killed. According to the invention, the, term “slight phytotoxicity” is intended to mean a percentage of bleached leaves of less than 25%, preferentially less than 10%, more preferentially less than 5%. It is also understood according to the present invention that application of the same toxic dose to a plant which is otherwise comparable but not transformed, i.e. which does not comprise at least one expression cassette according to the invention, would lead to the observation on said plant of phytoxicity symptoms greater than those observed for the transformed plant according to the invention.

[0122] In the two methods above, the application of the herbicide having HPPD as the target can be carried out according to the invention, equally in pre-sowing, in pre-emergence and in post-emergence of the crop.

[0123] For the purpose of the present invention, the term “herbicide” is intended to mean a herbicidal active material alone or combined with an additive which modifies its effectiveness, such as, for example, an agent which increases the activity (synergist) or which limits the activity (safener). The HPPD-inhibiting herbicides are in particular defined previously. Of course, for their practical application, the herbicides above are combined, in a manner known per se, with the adjuvants of formulations conventionally used in agrochemistry.

[0124] When the transformed plant according to the invention comprises another gene for tolerance to another herbicide (such as, for example, a gene encoding an EPSPS, which may or may not be mutated, imparting to the plant tolerance to glyphosate), or when the transformed plant is naturally insensitive to another herbicide, the method according to the invention may comprise the simultaneous application or the application at a different time of an HPPD inhibitor in combination with said herbicide, for example glyphosate.

[0125] The various aspects of the invention will be understood more clearly through the experimental examples below.

[0126] All the methods or operations described below in these examples are given by way of examples and correspond to a choice, made from the various methods available to achieve the same result. This choice has no bearing on the quality of the result and, consequently, any suitable method can be used by those skilled in the art to achieve the same result. Most of the methods for engineering DNA fragments are described in Coligan et al., (1995), Ausubel et al., (1995); Maniatis et al., (1982) and Sambrook et al.

[0127] The bibliographical references cited above are integrated into the present patent application by way of reference, in particular the bibliographical references defining the nucleic acid sequences encoding native, chimeric or mutated HPPDs, optionally combined with a signal peptide or a transit peptide.

EXAMPLE I Identification of the Gene Encoding the HPP Oxidase from Artbrobacter globxformzs

[0128] HPP oxidase (HPPO) converts HPP to 4-HPA via a decarboxylation reaction. This enzyme therefore catalyzes the first enzyme activity required to construct the metabolic pathway bypassing HPPD. HPP oxidase activity has been characterized in crude extracts of Rhodococcus erythropolis S1 (Suemori et al., 1995) or in a partially purified extract of Arthrobacter globiformis (Blakley, 1977). To our knowledge, the protein has not been purified. In order to be able to introduce this enzyme activity into the plant, it is necessary to identify the gene thereof. Various approaches can be envisaged: (1) insertional mutagenesis and therefore identification of the gene through the loss of the enzyme activity, (2) functional complementation of a microorganism using a genomic library, (3) purification of the protein in order to work back to the nucleic acid sequence.

[0129] The three approaches were used. The functional complementation and the insertional mutagenesis will be developed relatively little, since these techniques do not make it possible to identify the HPPO gene.

[0130] I.1 Materials and Methods

[0131] I.1.1—Culturing Conditions

[0132] I.1.1.1—Rich Media

[0133] Luria-Bertani (LB; sold by Bio101) medium is used to culture the bacteria (E. coli, P. fluorescens) in the molecular biology experiments. For culturing A. globiformis Columbia-ANC medium enriched with 5% of sheep blood (BioMèrieux) will be preferred. This rich medium contains two antibiotics (nalidixic acid and colimycin) which inhibit Gram-negative microorganisms. Although the three bacteria grow on rich medium at 37° C., A. globiformis and P. fluorescens are generally cultured at 29° C.

[0134] I1.1.2—M^(Ag) Culture Medium

[0135] The culture medium described by Blakley (1977) precipitates, and it is therefore necessary to filter it before use. We gradually changed the medium in order to achieve an optimal “minimal” medium. The factors considered are the growth rate of A. globiformis and the enzyme activity of HPPO. The medium selected (MAg) is an M9 medium (Maniatis et al., 1982) which is slightly modified: Na₂HPO₄, 12H₂O (6 g/L); KH₂PO₄ (3 g/L); NH₄Cl (1 g/L); NaCl (0.5 g/L); CaCl₂ (6 mg/L); FeSO₄ 7H₂O (6 mg/L); yeast extract (20 mg/L); and, finally, the substrate (HPP or tyrosine or citrate) at a concentration of 1 g/L. The medium is autoclaved. Before use, 1 mL of sterile 1 M MgSO₄ is added per liter of medium.

[0136] This minimum medium is also used to culture P. fluorescens

[0137] I.1.2—Construction of an Arthzrobacter globifoxmis Genomic Library

[0138] There is no reliable technique for making a complete bacterial cDNA library. We therefore decided to create an Arthrobacter globiformis genomic library. To produce this, we chose the cosmid system. The cosmid library was prepared for the functional complementation experiments and was then used later to search for the cosmid(s) containing the hppO gene.

[0139] I.1.2.1—The Cosmid Vector pLAFR5

[0140] I.1.2.1.1—Description of the Vector

[0141] We choose the conjugated cosmid vector pLAFR-5 (Keen et al., 1988) which can accept an insert of approximately 20 kb. Equipped with an origin of transfer and an origin of replication with a broad Gram-negative-host spectrum, it can be transmitted to other bacterial genera by tri-parenteral conjugation, which can be useful for testing functional complementation in various bacterial genera. It imparts resistance to tetracycline.

[0142] I.1.2.1.2—Preparation of the Vector

[0143] The plasmid pLAFR-5 is purified using an alkaline lysis protocol (Maniatis et al., 1982), treated with RNAse and then digested with Bam HI and Sca I. The digestion with Bam HI makes it possible to open the site into which the inserts of genomic DNA digested with Sau3A will be “ligated”. The digestion with Sca I makes it possible to release the cos sites which allow the encapsidation. After extraction with phenol then chloroform, the DNA is precipitated with ethanol. The dry DNA is dissolved in water. The vector thus prepared is stored at −20° C.

[0144] I.1.2.1—Preparation of the A. globiformis genomic DNA A 24-hour culture (200 mL, 180 rpm, 0.29° C.) prepared in the medium (200 mL) described by Blakley (1977) is centrifuged at 3000 g at 4° C. for 15 minutes. The cell pellet, taken up with 10 mL of lysis solution (TE pH 8; 0.5% SDS; 1 mg proteinase K), is incubated at 37° C. in a waterbath with gentle agitation every 20 minutes. After 90 minutes, the suspension of lysed cells is poured into a polypropylene JA-20 tube. 10 mL of phenol/chloroform/isoamyl alcohol (25/24/1) are then added, followed by centrifugation at 6000 g for 15 minutes at 4° C. The supernatant is then transferred into a new JA20 tube, to which 1.8 mL of 10 M ammonium acetate and 10 mL of isopropanol are added. After centrifugation at 20 000 g for 20 minutes at 4° C., the pellet is rinsed with 70% ethanol. The dry pellet is taken up with 1 mL of TE, pH 8, and then transferred into a 2 mL Eppendorf tube to which 10 ?L of RNAse (10 mg.mL⁻¹) are added. After 30 min at 37° C., 800 ?L of phenol/chloroform/isoamyl alcohol are added. After centrifugation, the supernatant is transferred to a-new Eppendorf tube and extracted with 0.8 mL of chloroform. The supernatant is then transferred into a final Eppendorf tube, to which 200 ?L of 10 M ammonium acetate and 800 ?L of isopropanol are added. After centrifugation, the pellet is rinsed with 70% ethanol and then, once dry, taken up in 500 ?L of water. The genomic DNA is then stored at −20° C.

[0145] I.1.2.3—Controlled Digestion of the A. globiformis Genomic. DNA

[0146] Only cosmids of 40-45 kb can be encapsidated. Since the vector is 21.5 kb, the inserts of A. globiformis genomic DNA should be between 19 and 22 kb in size. These fragments are obtained by performing a controlled digestion of the Arthrobacter globiformis genomic DNA. In order to define the optimal conditions for the controlled digestion, digestion of the A. globiformis genomic DNA are carried out with varying amounts of Sau 3A restriction enzyme. It, appears that the best digestion condition uses 0.08, Sau 3A enzyme units for 30 minutes at 37° C. The genomic DNA thus digested is between 15 and 22 kb in size. The genomic DNA thus digested is extracted with phenol, then with chloroform and, finally, precipitated with ethanol.

[0147] I.1.2.4—Ligation of A. globiformis Genomic DNA into the Cosmid Vector

[0148] The ligation reaction is carried out in a final volume of 10 ?L, containing 500 ng of pLAFR-5 digested with Bam HI and Sca I, 650 ng of genomic DNA digested with Sau 3A, 320 units of T₄ DNA ligase (N.E.B.) and 5 mM of ATP. The ligation takes place at 12° C. overnight (approximately 16 hours). The 5 mM of ATP makes it possible to avoid ligations between blunt ends (Sca I) (Feretti & Sgaramella, 1981) such that the dimers of vectors having no insert cannot become encapsidated in the head of the ? phages.

[0149] I.1.2.5—Encapsidation of the Cosmids and Amplification of the Cosmid Library

[0150] The encapsidation of the cosmids, carried out using the GIGAPACK II XL kit (Stratagene) respecting the supplier's instructions, provides an efficiency of transfection greater than those obtained with conventional transformation techniques. To amplify the cosmid library, Keen et al. (1988) advise using Escherichia coli DH-1 and HB101. Specifically, when the strains are cultured on maltose, they produce a membrane-bound protein which enables better attachment of the phage and therefore more efficient transfection of the cosmids. The library, amplified according to Stratagene's recommendations, is stored at −80° C. To evaluate the cosmid library, the plasmid DNA isolated from about thirty clones is digested with Apa I or Eco RI. The restriction profiles are reserved on a 0.8% agarose gel.

[0151] I.1.3—Purification of the HPP Oxidase

[0152] I.1.3.1—Colorimetric Assay for the HPP Oxidase Activity

[0153] In order to be able to control the purification steps, the. HPP oxidase activity is followed using the colorimetric assay described by Blakley (1977). The enzyme reaction is stopped by adding 2,4-dinitrophenylhydrazine (2,4-DNPH), in solution in 2 M HCl. The 2,4-DNPH reacts with the ketone function in the alpha position of a carboxylic function (example: HPP). A hydrazone thus forms, which can be revealed by basifying the medium. When the HPP is completely converted to 4-HPA during the enzyme reaction, the hydrazone cannot form, and the characteristic yellow color of *2,4-DHPA is therefore obtained in basic medium. If the HPP is not completely converted to 4-HPA during the enzyme reaction, the formation of hydrazone is possible. These hydrazones are brown in color in basic medium. A variation in color between these two extremes is obtained as a function of the amount of HPP consumed. The absorption measurements are carried out at 445 or. 450 nm. In order to make this assay more easy to handle, we adapted it to the 96-well microplate format. The reaction mixture comprises GSH (900 ?M); HPP (0.135 ?M); TPP (1.8 mM); MgCl₂ (4.5 mM); FAD (4 ?M.); potassium phosphate buffer (90 mM) pH 7.4. The mixture is kept on ice. 50 ?L of the test fraction and 150 ?L of reaction mixture are placed in each well. After 20 min at 30° C., the enzyme reaction is stopped with 13 ?L of 2,4-DNPH solution (0.1% in 2 M HCl). The mixture is left to react for 20 min at ambient temperature. The formation of hydrazone is revealed by adding 13 ?L of 10 M NaOH solution. To prepare the standard range, reaction mixtures with varying concentrations of HPP are prepared. The 50 ?L protein fractions are replaced with 50 ?L of protein extraction buffer. The standard curve is produced for each new solution of 2,4-DNPH (the 2,4-DNPH solution is stable for 6 months in the dark). The advantage of this assay is its rapidity and simplicity, but it has the defect of measuring the disappearance of substrate and not the appearance of product. In addition, the possibility of having false positives exists: a tyrosine amino transferase activity will give the same result as the, HPPO activity. Specifically, in both cases, the ketone function has disappeared. We therefore developed a rapid and sensitive HPLC method which makes it possible to confirm the production of 4-HPA.

[0154] I.1.3.2—Activity Assay Analyzed by HPLC

[0155] An HPLC method was developed using a small Spherisorb ODS2 column, 50 ? 4.6 mm and particle size 3 ?m. The chromatography is carried out under isocratic conditions A: 90%; B: 10% (where buffer A: H₂O, 0.1% TFA and buffer B: acetonitrile), flow rate 0.8 mL.min⁻¹ and the elution is followed at 230 nm. Under these conditions, it is possible to separate the 4-HPA, HGA, 3,4-DHPA and HPP in 5 minutes after injection. The column was custom made by Merck.

[0156] I.1.3.3—Purification of the Protein

[0157] The interests of simplicity were sought during the setting up of this protocol.

[0158] I.1.3.3.1—Preliminary Assays

[0159] The aim of the preliminary assays is to determine the influence of compounds (NaCl, KCl, 1-propanol, ethylene glycol, etc.) and of the pH on the enzyme activity. The reactions are carried out with crude extracts of A. globiformis cultured on M^(Ag) medium containing tyrosine as the only carbon source (M^(Ag)-tyrosine). The test compound is added to the reaction medium. To measure the influence of pH on the enzyme activity of HPPO, various phosphate buffers are prepared.

[0160] I.1.3.3.2—Purification Protocol

[0161] The Arthrobacter globiformis strain is plated out on LB agar medium or on Columbia-ANC agar medium. After culturing for 16 hours at 29° C., a colony is removed and seeded in 5 mL of LB medium, under growth conditions for 8 hours at 29° C., 180 rpm. 50 ?L of this preculture are then inoculated into 1.5 L of M^(Ag)-tyrosine or M^(Ag)-HPP medium, and the culturing is then carried out at 29° C., 180 rpm in Erlenmeyer flasks with thin rods (Belco). After culturing for 48 hours, the cells are collected by centrifugation at 5000 g for 15 minutes at 4° C. The cells are then resuspended in 50 mM Tris-HCl buffer, pH 7.4, and then centrifuged as previously. The pellet is taken up in 2 mL of 50 mM Tris-HCl buffer, pH 7.4. The cells are sonicated (Vibra Cell, Sonic Materials INC., Connecticut, USA) for 15 minutes, power 4, 30% pulse, in melting ice. The insoluble debris are eliminated by centrifugation for 25 min at 20 000 g, 0.4° C. The supernatant is recovered; it constitutes the “crude extract”. It can be frozen in liquid nitrogen and then stored at −80° C. (for 6 months without apparent loss of activity). The crude extract is loaded, without prior desalting, onto an “EMD/DEAE 650 S” weak anion exchange column (Merck) equilibrated in 50 mM phosphate buffer, pH 7.4. Elution of the enzyme activity is obtained by applying an NaCl concentration gradient (in solution in a 50 mM phosphate buffer, pH 7.4). The fractions containing the enzyme activity are pooled. The protein solution obtained is diluted 2.7-fold with 50 mM phosphate buffer, pH 7.4. The proteins are then loaded onto a “source Q” strong anion exchange column (XK16, Pharmacia) (30 mL, Pharmacia) pre-equilibrated with a 50 mM phosphate buffer, pH 7.4. The protein fractions of value, identified by the enzyme activity, are pooled and then concentrated through UVIKON 10 kDa membrane. The resulting protein extract is then desalted by the gel filtration technique using a “PD10” column (Pharmacia) equilibrated in 10 mM phosphate buffer pH 7.4, and eluted with this same buffer. The proteins are then loaded onto a hydroxyapatite column (XK9/15, Pharmacia) (2 mL; hydroxyapatite DNA grade Bio-Gel^(?) HTP gel; Bio-Rad) equilibrated with 10 mM phosphate buffer, pH 7.4. The enzyme activity is eluted by applying a phosphate gradient. The fractions containing the enzyme activity are pooled and concentrated. The active proteins are conserved when the protein concentration is greater than 1 mg/mL by adding FAD, GSH and glycerol in order to obtain the following final concentrations: 27 ?M FAD, 110 ?M GSH, 0.8% glycerol. The proteins thus prepared can be frozen at −80° C. for at least 6 months.

[0162] I.1.3.3.3—Assaying of Proteins

[0163] The proteins are assayed according to the Bradford method (1976) using ?-globulin for the standard.

[0164] I.1.3.3.4—Staining of Protein Gels

[0165] The protein fractions are analyzed on 10% polyacrylamide gel according to the Laemmli method (1970). After migration, the proteins in the gel are stained either using the Coomassie Blue method (Chua, 1980) or using the silver nitrate method (Schoenle et al., 1984).

[0166] I.1.4—Protein Microsequencing of the N-Terminal End and of Internal Peptides

[0167] The microsequencing of the protein is carried out using the Edman method (Laursen, 1971). To obtain the best results in the sequencing, the gel is prepared on the same day.

[0168] I.1.4.1—Preparation of the Acrylamide Gel and Electrophoresis Thereof.

[0169] The gels (8.5%, 10% or 12%) are prepared according to the Laemmli method (1970) using the Hoefer^(?) minigel system. The proteins are diluted to one third with a “denaturing loading blue” solution (150 mM Tris-HCl, pH 6.8; 4% SDS; 2% (v/v) ?-mercaptoethanol; 3.3% (v/v) glycerol; 0.03% bromophenol blue; qs 10 mL of milliQ water). After having been boiled for 5 minutes, the proteins are loaded onto the acrylamide gel. The migration is carried out at ambient temperature using a denaturing migration buffer (25 mM Tris base; 250 mM glycine; 0.014% (v/v) ?-mercaptoethanol; 0.1% SDS) and applying a strength of 15 mA per gel.

[0170] I.1.4.2—Preparations for the Sequencing of the N-Terminal End

[0171] In order to be able to carry out the sequencing of the N-terminal end, the gel is transferred onto a PVDF membrane (PROBLOTT^(?)—Applied Biosystems) using the semi-dry transfer technique. The electrotransfer of the polypeptides is carried out in 30 minutes at 300 mA with the “Semy Dry Electroblotter” device (Bio-Rad) and in a CAPS-based medium (transfer buffer: 10 mM CAPS, pH 11.0; 10% (v/v) methanol). The transfer buffer contains no glycine which would risk “polluting” the sequencing. After the transfer, the membrane is rinsed for a few seconds with milliQ water. It is then immersed for a few seconds in a staining solution based on amido-black (Aldrich; ref.: 19.524-3). The solution consists of 45% (v/v) methanol, 1% (v/v)-acetic acid, 0.1% (m/v) amido-black and 63.9% (v/v) water. When the band corresponding to the protein of interest is visible, the membrane is thoroughly rinsed with milliQ water and is then air-dried. The part of the membrane containing the protein of interest (60 kDa) is cut out and sent for sequencing.

[0172] I.1.4.3—Preparations in View of Sequencing the Internal Peptides

[0173] In order to visualize the proteins in the gel, an amido-black staining protocol is used which is slightly different from that used to stain the PVDF membrane. After migration, the gel is fixed for two times thirty minutes with a solution consisting of 50% methanol, 10% acetic acid, 40% milliQ water. The staining is carried out with a solution containing 45% methanol, 10% acetic acid, 45% water and 0.003% (w/v) amido-black. The proteins appear gradually. When the staining is sufficient to locate the protein, the gel is thoroughly rinsed with milliQ water. The band of interest is cut out and then dehydrated in a speed-vac (Savant). The gel band, having lost approximately a third of its length, is sent for sequencing. The internal peptides are obtained after digestion with the protein with Lys-C endoprotease (sequencing grade, Boehringer). The protein in the polyacrylamide gel is digested in 150 ?L of Tris-HCl buffer, pH 8.6 (0.1 M), containing 0.03% of sbs, at 35° C. for 18 hours in the presence of 0.4 ?g of Lys-C endoprotease. The digested protein is injected onto a DEAE-C18 HPLC column (diameter 1 mm); the peptides are eluted using a gradient of acetonitrile (from 2 to 75%) containing 0.1% TFA. The Lys-C endoprotease specifically cleaves the polypeptides on the carboxylic side of the lysines.

[0174] I.1.5.1—Theoretical Validation Using the Arthrobacter globiformis MndD Gene

[0175] A portion (867 bp) of the MndD gene is amplified by PCR using the primers “OZ-MndD-S711”: ACGTCACCGA AGAGGATGAA AAC and “OZ-MndD-AS1578”: ACGGCCATTT CGGACTTTTC. The PCR is carried out using the following program: 95° C. 5 min; 25 cycles: 95° C. 45 sec, 56° C. 45 sec; 72° C. 1 min; 72° C. 5 min; 4° C. on hold. The reaction mixture comprises 200 to 500 ?M of dNTP, 20 to 200 ng of cosmid or genomic DNA and 100 pmol of each primer in a final volume of 50 ?L.

[0176] I.1.5.2—Identification by PCR of a Portion of the Gene Encoding the HPP Oxidase

[0177] The PCR is carried out using the “Advantage^(?)-GC Genomic PCR” kit, (Clontech). This kit comprises, inter alia, a “GC melt” betaine-based adjuvant and a mixture of thermoresistant polymerases—mainly with Thermus thermophilus (Tth)−. The amplification is carried out on the Arthrobacter globiformis genomic DNA, using the following program: 94° C. 5 min; 30 cycles: 94° C. 20 sec, 60° C. 30 sec, 72° C. 3 min; 72° C. 6 min; 4° C. on hold. The reaction conditions are 400 ?M of dNTP, 50 ng of genomic DNA, 100 pmol of each primer and 1× “GC melt”, for a reaction volume of 50 ?L. Under these conditions, we amplify a band of 937 bp which we refer to as Z2.

[0178] The PCR amplification can also be carried out using Epicentre Tth or Tbr (Thermus brockianus—Finnzyme). Tbr is the only thermoresistant polymerase tested to be able to carry out the PCR without additives (DMSO, glycerol, betaine); it is also a high-fidelity enzyme.

[0179] I.1.6—Screening of the Cosmid Library

[0180] The cosmid library is screened using the digoxigenin-labeled cold probe technique (Boehringer Mannheim, 1995).

[0181] I.1.6.1—Preparation of the Z2-Dig Probe

[0182] The probe is labeled with digoxigenin by PCR in a final volume of 50 ?L, under the conditions defined in paragraph II.5.2, except for the mixture of dNTP consisting of: 90 ?M dUTP-Dig; 135 ?M dTTP; 225 ?M dATP; 225 ?M dCTP; 225 ?M dGTP. The amplified probe is quantified by loading 3 ?L of the reaction onto a 0.8% agarose gel. A slight background noise appears, i.e. the PCR is not sufficiently specific. In order to avoid all subsequent problems, the entire PCR is loaded onto a gel and the band of interest is extracted using the Qiaex II kit (Qiagen).

[0183] I.1.6.2 Transfer of the Cosmid Library onto Hybond N Membrane

[0184] The glycerol stock of the cosmid library prepared in E. coli HB101 is used to inoculate 2 mL of LBT¹⁵ medium. After growth for 8 hours, the OD₆₀₀ is estimated; sera dilutions are prepared in order to plate out approximately 1000 clones per dish (144 cm²). After growth for 16 hours at 37° C., the bacteria are transferred to Hybond N membranes (Amersham) and lysed according to Boehringer Mannheim's recommendations (1995). The DNA released is fixed to the membrane by exposure to U.V. (120 mJ delivered in 45 sec—Stratalinker; Stratagene). The cell debris are removed from the membranes by carrying out the proteinase K treatment as recommended by Boehringer Mannheim (1995).

[0185] I.1.6.3—Prehybridization—Hybridization—Detection

[0186] The steps of prehybridization and hybridization are carried out in a bag placed on a rocking platform, using the technique of hybridization with the digoxigenin-labeled probe (Boehringer Mannheim, 1995). The prehybridization (5 ? SSC; 0.5% SDS; 0.1% N-laurylsarcosine; 1% blocking agents (Boehringer Mannheim, ref.: 1096 176); 100 ?g.mL⁻¹ sonicated and denatured salmon sperm) is carried out for 0.4 hours at 65° C. Hybridization of the membrane is carried out overnight at 68° C. (fresh prehybridization medium containing 20 ng.mL⁻¹ of digoxigenin-labeled probe denatured for 5 min at 100° C.). The following day, the excess probe and the aspecific hybridizations are removed with four washes with buffer A (0.5 ? SSC; 0.1% SDS, 65° C.). The membranes are then equilibrated for 5 min at ambient temperature in buffer B (138 mM malic acid, 142 mM NaCl, adjusted to pH 7.5 with sodium hydroxide pellets, 0.3% tween 20). They are then saturated with blocking agents (Boehringer Mannheim) for 30 minutes, before being hybridized with the alkaline phosphatase-coupled anti-digoxigenin antibody (“anti-digoxigenin-AP, Fab fragments”; Boehringer Mannheim) diluted to {fraction (1/10000)} in a fresh solution of blocking agents. After 30 minutes the membranes are rinsed for two times 15 minutes in buffer B, and then equilibrated for 5 minutes in the alkaline phosphatase reaction buffer (0.1 M Tris; 0.1 M NaCl; 0.05 M MgCl₂, pH 9.5). The membranes are covered with 1 ml of ready-to-use CSPD and are then incubated for 15 min at 37° C. This step at 37° C. allows rapid activation of the alkaline phosphatase coupled to the antibody. The membranes are developed by exposing Hyperfilm^(?) ECL (Amersham) for 1 to 15 minutes.

[0187] I.1.6.4—Analysis of the Positive Cosmids by Southern and PCR

[0188] The cosmids identified in the hybridization on membrane are confirmed by PCR and by the Southern technique. In this case, the cosmid DNA, purified by alkaline lysis (Maniatis et al., 1982), is digested with restriction enzymes and then separated on a 0.8% agarose gel. The gels are transferred onto Hybond N+membrane (Amersham) by the Southern technique in 20 ? SSC (Ausubel et al., 1995). After transfer, the membrane is rinsed with 2 ? SSC and the DNA is then fixed to the membrane using U.V. (120 mJ delivered in 45 sec—Stratalinker; Stratagene). The membrane is then developed using the cold probe technique previously described.

[0189] I.1.7—Cloning Vectors and Host Bacteria

[0190] The PCR-amplified DNA sequences are generally cloned into the plasmid p-GEMT-easy (Promèga), which allows screening using the “blue-white” technique. For overexpression, the plasmid pKK223-3 (Pharmacia) is used, which places the gene under the control of a tac promoter. The clonings are generally carried out using E. coli DH5? (New England Biolabs) or E. coli XL1 Blue (Stratagene). For overexpression, E. coli BL21 (DE3) will be preferred.

[0191] I.1.8—Enzyme Activity of Acetolactate Synthase (ALS)

[0192] The acetolactate synthase (ALS) activity is measured using the colorimetric method described by Chang and Duggleby (1997). The reactions are carried out in microplates with a total volume of 250 ?L. For each reaction, 25 ?L of enzyme are incubated for 30 min at 37° C. in 225 ?L of reaction medium consisting of 50 mM KPi, pH 7.0; 50 mM sodium pyruvate; 1 mM TPP; 10 mM MgCl₂; 10 ?M FAD. The reaction is stopped by adding 25 ?L of 10% H₂SO₄. The microplates are then incubated at 60° C. for 15 min. 250 ?L of 0.5% creatine and 250 ?L of 5% ?-naphthol in 4M NaOH (the ?-naphthol solution should be prepared less than 10 min before use) are then added. The microplate is then incubated for 15 minutes at 60° C. and then 15 minutes at ambient temperature. A cherry red color appears. The reading is carried out at 525 nm (?M=22 700 M cm.).

[0193] I.2—Results—Discussion

[0194] HPP oxidase is the first enzyme activity which we wish to introduce into the plant in the context of creating the metabolic pathway bypassing HPPD. In order to be able to identify the gene encoding the HPP oxidase activity, various approaches were developed: (1) insertional mutagenesis and therefore identification of the gene through the loss of the enzyme activity, (2) functional complementation of a microorganism using a genomic library, (3) purification of the protein in order to work back to the nucleic acid sequence. It is the third approach which was preferred.

[0195] I.2.1—Purification of the HPPO

[0196] I.2.1.1—Optimization of the Culture Conditions

[0197] Before beginning to purify the protein, it is useful to determine which culture conditions allow its expression in the bacterium. The results of optimization of the culture conditions show that the HPP oxidase activity is not detectable when the growth of A. globiformis depends on a carbon source such as succinate, fumarate or glucose. On the other hand, the HPP oxidase activity is detected when A. globiformis is cultured using HPP, tyrosine or phenylalanine as the only carbon source. If the amount of yeast extract is increased (for example 200 mg.L⁻¹ instead of 20 mg.L⁻¹), a decrease in the enzyme activity produced is observed. The M^(Ag) medium is defined on the basis of these observations. Finally, it is observed that a high-density culture (at the beginning of the stationary phase; OD₆₀₀˜1) exhibits a weaker HPP oxidase enzyme activity than in the case of a culture in the exponential growth phase (OD₆₀₀˜0.4).

[0198] I.2.1.2—Preliminary Assays

[0199] We have just defined the optimal medium for the production of the HPPO, we now search for the conditions which do not impair the stability of the HPP oxidase during the purification processes. For the chromatographies involving anion exchange resins and the chromatographies as a function of pH, it is important to know the sensitivity of the enzyme to pH and to salts. We observe that the optimum pH is between pH 7.0 and 7.8, as has been demonstrated by Blakley (1977). The enzyme appears to be relatively insensitive to salts (NaCl and KCl) since concentrations of greater than 750 mM are necessary to observe a decrease in enzyme activity. We now know the conditions for good expression of the enzyme activity and we have determined the sensitivity of the HPP oxidase activity to factors possibly intervening during the purification. The purification of the HPPO can therefore begin.

[0200] I.2.2.3—Purification of the HPPO

[0201] To purify the HPPO, the protocol described above is applied. The enzyme activity is eluted from the DEAE EMD 650S with 150 to 200 mM of NaCl in solution in a 50 mM phosphate buffer, pH 7.4. The fractions containing the enzyme activity are pooled and conserved overnight at 4° C. Freezing at this step in fact leads to a loss of activity. The proteins are then loaded onto a Source Q resin. The enzyme activity is then eluted with an NaCl concentration of between 150 and 0.200 mM in solution in a 50 mM phosphate buffer, pH 7.4. The fractions containing the enzyme activity are pooled and then concentrated on UVIKON 10 kDa membrane, and stored at 4° C. overnight. Finally, the HPPO is purified in a third step by applying a phosphate gradient to a hydroxyapatite column. The activity is eluted with a concentration of phosphate in the region of 30 mM. The fractions containing the HPP oxidase enzyme activity, at the hydroxyapatite column outlet, are then analyzed on an SDS-8.5% PAGE gel stained with silver nitrate. The gel exhibits the development of two protein bands. By comparison between the enzyme activity profile and the protein elution profile, we consider that the HPPO corresponds to the high molecular protein (approximately 60 kDa). In the attempt presented, the purification is initiated with 1.5 g of soluble proteins extracted from A. globiformis, and we recovered 150 ?g of a mixture of proteins (including approximately 70 ?g of HPPO). The purification factor in terms of specific activity was not determined. As a result, we used total reaction conditions to follow the elution of the enzyme activity. In addition, the problem was more the identification of the protein than the development of a purification protocol. The HPLC analysis, of the reactions carried out at the end of each purification step, shows the appearance of a product which has the same retention time as the 4-HPA standard (SIGMA). Forty picomoles of the HPPO protein (60 kDa) are transferred onto a PVDF membrane and are sent for sequencing at the same time as 40 pmol of the protein included in the acrylamide gel. The proteins transferred onto membranes serve to determine the N-terminal sequence, whereas the proteins included in the gel are used to determine the sequence of internal peptides.

[0202] I.2.2.4—Results of Sequencing the HPPO

[0203] Few internal peptides are obtained on exiting HPLC, after digestion of the HPPO with Lys-C endoprotease. This result suggests that the protein contains little lysine; specifically, Lys-C endopeptidase cleaves after lysines. If lysine is relatively infrequent, digestion with endopeptidase K generates long peptide fragments which remain adsorbed in the column and cannot be eluted, even using very hydrophobic conditions. Based on the shape of the chromatographic peaks and also on the apparent amount, three peptides were selected and then sequenced. They are named as a function of their order of leaving the HPLC column: peptide No. 4, peptide No. 6, peptide No. 11. Their sequence is respectively: (A)WWAEALK, AAAGRILRLL DDAAGANASK, XDNRFTAVDF XT (where X is an undetermined amino acid). The sequence of the first 30 N-terminal amino acids is obtained with an initial yield of 40%: TSLTVSGRVA QVLSSYVSD VFGVMGNGNV Y. The amino acid (methionine or valine) corresponding to the initiation codon (ATG or GTG) is not found. The initial yield obtained (15 pmol BSA equivalent), compared with that obtained for the internal peptides (30 to 35 pmol BSA equivalent), suggests that some of the proteins were blocked at the N-terminal. The N-terminal sequence and the internal sequences obtained show no homology in the databases. Based on the peptide sequences obtained, degenerate oligonucleotides are synthesized in order to identify the HPPO gene by PCR.

[0204] I.2.3—Validation of the PCR Techniques and Identification of a Portion of the hppO Gene

[0205] I.2.3.1—Validation of the PCR Techniques

[0206] The content of guanine and cytosine base (SC %) of the majority of Arthrobacter sp. genomic DNAs is between 59 and 66%; however, it is 67 to 69% for A. agilis (formerly Micrococcus agilis) (Koch et al., 1995), 70% for A. atrocyaneus (Jones et al., 1991) and 73% for an Arthrobacter sp. identified in arctic ices (Junge et al., 1998). These high contents of guanine and cytosine can make it more difficult to carry out PCR. For this reason, we validated our PCR methods (genomic DNA, polymerases, etc) using the gene encoding Arthrobacter globiformis “Manganese dependent Dioxigenase” (MndD) (Boldt et al., 1995). This enzyme of the HPP degradation pathway catalyzes the opening of the aromatic ring of 3,4-dihydroxyphenyl acetate. For the control amplification of the MndD gene, we tested thermophilus aquaticus (Taq) thermoresistant polymerases marketed by various suppliers (Perkin Elmer, ATGC, Appligène, Qiagen, Sigma). In all cases, amplification of the MndD gene is obtained. However, under equivalent conditions, using the degenerate primers encoding the HPPO peptides, amplification of the hppO gene is not obtained even using additives (DMSO, glycerol).

[0207] I.2.3.2—Identification by PCR of the N-Terminal Portion of the hppO Gene

[0208] We specifically amplified a 936 bp DNA sequence which might correspond to the N-terminal portion of the hppO gene. The amplification was obtained using, firstly, the degenerate primers Ox3: TTNGCNCCNG CNGCRTCRTC and OZ10N: GAYGTNTTYG GNGTNATGGG NAAYGG corresponding, respectively, to a portion of peptide No. 6 and to a portion of the N-terminal peptide sequence and, secondly, the “Advantage GC Genomic PCR” kit (Clontech). The Clontech kit is designed to carry out PCRs on GC-base-rich genomes. It contains a mixture of thermoresistant polymerases (including Tth) and a betaine-based additive. Tth is a thermoresistant polymerase purified from Thermus thermophilus. The degeneracy of each primer is 1024, i.e. one primer out of 1024 exhibits the exact nucleic acid sequence of the gene being sought. The degeneracy originates from the fact that an amino acid can be encoded by several codons; for example, alanine is encoded by four codons (GCA, GCC, GCG, CGT). The degeneracy code used for the primers is defined as follows: N=A or T or G or C; R=A or G; Y=T or C. The theoretical hybridization temperatures are, respectively, 55.4° C. and 57.6° C. Despite a hybridization temperature of 60° C. used in the PCR, the OX3 primer alone allows nonspecific amplifications. We specifically amplified, by PCR, a 936 bp DNA fragment, using two degenerate primers. We must be sure that this amplified DNA corresponds correctly to the hppO gene being sought.

[0209] I.2.4—Characteristic of the 936 bp DNA Fragment

[0210] The 936 bp DNA fragment amplified by PCR is purified on agarose gel. It is then cloned into pGEM-T easy, according to the supplier's instructions, and then sequenced. When the nucleic acid sequence obtained is translated, it is observed that it encodes, at the two ends, for the entire peptide No. 6 and for a large part of the N-terminal sequence. We are therefore sure to have amplified a portion of the gene encoding the purified and microsequenced protein, the HPPO. The nucleic acid sequence contains 73% of guanine (G) and cytosine (C) bases; the possible formation of secondary “stem-loop” structures is also noted in the first 250 bases of the messenger RNA. This high content of G and C bases and also the existence of the secondary structures may partly explain the difficulties encountered in achieving the PCR amplification of part of this gene. The 936 bp nucleic acid sequence and also the corresponding protein sequence exhibit no homologies with the sequences recorded in the databases. We now have a 936 bp sequence oriented from the N-terminal toward internal peptide No. 6. Since the protein is approximately 60 kDa, a gene of approximately 1650 bp is sought. There remains therefore approximately 700 bp to be identified. For this, we will screen the A. globiformis genomic library produced in the cosmid pLAFR5 and amplified in E. coli HB101.

[0211] I.2.5—Screening of the A. globifomis Cosmid Library

[0212] The genomic library prepared is transferred onto membranes and is then screened using, as probe, the 936 bp DNA fragment labeled with digoxigenin. The standard protocol is adapted for a “conventional” DNA (60% AT), while the 936 bp fragment exhibits an estimated proportion of 23% AT. If we keep the same dUTP-Dig/dTTP ratio as in the case of a conventional DNA, we obtain a weakly labeled probe and therefore a less sensitive detection. We therefore optimize the dUTP-Dig/dTTP proportion necessary for labeling the probe (paragraph II.7.1). Screening of the genomic library made it possible to identify four cosmids (Cos1A, Cos2A, Cos4A, Cos17A1) having different restriction profiles. By comparing the results of Southern hybridization obtained using the cosmids with those obtained using the Arthrobacter globiformis genomic DNA, we selected the cosmid 2A. Figure No. 14 illustrates the approach used taking as an example digestion of the cosmids with the Not I restriction enzyme. It is observed first of all that the cosmid vector pLAFR5, digested with Not I, does not hybridize with the Z2-Dig probe. On the other hand, it is observed that the cosmid 1A exhibits a single hybridization band at 2.3 kb while, the cosmids 2A, 4A and 17A exhibit two hybridization bands at 4.3 and 2.3 kb. Now, digestion of the A. globiformis genome with Not I produces two bands of 4.3 and 2.3 kb; as a result, we consider that the cosmid 1A does not contain all the information sought. Based on other restrictions and using an equivalent approach, the cosmids 4A and 17A, are eliminated. The cosmid 2A is then sequenced over a distance of approximately 3 kb on either side of the Not I site identified in the middle of the Z2-Dig probe. The results of hybridization of the genomic DNA also show that the gene is present in a single copy. We have identified the cosmid 2A which we have sequenced over 6.2 kb. We will now be able to analyze this DNA sequence derived from the Arthrobacter globiformis genome.

[0213] I.2.6—Overall Analysis of the 6.2 kb of Arthrobacter globifoxmis Genomic DNA

[0214] Using Vector Nti software, the position of the potential genes is defined from the nucleic acid sequence of 6255 bp obtained by sequencing the cosmid 2A. The 936 bp sequence, identified by PCR, is found to be part of a potential gene. This potential gene therefore probably corresponds to the hppO gene. Four other genes (A, B, C, D) are potentially identified (FIG. 3) by carrying out a search by homology using the BLASTX algorithm. Gene A will encode an amino acid transporter, Gene B will encode a histidinol-phosphate amino transferase; however, previous studies show that this enzyme has tyrosine amino transferase activity in the Gram-positive bacterium Bacillus subtilis (Nester & Montoya, 1976) gene C will encode a transcription regulator, while gene D will encode an operon regulator.

[0215] I.2.7—Analysis of the hppO Gene

[0216] I.2.7.1—General Description

[0217] Over the 6256 bp sequence obtained, the hppO gene (in green) is delimited in 5′ by the ATG initiation codon at position 3143 and in 3′ by the stop codon TAG (in red) at position 4823. The gene therefore has a real length of 1680 bp. It exhibits a high content of G and C bases (71.4%, GC). The search for homologies in the nucleic acid sequences (BLASTN) gives no identification. In order to more thoroughly characterize the gene, the specific elements of transcription and of translation are sought.

[0218] I.2.7.2—Elements Characterizing the Transcription and Translation of the hppO Gene

[0219] The potential transcription promoter boxes are identified (FIG. 4). Box “−10”, termed “Pribnow box” is located between 3082 to 3088 (AAAAATA) and box “-35” is located at position 3055 to 3059 (TTGCA). These boxes thus defined are slightly different from the canonic sequences (respectively TATAAT and TTGACA; Singer & Berg, 1992). This may reflect a weak interaction with the factors allowing constitutive transcription or else the necessary interaction with different transcription factors. The adenine at position 3096 might be the transcription initiation base. Finally, a sequence corresponding to the binding site for the CAP protein (catabolic gene activator protein) is identified between positions 3068 to 3072 (TGTGA). Finding this CAP protein-binding site is in agreement with the results obtained in the optimization of the culture conditions. In conclusion, the transcription of the hppO gene is probably under the control of a weak promoter, in particular regulated by glucose. The Shine-Dalgarno sequence (Singer & Berg, 1992) allows binding of the ribosomal small subunit. It is identified (GACGAT; at positions 3131 to 3136) 12 bases upstream of the translation initiation codon (ATG), by analogy with the AGGA consensus sequence. It is also observed that the 5′ terminal portion (approximately 250 bases) of the messenger RNA is capable of forming a stem-loop structure. Now, the secondary structure of the region of the mRNA which is in the region of the initiator ATG influences the translation initiation step. Thus, the initiation is zero or relatively inefficient when the initiator ATG or the Shine-Dalgarno sequence is involved in intramolecular pairing. The question may therefore be posed of whether the step-loop structures observed have a possible role in regulating the translation.

[0220] I.2.7.3—Expression of the HPPO Under the Control of the Tac Promoter

[0221] Overexpression of the HPPO is advantageous for defining the kinetic characteristics, to allow the production of antibodies, but also for the purpose of structural analysis. The gene is cloned into a vector pKK223-3 in two stages. The gene, amplified by PCR under the conditions defined for the identification of the hppO gene and using the primers HPP-N-sense (CATGACTTCA CTTACAGTGT CC) and HPP-C-term (CAAACTGAGT AGCAGCTCAG G), is cloned into the vector pGEMT-easy. The clone exhibiting the hppO gene in the antisense direction with respect to the lac promoter is selected. It is then digested with Eco RI. By doing this, the hppO gene is recovered, and is inserted into the vector pKK223-3 digested with Eco RI. The clone pKK3-2, exhibiting the hppO gene under the control of the tac promoter, is selected. When the expression of the clone pKK3-2 is induced by adding IPTG, HPP oxidase activity can be detected. However, the overexpressed protein (57.4 kDa) cannot be detected in a crude extract separated on denaturing acrylamide gel. The overexpression protocol therefore remains to be improved. We also envision cloning the HPPO as a fusion with a Tag sequence (GST, polyhistidine, protein A, etc) in order to facilitate purification of the overexpressed protein. We have just definitively shown that the identified gene encodes an HPP oxidase activity. However, in carrying out homology searches at the protein sequence level (BLASTX or BLASTP), it is observed that the HPPO protein exhibits up to 25% identity with acetolactate synthases (ALSs), pyruvate oxidases (POXs) and pyruvate dehydrogenases (PDHs). It is thus possible to identify very conserved motifs such as those regarding TPP cofactor binding (FIG. 5). In addition, the hydrophobicity profile of the HPPO is very close to that obtained for ALSs (not shown). In order to be sure that the identified gene really encodes the HPPO and not an ALS, a POX or a PDH having a secondary activity of the HPP oxidase type, we decided to test the HPPO for a possible secondary activity.

[0222] I.2.8—HPPO Versus ALS

[0223] The protein homology searches show that HPPO exhibits up to 25% identity with ALSs. This result, although initially surprising, has a certain logic. Specifically, these two enzymes use FAD and TPP as reaction cofactors. They both carry out a decarboxylation. Moreover, one of the substrates of ALS is pyruvate; now, our substrate is a ?-substituted pyruvate: hydroxyphenyl pyruvate. It is therefore possible that the structure of the active site is close and that, consequently, these proteins share common enzyme activities. We used the recombinant large subunit and purified ALSs from Arabidopsis thaliana (Chang & Duggleby, 1997) and from E. coli (Hill & Duggleby, 1998) to serve as a positive control in our experiments carried out in order to search for ALS activity in the HPPO. The results obtained show that the HPPO does not exhibit any ALS activity. We show on this occasion that the two ALSs tested have no HPP oxidase activity. Finally, we observe that the HPPO is not inhibited by 115 ppm of imazapyr (ALS inhibitor, cyanamid). These results clearly show that, despite common points (protein sequence and hydrophobicity), ALSs and the HPPO are clearly different enzymes which do not have secondary enzyme activities.

EXAMPLE 2 Identification of the Genes Encoding 4-HPA 1-Hydroxylase

[0224] 4-HPA 1-hydroxylase (HPAH) converts 4-HPA to HGA via a hydroxylation reaction accompanied by displacement of the acetyl chain. Its activity has been characterized on crude extracts of Rhodococcus erythropolis S1 (Suembri et al., 1995) or on partially purified extracts of P. acidovorans (Hareland, 1975). It was purified by Suemori et al. (1996), but the protein and gene sequences are not published. In order to be able to introduce this enzyme activity into the plant, it is necessary to identify the gene.

[0225] Various approaches can be envisioned: (1) phenotypic and/or functional complementation using a genomic library, (2) insertional mutation and therefore identification of the gene through the loss of the enzyme activity, (3) purification of the protein in order to work back to the nucleic acid sequence. We chose to develop these three approaches with Pseudomonas acidovorans because there are many molecular biology tools whose effectiveness has been demonstrated on various species and strains of Pseudomonas. By way of examples, mention may be made of the mini-Tn5 transposon (De Lorenzo et al., 1990), the broad host spectrum vectors such as pBBR1MCS (Kovach et al., 1994, 1995; D'Souza et al., 2000), and the techniques for transfer by conjugation., The mini-Tn5 transposon can be used either to disturb a gene (de Lorenzo et al., 1990; Fedi et al., 1996; Campos-Garcia et al., 2000) or to introduce a gene into the bacterial genome (Prieto et al., 1999). We began with the approach by phenotypic, complementation because this appeared to be the most rapid and the most simple. This approach was followed by the two other simultaneously.

[0226] However, we will not tackle the approach by insertional mutagenesis here since this approach was not subsequently exploited.

[0227] II.1—Materials and Methods

[0228] II.1.1—Construction of a P. acidovorans. Genomic Library in E. coli

[0229] To construct the library we used the cosmid pLAFR5 and the genomic DNA of P. acidovorans. We used the host strain E. coli HB101.

[0230] II.1.2—Purification of the 4-HPA 1-Hydroxylase

[0231] II.1.2.1—Spectrophotometric Activity Assay

[0232] In the reaction catalyzed by 4-HPA 1-hydroxylase, described by Hareland et al. (1975), molecular oxygen and NADH,H⁺ are consumed. We chose to measure the enzyme activity by following the oxidation of NADH,H⁺ to NAD⁺. The reaction medium comprises: 300 ?M NADH,H⁺; 6.7 ?m FAD; 100 mM KPi; 1 mM DDT; 10 to 50 ?g of proteins. The reaction is triggered by adding the substrate: 1 mM 4-HPA. The reaction is followed at 340 nm or at 292 nm, for 2 to 10 min. Specifically, the consumption of NADH,H⁺ results in a decrease in absorbance at 340 nm, while the production of homogentisate results in an increase in absorbance at 292 nm. The spectrophotometric assay is very rapid, it is used routinely to follow protein elution in purification steps.

[0233] II.1.2.1-HPLC Activity Assay

[0234] Analysis of the enzyme reactions by HPLC makes it possible to confirm the production of HGA (retention time, UV spectrum). The enzyme assay is carried out under the same conditions as above. However, the reaction is stopped by adding a third of a volume of 20% perchloric acid. The reactions are then analyzed by HPLC using isocratic elution with 90% of phase A and 10% of phase B or 92% of phase A and 8% of phase B. Phase A is milliQ water containing 0.1% of trifluoroacetic acid (TFA) and phase B corresponds to acetonitrile. In the 90%-10% isocratic elution, the HGA is eluted in 1.2 min whereas in the 92%-8% isocratic system, it is eluted in 1.4 min. The elution is generally recorded at 230 nm. Van den Tweel et al. (1986) used 2,2′-bipyridyl (non-heme iron protein inhibitor) to inhibit the homogentisate dioxygenase and thus allow accumulation of the HGA. For this reason, 2 mM of 2,2-bipyridyl is added to certain reaction media. Under these chromatographic conditions, it is possible to identify the 4-HPA and the HGA. The HPLC system consists of an Alliance 2690 HPLC (Waters) and a 996 diode array detector (Waters).

[0235] II.1.2.3—Purification of the HPAH Protein

[0236]Pseudomonas acidovorans is cultured for 48 hours on M63 medium containing 4-HPA as the only carbon source, at 29° C., 220 rpm. The bacteria are centrifuged at 3000 g for 15 min at 6° C. (Beckmann J2/21 M/E centrifuge). The bacterial pellet is taken up in the sonication buffer (0.1 M KPi, pH 7.2; 1 mM MgSO₄; 1 mM DTT; 1 mM benzamidine hydrochloride; 5 mM caproic acid). Benzamidine hydrochloride and caproic acid are protease inhibitors. The sonication is carried out for 9 minutes, sonicating every forty seconds for twenty seconds at power 5 (Vibra Cell, Sonic Materials INC., Connecticut, USA). During the sonication, the sample is kept at the temperature of melting ice. The sonicated extract is centrifuged at 15 000 g for 15 min at 4° C. The supernatant recovered is precipitated with 1% of streptomycin sulfate. The precipitate is eliminated by centrifugation at 15 000 g for 15 min at 4° C. The supernatant is desalified on a PD10 column (Pharmacia) and then loaded onto a DEAE/EMD 650 S column equilibrated in buffer A (20 mM KPi, pH 7.2, 10% glycerol, 1 mM MgSO₄, 1 mM DTT). The elution is carried out using a buffer B (buffer A; 1 M KCl; 100 ?M FAD). The 4-HPA 1-hydroxylase activity is eluted for a KCl concentration in the region of 150 mM. The active fractions, concentrated through UVIKON 10 kDa membrane and then desalified on a PD10 column, are then loaded onto a Red affinity column (Red 120 Agarose type 3000 CL, SIGMA Ref R-0503) equilibrated in buffer A (above). The elution is carried out in two stages. The first is washing of the Red column using buffer A enriched with FAD at a final concentration of 50 ?M. The second allows elution of the protein; for this, buffer A is enriched in FAD (3 mM) and in NADH,H⁺ (10 mM). The fractions, containing the protein of interest, are pooled, concentrated and frozen at −80° C.

[0237] II.1.3—Protein Microsequencing of the N-Terminal End and of Internal Peptides

[0238] The same protocol as that described in the case of the HPP oxidase was used to carry out the sequencing of the purified protein. However, in order to produce the internal peptides, the protein was digested with trypsin instead of Lys-C endopeptidase. Trypsin cleaves after arginines and lysins. Digestion with trypsin generally leads to the production of fragments which are smaller than those obtained in a digestion with Lys-C endopeptidase. In order to be able to sequence with precision the recovered peptides, it is sometimes necessary to repurify the recovered peptides by HPLC.

[0239] II.1.4—Identification of a Portion of the Gene Encoding the HPAH by Degenerate PCR

[0240] The degeneracy code given on page 43 [of the original] is used for the synthesis of the degenerate primers. The PCR is carried out in a final volume of 50 ?L, in 200 ?L tubes. The reaction solution contains the Perkin Elmer buffer, 250 ?M dNTP, 50 ng of P. acidovorans genomic DNA, and 2 enzyme units of AmpliTaq (Perkin Elmer). The reaction is carried out using a “Hybaid Touchdown” thermocycler: 3 min at 94° C., then forty five cycles: 30 sec at 94° C., 1 min at 50° C., 1 min 30 sec at 72° C., followed by a final elongation of 5 min at 72° C. before returning to 4° C., The PCR is evaluated after loading 10 ?L onto a 1% agarose gel. Under these conditions, a 536 bp band is identified.

[0241] II.1.5—Screening of the P. acidovorans Cosmid Library

[0242] The cosmid library is plated out on LBT¹⁵ medium and allowed to grow for 16 h at 37° C. The dishes are then transferred to 4° C. After one hour, the colonies are transferred to Hybond N membranes (Amersham) according to the method of Grunstein & Hogness (1975). The membranes are hybridized using the 536 bp PCR fragment previously identified and purified. Detection is carried out with ³²P. The probe is labeled using the “DNA Ready to Go” kit (Pharmacia). The prehybridization, hybridization and washing are carried out in vials. The membranes are prehybridized in a solution composed of 5 ? SSC, 6% Denhardt's and 0.5% SDS, for 4 hours at 68° C. The hybridization is carried out for 16 hours at 68° C. The washes are carried out at 65° C. in 2 ? SSC, 0.1% SDS. The membranes are developed by exposing Kodak or Amersham films.

[0243] II.1.6-P. putida Growth Media

[0244]Pseudomonas putida is cultured on Luria-Bertani (LB) or 2YT rich medium containing 100 ?g.mL⁻¹ of rifampicin. Other antibiotics are added as needed (example: tetracyclin at 15 ?g.mLi⁻¹). The minimum medium M63 containing 1.5 g.L⁻¹ of 4-HPA as the only carbon source is used to test the functional complementation. In this case, the antibiotics are omitted. All the cultures are prepared at 29° C.

[0245] II.1.7—Transformation of P. putida by Electroporation

[0246] 1 liter of LB Rifampicin (100 ?g.mL⁻¹) medium is inoculated with a culture of P. putida grown at 29° C. for approximately 16 hours with shaking at. 180 rpm. When the OD_(600 nm) is in the region of 1.2, the cells are collected by centrifugation for 15 min at 3000 g, 4° C. The culture medium is removed and the cells are taken up with 400 mL of 10% glycerol at 4° C. The cells are centrifuged once again at 3000 g for 20 min at 4° C. Two further washing steps are carried out with, respectively, 200 then 100 mL of 10% glycerol at 4° C. Finally, the bacteria are taken up with 3 to 10 mL of 10% glycerol and then distributed into 100 ?L aliquots which are immediately frozen in liquid nitrogen. The bacteria thus prepared are conserved for at least six months at −80° C. During the preparation, a loss of bacteria due to lysis is observed. The cosmid (Tet^(R)) DNA is introduced into the P. putida (Rif^(R)) by electroporation. The electroporation (Bio-Rad Gene Pulser™) of 80 ng of cosmid DNA into 100 ?L of electrocompetent P. putida is carried out in a 2 mm electroporation cuvette under a voltage of 0.9 volts with an electroporator resistance of 200 ?. Under these conditions, the time constant ? □ is approximately 4.5 msec. After the electric shock, the cells are taken up with 900 ?L of LB and cultured for 1 h 30 at 29° C., 180 rpm. The transformed P. putida are selected on LB Rif¹⁰⁰ Tet¹⁵ agar medium.

[0247] II.1.8—Modification of the Broad Host Spectrum Vector pBBR1MCS-Gm^(R)

[0248] We used the broad GGram-negative host spectrum vectors of the pBBR1MCS series (Kovach et al., 1994, 1995). These plasmids, which have a Bordetella bronchiseptica origin of replication replicate at approximately 20-30 copies per cell in E. coli. They contain two Not I sites. In order to facilitate the subsequent clonings, the Not I site present outside the multiple cloning site (MCS) on the plasmid pBBR1MCS-Gm^(R) is deleted. For this, the plasmid is cleaved with Sfi I (50° C.) and then treated with T4 DNA polymerase in order to obtain blunt ends. The plasmid is religated on itself (T4 DNA Ligase—New England Biolabs). After ligation (16 hours, 16° C.), a digestion with Sfi I is carried out in order to eliminate the possible “wild-type” plasmids, and then E. coli DH5? are electroporated. The plasmid DNA is isolated from the clones selected on LB Gm²⁰ medium. The plasmid DNAs are characterized with two digestions: Not I and Not I/Bgl II. A clone is selected: pBBR1MCS-Gm-Not-U.

[0249] II.1.9—Subcloning of Ccos8 in pBBR1MCS-Gm-U

[0250] The cosmid Ccos8 is restricted with Not I and then loaded onto an agarose gel. After migration, 6 DNA bands are visualized: 1.7; 3; 4; 5; 8; 10 kbp. The bands are purified with Quiaex II. Moreover, pBBR1MCS-Gm-Not-U is restricted with Not I, and dephosphorylated using shrimp alkaline phosphatase (SAP). The various bands are then ligated (T4 DNA ligase, 16 hours, 16° C.) into the vector using varying “insert/vector” ratios. E. coli DH5? are transformed with the ligation products.

[0251] II.1.10—Triparental Conjugation between E. coli and P. putida

[0252] In order to transfer the various Ccos8 (Gm^(R)) subclones from E. coli DH5? to P. putida (Rif^(R)), triparenteral conjugation is carried out on a filter using the protocol described by De Lorenzo et al. (1990). The bacteria recovered are plated out on LB Rif¹⁰⁰ Gm²⁰ and on M63 having 4-HPA as the only carbon source.

[0253] II.1.11—Elimination of the Plasmid p5kbC

[0254] In order to rapidly eliminate the plasmid p5kbC of P. putida, the incompatible origins of replication strategy is used, and the loss of p5kbC is forced using antibiotics. P. putida (Rif¹⁰⁰) complemented with the plasmid p5kbC (Gm^(R)) is transformed with pBBR1MCS Kn^(R). The clones obtained (Rif¹⁰⁰ Gm^(R) Kn^(R)) are verified for their complementation activity. The clones are then cultured on two media: LB Rif¹⁰⁰ Kn¹⁵⁰ Gm²⁰ and LB Rif¹⁰⁰ Kn¹⁵⁰. In doing this, the selection pressure for p5kbC and pBBR1MCS KnR or else only for pBBR1MCS Kn^(R) is maintained. Growth is carried out at 29° C. The subculturing is carried out every three days. At the eighth subculturing, the colonies are subcultured on 4 different media (M63, M63+4-HPA, LB Rif¹⁰⁰ Kn¹⁵⁰ Gm²⁰ and LB Rif¹⁰⁰ Kn¹⁵⁰) whatever the dish of origin. The state growth is then recorded after 2 and 7 days.

[0255] II.1.12—Identification, of the Proteins Contributing to the Enzyme Activity

[0256] II.1.12.1—Preparation of Crude Extracts of P. putida

[0257] Two P. putida clones are cultured on LB Gm²⁰ for 24 hours. The first comprises the plasmid pBBR1MCS-Gm-Not-U, while the second contains the complementation plasmid p5kbC. After sonication in a buffer (0.1 M KPi; 1 mM MgSO₄; 1 mM DTT; 1 mM benzamidine hydrochloride; 5 mM caproic acid), then centrifugation at 20 000 g for 10 min at 4° C., the supernatant is tested for its 4-HPA 1-hydroxylase activity using the two methods for measuring enzyme activity. The crude extracts are also analyzed by SDS-10% PAGE.

[0258] II.1.12.2—Transfer onto Membrane, N-terminal Sequencing

[0259] The sequencing is carried out as in Example I.

[0260] II.1.12.3—S75 Gel Filtration.

[0261] The eluate (5 mL) is concentrated 10-fold using a 10 K Macrosep™ (Pall Filtron) for two hours at 4° C. The concentrated 500 ?L are injected onto a Superdex™ 75 prep grade gel filtration column (HiLoad 16/60, Pharmacia) pre-equilibrated with 700 mL of buffer (0.02 M KPi, pH 7.2; 10% glycerol; 1 mM MgSO₄; 1 mM DTT; 4° C.) at a flow rate of 0.7 mL.min⁻¹. The chromatography is carried out at 4° C. with a flow rate of 1 mL.min⁻¹. The fractions are collected every minute and stored at 4° C.

[0262] II.1.12.4—Construction of pBBR1MCS FT12?1

[0263] To construct the plasmid pBBR1MCS FT12?1, a two-step cloning strategy is used. The plasmid p5kbC is digested with Nsi I and Not I. The insert obtained, encoding genes 1, hpaH and 3, is then cloned into pBBR1MCS-Gm-Not-U digested with Pst I and Not I. The resulting clone, named pBBR1MCS FT12, is restricted with Hind III and Asc I, then blunt-ended and, finally, religated. In doing this, genes 1 and 3 are destroyed and the hpaH gene is under the control of the lac promoter of the original vector. The plasmid pBBR1MCS FT12?1 is thus obtained (FIG. 6).

[0264] II.1.12.5—Construction of pL1lac2

[0265] The laboratory possesses a plasmid named “Clone L”. This construct corresponds to the cloning of the P. fluorescens HPPD gene promoter into the vector pBBR1MCS-Kn^(R). The HPPD gene promoter is functional in P. putida and in E. coli. The plasmid “Clone L” is digested with Bam HI and Hin dIII, which makes it possible to recover the insert containing the promoter and the HPPD gene of P. fluorescens. This insert is then ligated into the vector pBBR1MCS-Gm^(R) digested with Bam HI and Hin dIII. The resulting clone is named pBBRG-L-HPPD. The plasmid obtained, digested with Nco I to remove the gene encoding HPPD, is ligated with the hpaC gene amplified by PCR and digested with Afl III. The construct obtained is called pBBRG-L-ORF1. To amplify the hpaC gene by PCR, primers which make it possible to introduce an Afl III site at the beginning and at the end of the gene (the Afl III site is compatible with the Not I site) are used. The primers used are: positioned 5′ of the gene: GCAGGATGCA CATGTCCACC AAGAC and positioned 3′ of the gene: CGGACGCCGA CATGTATCAG CCTTC. The PCR is carried out using 1 unit of KlenTaq polymerase (Sigma), 250 ?M of dNTP, 200 nM of each primer and 50 ng of the plasmid p5kbC. The PCR program is defined as follows, on a Perkin Elmer 9600: 3 min at 95° C.; then 20 cycles: 94° C. for 1 min, 60° C. for 30 sec, 68° C. for 3 min; finally, a last step of 10 min at 68° C. is carried out. The plasmid pBBR1MCS FT12?1 previously obtained is restricted with Ssp I and Not I. The Not I site is blunt-ended by treatment with Pfu. The fragment recovered (2468 bp), containing the hpaH gene under the control of the lac promoter, is ligated into pBBRG-L-ORF1 digested with Ssp I. The clone containing the hpaC gene and hpaH gene in the antisense direction is selected and is named pL1lac2. All this cloning is carried out in E. coli DH5?.

[0266] II.2—Results

[0267] Various approaches can be envisioned for identifying the gene encoding the 4-HPA 1-hydroxylase activity of P. acidovorans. We decided initially to use an approach by phenotypic coloration. This approach appears to be simple and rapid. We in fact possess in the laboratory a phenotypic screening tool for detecting the production of HGA. Now, the enzyme being sought converts 4-HPA to HGA.

[0268] II.2.1—Approach by Phenotypic Coloration

[0269] We have observed in the laboratory that E. coli K12 cannot grow using tyrosine or 4-HPA as the only carbon source. In addition, we know that E. coli K12 has tyrosine aminotransferase activity which allows synthesis of tyrosine from HPP. This enzyme activity is reversible, and the cell can therefore produce HPP from tyrosine. If the rich culture medium is enriched in tyrosine (1 g.L⁻¹), the tyrosine is imported into the bacteria, which accumulate it and then convert it to HPP, according to the equilibrium constant for the conversion reaction between HPP and tyrosine. In the laboratory, we have already observed that, if we introduce the P. fluorescens HPPD into E. coli K12, then the HPP produced during the deamination of tyrosine is converted into homogentisate (HGA). Since the reaction catalyzed by the HPPD is irreversible, the HGA accumulates in the cell, where it is oxidized then polymerizes spontaneously to form an ochronotic pigment which is brown in color. This therefore gives us a means of detecting the production of HGA. The 4-HPA 1-hydroxylase being sought converts 4-HPA to HGA. The E. coli HB101 containing the Pseudomonas acidovorans genomic library are therefore plated out on 2YT agar medium enriched in 4-HPA. After two days, two colonies become brown: they therefore produce homogentisate. However, the enzyme activities detected on the crude extracts of these two clones reveal enzyme activity of the HPPD type whereas the 4-HPA 1-hydroxylase activity sought is discrete, or even nonexistent. A priori, this approach made it possible to select the clones for which the cosmid contains the gene encoding a P. acidovorans HPPD and not the 4-HPA 1-hydroxylase. In the in vitro preliminary study on the crude extracts of P. acidovorans, the HPPD activity was not identified. It may be presumed that the P. acidovorans HPPD activity would be expressed when the bacterium is cultured on rich medium, whereas the 4-HPA 1-hydroxylase activity would be expressed when 4-HPA is the only carbon source. Since this approach did not make it possible to identify the 4-HPA 1-hydroxylase, we decided to purify the enzyme. Once the protein is identified, it is possible to work back to the corresponding gene.

[0270] II.2.2—Purification of the 4-HPA 1-Hydroxylase

[0271] In order to follow the purification of the protein, its 4-HPA-dependent NADH,H⁺ oxidase activity is assayed. The protein is thus purified to virtual homogeneity by applying the purification protocol described above. The enrichment factor for the specific NADH,H⁺ oxidase activity is generally between 50 and 100 depending on the preparations. On SDS-PAGE, the protein has an apparent molecular weight of 60 kDa. In fact, it is observed that the NADH,H⁺ oxidase activity and the production of HGA are visible on leaving DEAE/EMD 650S. On the other hand, on leaving an affinity column, the production of HGA is very difficult to detect; the NADH,H⁺ oxidase activity remains, however, dependent on 4-HPA being added to the reaction medium. If the hypothesis that the enzyme is monomeric is taken as a basis, the loss of catalytic activity allowing the production of HGA can be explained by supposing that a part of the protein has been damaged (for example: loss of a strongly associated cofactor) during its passage through the Red column. The site catalyzing the oxidation of NADH,H⁺ would not be affected. It may also be supposed that the enzyme sought is a heterodimer. The loss of catalytic activity would then be explained by the loss of the monomer responsible for the production of HGA. Many heterodimeric flavin monooxygenases have been identified in the literature, all having an aromatic substrate, in varied bacterial species (Adachi et al., 1964; Arunachalam et al., 1992, 1994; Prieto et al., 1993; Prieto & Garcia, 1994; Arunachalam & Massey, 1994; Takizawa et al., 1995; Xun, 1996; Xun & Sandvik, 2000). However, two hypotheses exist to explain the function of these heterodimeric enzymes:

[0272] (1) Arunachalam et al. (1992, 1994) proposed that the 4-hydroxyphenylacetate 3-hydroxylase of P. putida consists of a 65 kDa homodimeric flavoprotein and also a 38.5 kDa coupling protein. The flavoprotein alone is capable of oxidizing NADH,H⁺ independently of the presence of 4-HPA. This oxidation of NADH,H⁺ makes it possible to renew the NAD⁺ “pool”, but produces H₂O₂ in stoichiometric proportions. If the coupling protein is added, the protein complex becomes capable of hydroxylating 4-HPA to 3,4-dihydroxyphenylacetic acid. Thus, the oxidation of NADH,H⁺ is not wasted and allows the synthesis of a metabolite. The coupling protein alone has no enzyme activity.

[0273] (2) Prieto et al. (1993, 1994) and Xun & Sandvik (2000) suggest that the 4-HPA 3-hydroxylase of E. coli W (ATCC 11105) is considered to be a new member of the two-component flavin-diffusible monooxygenases (TC-FDM). The two components would be, firstly, 4-hydroxyphenylacetate 3-hydroxylase, a 59 kDa monomeric enzyme encoded by the HpaB gene and, secondly, a 19 kDa monomeric flavin: NADH oxidoreductase encoded by the HpaC gene. In this case, FAD is reduced at the expense of NADH,H⁺ by the flavin: NADH,H⁺ oxidoreductase. The FADH₂ is then used by the oxygenase to allow oxidation of the substrate using molecular oxygen.

[0274] The enzyme that we purified strongly oxidizes, NADH,H⁺ but produces very little homogentisate. In addition, the oxidation of NADH,H⁺ is dependent on 4-HPA being added. This suggests that we have an enzyme of the type of that described by Prieto et al. We therefore consider that the purified enzyme is the 4-HPA 1-hydroxylase (HPAH) sought. It is possible that, subsequently, it will be necessary to identify a coupling protein in order to optimize the enzyme activity. The biochemical approach can therefore be continued with the purified protein.

[0275] II.2.3.—Production of the Internal Peptides and of the N-Terminal Sequence

[0276] The purified protein was sent to the Pasteur Institute to be microsequenced. Thus, the N-terminal sequence SHPAISLQAL RGSGADIQSI HIPYER and six internal peptides named, respectively, peptides No. 11C, 12D, 20A, 22B, 23 and 24, as a function of the order in which they leave the column: ATDFITPK, LGVGQPMVDK, VVFAGDSAHG VSPFX, VTALEPQAEG AL, IDFQLGWDAD PEEEK, LSVPATLHGS ALNTPDTDTF, were thus obtained. The amino acid (methionine or valine) normally corresponding to the initiation codon of the gene (ATG or GTG) is not found on the N-terminal sequence. Homology analyses in the protein bases using the BLASTP algorithm do not make it possible to identify homologous proteins. On the basis of the protein sequences obtained, the corresponding degenerate oligonucleotides were synthesized. These oligonucleotides were used in PCR reactions in order to identify a portion of the gene encoding the purified and partially sequenced HPAH protein.

[0277] II.2.4—Production of the PCR Fragment

[0278] PCR amplification of a portion (536 bp) of the gene encoding the 4-HPA 1-hydroxylase was obtained using the degenerate primers Hy4R: TCYTCNGGRT CNGCRTCCCA and Hy5F: GGNGTNGGNC ARCCNATGGT which encode, respectively, peptides 23 and 12D. These primers have a hybridization temperature of 55.4° C. and exhibit a degeneracy of 128 and 512 respectively. The amplified sequence is cloned into the vector pGEMT-easy and is then sequenced. Analysis of the sequence obtained makes it possible to find, besides the sequences encoding the peptides Hy4R and Hy5F, the nucleic acid sequence encoding internal peptide 22B. The latter element makes it possible to confirm that we have indeed amplified a portion of the gene encoding the purified HPAH protein. At this stage, homology searches in the protein bases, using the BLASTX algorithm, bring up some weak homologies with hydroxylases, oxidases and monooxygenases. Using the 536 bp PCR-amplified sequence, we will be able to screen a P. acidovorans cosmid library in order to search for the cosmid containing the complete gene.

[0279] II.2.5—Screening of the P. acidovoranu Cosmid Library

[0280] Screening of the cosmid library, using as probe the sequence obtained above, made it possible to identify 4 groups of cosmids considered to be different on the basis of their restriction and hybridization profiles after transfer by the Southern technique. Cosmids No. 1, 2 and 6 form the first group, cosmids No. 3, 7 and 9 form the second, while cosmids No. 5 and 8 form the third. The final group is represented by cosmid No. 4. The hybridization results suggest, in addition, that the hpaH gene sought is present as a single copy in the genome of Pseudomonas acidovorans. We identified cosmids comprising at least a portion of the gene encoding the purified HPAH protein. In the meantime, we observed that P. putida was incapable of growing on 4-HPA but could grow using HGA as the only carbon source. This therefore gives us an excellent screen for functional complementation; we will thus be able to define which of these cosmids comprises the functional gene encoding the 4-HPA 1-hydroxylase activity.

[0281] II.2.6—Functional Complementation with the Cosmids

[0282] The nine cosmids previously identified are introduced into P. putida by electroporation. The clones obtained are then subcultured on M63 medium containing 4-HPA as the only carbon source. After 7-8 days, only the bacteria containing cosmid No. 8 succeeded in growing; that is to say, only cosmid. No. 8 contains all the expressible information allowing conversion of 4-HPA to HGA which can be used by P. putida. The cosmid is named Ccos8. The transformation with all the cosmids was repeated. It was always cosmid 8 which allowed complementation after a certain period of time (6-10 days). In order to be able to move forward in our approach of determining the minimum DNA fragment expressing the 4-HPA 1-hydroxylase activity, it is necessary to subclone Ccos8. The subclone of interest is selected using the functional complementation screen.

[0283] II.2.7—Subcloning by Functional Complementation

[0284] Digestion of the cosmid with Not I makes it possible to obtain 6 DNA fragments of between 1.7 and 10 kb in size. These fragments were subcloned into pBBR1MCS-Gm-Not-U. Five subclones of Ccos8 were obtained. Restriction analysis showed that the 4 and 10 kb fragments were not subcloned. On the other hand, we observed that the 5 kb band initially observed was in fact a double band of 5.1 and 5.2 kb. These clones were passed, by triparenteral conjugation, from E. coli to P. putida. After 5 days, only P. Putida containing the subclone corresponding to the 5.2 kb band of the cosmid Ccos8 grew on M63 containing 4-HPA as the only carbon source. We had therefore just, identified the minimum fragment comprising the 4-HPA 1-hydroxylase activity. The clones corresponding to the 5.2 kb are named 5 kbC. To confirm the result of the functional complementation, we caused the plasmid p5kbC to be eliminated using the strategy of incompatible origins of replication and forcing the elimination of the plasmid p5kbC, by selection pressure from the antibiotics used. We observed that P. putida lost the ability to grow on 4-HPA as the only carbon source when it lost the plasmid p5kbC. We concluded therefrom that the 4-HPA 1-hydroxylase enzyme activity is clearly carried by the plasmid p5kbC. We could therefore have the 5.2 kb insert sequenced, which should allow us to identify the functional hpaH gene.

[0285] II.2.8—Analysis of the 5.2 kb Sequence

[0286] The 5.2 kb insert of the plasmid p5kbC was sequenced. A nucleic acid homology search (BLASTN) thus made it possible to identify three portions in the insert. The first portion between bases No. 1 and 1465 is completely homologous to a portion of the plasmid Birmingham IncP-alpha. It is therefore probably, a sequence derived from pLAFR5. A second nucleic acid portion between bases No. 1466 and 1695 exhibits complete homology with a portion of the cloning plasmid M13 mp8/pUC8. This sequence is therefore also part of pLAFR-5; specifically, the multiple cloning site of pLAFR-5 originates from pUC8 (Keen et al., 1988). Thus, the Eco RI and Sma I sites (FIG. 7) at respective positions 1689 and 1695 are probably the cloning sites of pLAFR-5. The third portion, between bases 1696 and 5264 (i.e. 3568 bp), does not exhibit any strong homologies. This portion of DNA originates from the P. acidovorans genome. When the 5.2 kb sequence is analyzed using the BLASTX algorithm, probable proteins are identified (FIG. 7). Thus, the protein encoded by gene 1 exhibits weak homologies with beta-lactamases, dehydrases and cyclases. The purified protein is encoded by gene 2 since the sequences encoding the internal peptides previously obtained are found; it is therefore probably the 4-HPA 1-hydroxylase. The protein alignments show that this protein exhibits some homologies with oxygenases and hydroxylases. The protein potentially encoded by gene 3 exhibits no homologies with the databases. Finally, gene 4 probably encodes an operon regulator.

[0287] A finer analysis of hpaH gene will now be made. According to the N-terminal protein sequence obtained, the ATG initiation codon of the 4-HPA 1-hydroxylase protein is in fact 78 bp downstream of a GTG initiator codon in phase with the ATG. The Shine-Dalgarno sequence AGGA, allowing ribosome binding, is found upstream of the initiator ATG but not upstream of the GTG initiator codon, which confirms that the coding region begins at the ATG initiator codon. The portion between the GTG and ATG codons probably does not therefore correspond to a preprotein. Thus defined, the hpaH gene is 1737 bp long and ends with the TGA stop codon. The gene consists of 70.9% of GC bases.

[0288] Now that we have defined with precision the limits of the hpaH gene, the product of its translation: the HPAH protein, will be analyzed.

[0289] II.2.9—Analysis of the HPAH Protein

[0290] The hpaH sequence is translated using the universal codon system. A 563 amino acid protein is thus obtained, which represents a molecular weight of 62.2 kDa. The protein homology searches (BLASTP) show that the HPAH exhibits approximately 15 to 25% identity essentially with proteins of Gram-positive organisms, encoding enzyme activities apparently very different from that sought. Thus, a Streptomyces argillaceus oxygenase, E. coli 3-(3-hydroxyphenyl)propionate hydroxylase (EC 1.14.13.-), Sphingomonas sp. 2,4-dihydroxybenzoate monooxygenase, the enzyme catalyzing the 6-hydroxylation of tetracycline in Streptomyces aureofaciens, and a potential Streptomyces fradiae oxygenase are found. In fact, the HPAH exhibits homologies with the proteins of the phenol monooxygenase (pheA) family and those of the 2,4-dichlorophenol hydroxylase (tfdb) family. The alignment corresponding to the abovementioned proteins is performed using the ClustalW algorithm (FIG. 8). It makes it possible to demonstrate very conserved boxes. Three units of interaction with FAD are noted, inter alia. The first (GXGXXG) corresponds to the ?-?-? structural unit which allows interaction of the ADP component of FAD with the protein. The second unit, (A/C)DG, is involved in the binding of FAD, while the third unit, G(R)VXX(A)GD(A)XH, allows interaction with the flavin component of FAD. Although the enzyme uses NADH,H⁺, the corresponding binding site (GDH) is not identified. This absence of NADH,H⁺-binding site is a characteristic often observed in other FAD monooxygenases. Finally, a unit (DXXXLXWKLX XXXXXXXXXX LLXXYXXER) is observed which is also found in other hydroxylases (Ferrandez et al., 1997), but the meaning of which is not understood. Although the 3-(3-hydroxyphenyl)propionate hydroxylase of E. coli catalyzes a hydroxylation reaction on a substrate structurally close to 4-HPA, the information acquired with this bioinformatic analyses does not make it possible to be sure that we have indeed identified the 4-HPA 1-hydroxylase. The only way to do this is to express the hpaH gene and to study its enzyme activity.

[0291] II.2.10—Identity of the Proteins Involved in the 4-HPA 1-Hydroxylase Activity

[0292] II.2.10.1—Expression of the hpaH Gene Encoding the 4-HPA 1-Hydroxylase

[0293] In order to confirm that the hpaH gene encodes the 4-HPA 1-hydroxylase activity, it is necessary to express the gene. To do this, a two-step cloning strategy is used, making it possible to eliminate genes No. 1 and 3 and to place the hpaH gene under the control of the lac promoter of the original vector pBBR1MCS-Gm-Not-U. The plasmid obtained is named pBBR1MCS FT12?1. A crude extract is produced from a culture, on rich medium, of P. putida transformed with this plasmid. The search for activity by spectrophotometry (at 340 and 292 nm) shows that the clone definitely has the NADH,H⁺ oxidase activity induced by adding 4-HPA, but does not have the ability to synthesize homogentisate from the 4-HPA. On the other hand, the appearance of a molecule Z having a very close retention time (tr=1.2 minutes versus 1.4 minutes) but a UV spectrum very different from that of HGA. We put forward the hypothesis that HPAH oxidizes NADH,H⁺ so as to reduce its cofactor FAD. The reoxidation of FAD takes place to the detriment of 4-HPA since it is the addition of 4-HPA which initiates the reaction. The 4-HPA is therefore converted to metabolite Z. The UV spectrum of this metabolite suggests that the ring is no longer aromatic but may, however, be unsaturated. A structural hypothesis for metabolite Z is presented in FIG. 2. This experiment shows that the lac promoter is functional in P. putida in the absence of IPTG inducer, which suggests that the lacI repressor is naturally absent in P. putida. We also demonstrate that the protein initially purified (HPAH) is really a 4-HPA-dependent NADH,H⁺ oxidase which converts 4-HPA to metabolite Z. The HPAH does not produce HGA. It is therefore necessary to identify the partner protein(s) of this NADH,H⁺ oxidase dependent on 4-HPA, the addition of which makes it possible to restore the 4-HPA 1-hydroxylase activity.

[0294] II.2.10.2—Identification of the HPAC Protein by Gel Filtration

[0295] We have seen that the 4-HPA 1-hydroxylase activity disappeared during the purification of the HPAH on a Red affinity column. We therefore put forward the hypothesis that the partner protein(s) of the 4-HPA-dependent NADH,H⁺ oxidase were not retained by the Red 120 agarose affinity resin and are therefore recovered in the flow-through. We therefore decided to purify the flow-through and to search for the protein(s) which, when added to the HPAH, made it possible to restore the 4-HPA 1-hydroxylase activity. To do this, the flow-through is concentrated by ultrafiltration (10K Macrosep™) and then loaded onto an S75 gel filtration column. A flow rate of 1 mL.min¹ is applied and the 1 mL fractions are collected. Enzyme reactions are then carried out, mixing together 50 ?L of each fraction and 10 ?L of HPAH purified beforehand on a Red column, under normal reaction conditions. The stopped reactions are then analyzed by HPLC. It is observed that fractions 90 to 108, when added to HPAH protein, make it possible to produce more metabolite Z. The production of metabolite Z is detected in these same fractions in the absence of introduction of HPAH. Moreover, on the acrylamide gel corresponding to these fractions, we observe a protein of molecular weight equivalent to HPAH. We concluded that the flow-through still contained a little HPAH protein. When fractions 109 to 143 are added to the HPAH protein, the production of HGA is observed. The greater the production of HGA, the weaker the production of metabolite Z. The maximum production of homogentisate is obtained for fractions 116 to 128. Loading the fractions between 95 and 145 onto acrylamide gel shows that a protein is highly enriched in fractions 109 to 143, i.e. the chromatographic profile of this protein coincides with the production profile of HGA. We decided to name this protein HPAC. The HPAC protein is excised from the gel and then microsequenced at the N-terminal. The sequence obtained, MTTKTFA, shows that this protein is encoded by gene 1 (FIG. 7), which we henceforth named hpaC. This experiment shows that the 4-HPA 1-hydroxylase activity involves two proteins, HPAH and HPAC. However, we have not defined the nature of the interaction between these two proteins: (1) are HPAH and HPAC both enzymes, or else (2) does HPAH have an enzyme activity which is modifiable as a function of the interaction with HPAC.

[0296] II.2.10.3—Nature of the Interactions between HPAH and HPAC

[0297] The preceding experiment demonstrates that the HPAH and HPAC proteins are necessary to reconstitute the 4-HPA 1-hydroxylase activity. Two hypotheses to explain the respective role of these proteins are put forward. In this paragraph, we present the results which suggest that HPAC is an enzyme in its own right. Fractions 100, 101 and 102 from the gel filtration are pooled. They contain the HPAH, i.e. the NADH,H⁺ oxidase activity which makes it possible to produce metabolite Z from 4-HPA. Moreover, fractions 123, 124 and 125 from the gel filtration are pooled. They contain the HPAC. Various enzyme reactions are carried out using the HPAH and/or the HPAC. These reactions are carried out in two steps. A first reaction is carried out with the HPAH (respectively HPAC), and it is stopped after 30 minutes by heat treatment (100° C., 10 min). The HPAC (respectively HPAH) is then added and the reaction is pursued for 30 minutes. The reaction is finally stopped by adding perchloric acid. Reactions are also carried out by replacing one of the enzymes with water. Finally, equivalent experiments are carried out by filtering the reactions through 10 kD Nanosep™ (Pall Filtron) instead of boiling them. TABLE NO. 1 summarizes the results obtained Experiment Metabolite No. Enzyme No. 1 Enzyme No. 2 observed HPAH, HPAC / HGA A HPAH H₂O metabolite Z B HPAH HPAC HGA C H₂O HPAC / D HPAC H₂O / E HPAC HPAH metabolite Z F H₂O HPAH metabolite Z

[0298] We observe that the only way to produce the HGA is to have the two proteins HPAH and HPAC simultaneously or successively in this order. When the HPAH is alone, or when the HPAC is introduced before the HPAH, only metabolite Z is detectable. Finally, the HPAC protein has no enzyme activity on 4-HPA. These results suggest that metabolite Z is a reaction intermediate. The HPAH would convert 4-HPA to metabolite Z, this reaction allowing the oxidation of NADH,H⁺. Metabolite Z would then be converted to HGA by the HPAC. Physical interactions between the two proteins do not appear to be necessary since the HPAH protein can be denatured or removed by filtration before adding the HPAC. We have shown, in vitro, that the 4-HPA 1-hydroxylase activity depends on the HPAC and HPAH protein. However, the HPAC protein is not pure on exiting on gel filtration, it is only enriched. It therefore remains possible that, in reality, it is another protein contained in this enriched extract which converts metabolite Z to HGA. In order to eliminate the doubts, we decided to clone the two genes (hpaC and hpaH) on the same vector; in this case, we should produce the 4-HPA 1-hydroxylase activity and therefore be able to make P. putida grow on minimum medium containing 4-HPA as the only carbon source.

[0299] II.2.10.4—Functional Complementation of P. putida with hpaH and hpaC

[0300] The plasmid pL1lac2 (FIG. 9) is a vector pBBR1MCS-Gm^(R) containing the hpaC gene under the control of the P. fluorescens HPPD promoter and, in the opposite direction, the hpaH gene under the control of a lac promoter. The plasmid is introduced into P. putida by electroporation. The bacteria are then plated out on minimum medium containing or not containing 4-HPA as the only carbon source. After 5 days, the colonies are visible only on dishes containing 4-HPA as the only carbon source. After 8 days, the colonies are a good size. The plasmid DNA extracted from these colonies confirms the presence of the whole plasmid pL1lac2. Moreover, P. putida is incapable of growing on 4-HPA when the bacterium is transformed with the vector pBBR1MCS-GMR containing either the hpaC gene or the hpaH gene. The functional complementation obtained in this experiment confirms that the hpaC and hpaH genes are necessary and sufficient to initiate the 4-HPA 1-hydroxylase activity sought.

EXAMPLE III Construction of the Various Cytosolic Expression Cassettes

[0301] III.1-HPAC

[0302] The HPAC gene was isolated from Pseudomonas acidovorans by PCR on a plasmid derived (p5kbC) from a genomic DNA cosmid library, using the following oligonucleotides: Start ORF1 (AflIII): GCAGGATGCA CATGTCCACC AAGAC ORF1 Fin (HindIII): CGGACGCAAG CTTGCATCAG CCTTC

[0303] The reaction was carried out according to standard conditions. The amplified fragment, 993 bp in size, was subcloned into the plasmid pGEMTeasy (Promega) according to the supplier's protocol. The plasmid pOZ150 thus obtained was sequenced. The cassette obtained by EcoRI+SpeI digestion was cloned into the plasmid pBluescriptII-KS+ opened with the same enzymes, to give the plasmid, pEPA13. The CsVMV promoter is isolated from the plasmid pCH27, derived from the plasmid pUC19 containing the expression cassette for a herbicide tolerance gene under the control of CSVMV. For this, a standard PCR was carried out on a thermocycler with Pfu polymerase generating blunt ends; 1 cycle of 5 min at 95° C., 30 cycles [95° C. 30 sec, 57° C. 30 sec, 72° C. 1 min], 72° C. 3 min. The primers used are: N-CsVMV: GCCCTCGAGG TCGACGGTAT TGATCAGCTT CC introducing the XhoI and BclI sites

[0304] C-CsVMV: CGCTCTAGAA TTCAGATCTA CAAAC (EcoRI)

[0305] The 565 bp fragment generated is digested with XhoI+EcoRI before being inserted into the plasmid pEPA13 digested beforehand with XhoI+EcoRI; the plasmid pEPA14 is obtained. The Nos terminator is isolated from the plasmid pRD11, derived from pBlueScript II-SK(−) in which the Nos terminator is cloned, by HindII+NotI digestion. The 292 bp fragment obtained is cloned into the plasmid pEPA14 opened with the same enzymes, giving pEPA15.

[0306] pEPA15 cassette=CsVMV promoter-hpa C-Nos terminator (FIG. 10; SEQ ID No. 19).

[0307] III.2. HPAH

[0308] The HPAH gene was isolated from Pseudomonas acidovorans by PCR on a plasmid derived (p5kbC) from genomic DNA cosmid library, using the following oligonucleotides:

[0309] Start ORF2 (AflIII): CAGAGGACGA ACAACATGTC CCACC

[0310] ORF2 Fin3 (HindIII): CTGTGGATGA AGCTTAAGAG GTTCAGGC

[0311] The reaction was carried out according to standard conditions. The amplified fragment, 1729 bp in size, was subcloned blunt-ended into the plasmid pBlueScript II SK digested with EcoRV. The plasmid pEPA16 thus obtained was sequenced. The CaMV 35S promoter is isolated from the plasmid pCH14, derived from the plasmid pBI 121 containing the GUS expression cassette: CaMV 35S promoter-GUS-Nos terminator. For this, a standard PCR was carried out on a thermocycler with Pfu polymerase generating blunt ends; 1 cycle of 5 min at 95° C. 30 cycles [95° C. 30 sec, 63° C. 30 sec, 72° C. 1 min], 72° C. 3 min. The primers used are:

[0312] N-CaMV: GCATGCCTCG AGCCCACAGA TGG introducing the XhoI site

[0313] C-CaMV: CCACCCGGGG ATCCTCTAGA G introducing the BamHI site.

[0314] The 839 bp fragment generated is digested with XhoI+BamHI before being inserted into the plasmid pEPA16 digested beforehand with XhoI+BclI: the plasmid pEPA17 is thus obtained. The Nos terminator is isolated from the plasmid pRD11 by PCR, under the same conditions as previously, for 1 cycle of 5 min at 95° C., 30 cycles [95° C. 30 sec, 57° C. 30 sec, 72° C. 1 min], 72° C. 3 min, with the following primers:

[0315] N-Nos: CAAGCTTATC GATACCGTCG ACG introducing HindIII

[0316] C-Nos: GSSTTGCGGC CGCAATTCCC GACCTAGGA ACATAG introducing-NotI an AvrII.

[0317] The 305 bp fragment obtained is digested with NotI+HindIII before being cloned into the plasmid pEPA17 opened with the same enzymes, giving pEPA18. pEPA18 cassette=CaMV 35S promoter-hpaH-Nos terminator (FIG. 11; SEQ ID No. 17).

[0318] II.3. HPPO

[0319] The HPPO gene was isolated from Arthrobacter globiformis by PCR on the cosmid 2A derived from a genomic DNA cosmid library, using the following oligonucleotides:

[0320] N-term-HPPO-ScaI: GAATTCAGTA CTTCACTTAC AGTGTCCGGC introducing the EcoRI and ScaI restriction sites;

[0321] C-term-HPPO-AsuII-XhoI: GAATTCTCGA GTTCGAACAA ACTGAGTAGC AGCTCA introducing the EcoRI, XhoI and AsuII sites.

[0322] The reaction was carried out according to standard conditions. The 1800 bp fragment obtained is cloned into the vector pGEMT-easy (Promega) according to the supplier's protocol. The plasmid pOZ151 thus obtained was sequenced. The cassette obtained by digestion with SphI+XhoI was cloned into the plasmid pBBR1-MCS (Gm) opened with the same enzymes, to give the plasmid pEPA20. The histone simple promoter is isolated from the plasmid pCH9, derived from the plasmid pUC19 containing the expression cassette for EPSPS: histone simple promoter-intron2-OTP-EPSPS-histone terminator. For this, a standard PCR was carried out with Pfu polymerase generating blunt ends; 1 cycle of 5 min at 95° C., 5 cycles [95° C. 30 sec, 45° C. 30 sec, 72° C. 1 min], 30 cycles [95° C. 30 sec, 65° C. 30 sec, 72° C. 1 min], 72° C. 3 min. The primers used are:

[0323] N-SH: GCTTGCATGC CTAGGTCGAG GAGAAATATG introducing the SphI and AvrII sites

[0324] C-SH: CATGAGGGGT TCGAAATCGA TAAGC

[0325] The 970 bp fragment generated is digested with SphI before being inserted into the plasmid pEPA20 digested beforehand with SphI+ScaI; in the plasmid pEPA21 obtained, the initiating ATG of the HPPO gene is recreated behind the simple histone promoter. The histone terminator is isolated from the same plasmid pCH9 by PCR, under the same conditions as previously, for 1 cycle of 5 min at 95° C., 35 cycles [95° C. 30 sec, 55° C. 30 sec, 72° C. 1 min], 72° C. 3 min, with the following primers:

[0326] N-Hister: CTAGACCTAG GGGATCCCCC GATC introducing AvrII

[0327] C-Hister: CCCACTAGTG TTTAAATGAT CAGTCAGGCC GAAT introducing SpeI and BclI.

[0328] The 726 bp fragment obtained is digested with SpeI+AvrII before being cloned into the plasmid pEPA21 opened with SpeI, giving pEPA22.

[0329] pEPA22 cassette=histone simple promoter-hppO-histone terminator (FIG. 12; SEQ ID No. 15).

[0330] III.4. Association of the Genes

[0331] The cassette containing the HPAC gene is extracted from pEPA15 by NotI digestion and cloned into pEPA18 (NotI+Bsp120I) so as to form pEPA19 (FIG. 13; SEQ ID No. 21). The latter is digested with AvrII so as to clone the extracted cassette into the AvrII+SpeI sites of pEPA22. The plasmid containing the three constructs is pEPA23 (FIG. 14; SEQ ID No. 22).

[0332] III.5. Binary Vector

[0333] In order to transform the plants with Agrobactetium, the three constructs can be extracted with BclI in order to be introduced into a binary vector of Agrobacteria. Abbreviations: 3,4-DHPA 3,4-dihydroxyphenylacetic acid 4-HPA 4-hydroxyphenylacetic acid DNA deoxyribonucleic acid APcI Atmospheric Pressure chemical Ionization RNA ribonucleic acid mRNA messenger ribonucleic acid ETB ethidium bromide BLAST Basic Local Alignment Search Tool BSA bovine serum albumin C¹⁰⁰ carbenicillin (100 ?g/mL) CRLD Centre de Recherche La Dargoire [La Dargoire Centre for Research] Da Dalton DKN isoxaflutole diketonitrile DMSO dimethyl sulfoxide dATP 2′-deoxyadenosine 5′-triphosphate dCTP 2′-deoxycytidine 5′-triphosphate dGTP 2′-deoxyguanosine 5′-triphosphate dNTP 2′-deoxynucleotide 5′-triphosphate dTTP 2′-deoxythymidine 5′-triphosphate DTE dithioerithritol DTT 1,4-dithiothreitol EDTA ethylenediaminetetraacetic acid FAD flavin adenine dinucleotide FPLC fast protein liquid chromatography Gm²⁰ gentamycin (20 ?g/mL) HGA homogentisic acid HPLC high performance liquid chromatography HPP hydroxyphenylpyruvic acid HPPD hydroxyphenylpyruvic acid dioxygenase HPPO hydroxypherlylpyruvate oxidase IFT isoxaflutole IPTG isopropyl-?-thiogalactopyranoside Kn⁵⁰ kanamycin (50 ?g/mL) kb kilo bases Km Michaelis Menten constant L-DOPA 3,4-dihydroxyphenylalanine LB Luria Bertani medium min minutes mJ millijoules MNDD manganese dependent dioxygenase MndD gene encoding MNDD NAD⁺ (H, H⁺) nicotinamide adenine dinucleotide (oxidized form/reduced form) GMO genetically modified organism OTP optimized transit peptide bp base pairs pBBR1MCS-Gm plasmid pBBR1MCS resistant to gentamycin PCR polymerase chain reaction ppm parts per million; mg.L⁻¹ PVDF polyvinylidene difluoride qs quantity sufficient for Q.r. respiratory coefficient Rif¹⁰⁰ rifampicin (100 ?g/mL) NMR nuclear magnetic resonance SDS sodium dodecyl sulfate sec second TBE trisborate EDTA TEV tobacco etch virus TEA trifluoroacetic acid TrEMBL translated EMBL bank Tris tris(hydroxymethyl)aminomethane U.V. ultraviolet vs versus X-gal 5-bromo-4-chloro-3-?-D-galactopyranoside

REFERENCES

[0334] Abe, H.; Uchiyama M.; Sato, R. (1974) Isolation of phenylacetic acid and its p-hydroxyderivative as auxin-like substances from Undaria pinnatifida. Agric. Biol. Chem. 38: 897-898

[0335] Adachi, K.; Takeda, Y.; Senoh, S.; Kita, H. (1964) Metabolism of p-hydroxyphenylacetic acid in Pseudomonas ovalis. Biochem. Biophys. Acta 93: 483-493

[0336] Appert, C.; Logemann, E.; Hahlbrock, K.; Schmid, J.; Amrhein, N.; (1994) Structural and catalytic properties of the four phenylalanine ammonia-lyase isoenzymes from parsley (Petroselinum crispum Nym.); Eur. J. Biochem.; 225:491-499

[0337] Arunachalam, U.; Massey, V.; Vaidyanathan, C. S. (1992) p-hydroxyphenylacetate 3-hydroxylase. J. Biol. Chem. 267:25848-25855

[0338] Arunachalam, U.; Massey, V. (1994) Studies on the oxidative half-reaction of p-hydroxyphenylacetate 3-hydroxylase. J. Biol. Chem. 269: 11795-11801

[0339] Arunachalam, U.; Massey, V.; Miller, S. L (1994) Mechanism of p-hydroxyphenylacetate 3-hydroxylase. J. Biol. Chem. 269: 150-155

[0340] Aubert, S. (1994) Effet multiples du glycèrol sur le mètabolisme de la cellule vègètale non chlorophylienne [Multiple effect of glycerol on the metabolism of the non-chlorophyll-containing plant cell]. Thesis. University Joseph Fourier—Grenoble—France

[0341] Aubert S.; Gout, E.; Bligny, R.; Marty-Mazars, D.; Barrieu, F.; Alabouvette, J; Marty, F.; Douce, R. (1996a) Ultrastructural and biochemical characterization of autophagy in higher plant cells subjected to carbon deprivation: control by the supply of mitochondria with respiratory substrates. J. Cell Biol. 133: 1251-1263

[0342] Aubert, S.; Alban, C.; Bligny, R.; Douce, R. (1996b) Induction of beta-methylcrotonyl-coenzyme A carboxylase in higher plant cells during carbohydrate starvation: evidence for a role of MCCase in leucine metabolism. FEBS Lett. 383: 175-180

[0343] Aubert, S.; Bligny, R.; Douce, R. (1996c). NMR studies of metabolism in cell suspensions and tissue cultures, in “Nuclear Magnetic Resonance in Plant Physiology” (Y. Shachar-Hill and P. Pfeffer, Eds.), pp.109-154, American Society of Plant Physiologists, Rockville, USA.

[0344] Aubert, S.; Bligny, R.; Day, D. A.; Whelan, J.; Douce, R. 1997. Induction of alternative oxidase synthesis by herbicides inhibiting branched-chain amino acid synthesis. Plant J. 11:649-657

[0345] Aubert, S.; Curien, G.; Bligny, R.; Gout, E.; Douce, R. (1998) Transport, compartimentation and metabolism of homoserine in higher plant cells. Carbon-13 and phosphorus-31-nuclear magnetic resonance studies. Plant Physiol. 116: 547-557

[0346] Aubert, S.; Pallett, K. (2000) Combined use of ¹³C- and ¹⁹F-NMR to analyse the mode of action and the metabolism of the fluoride herbicide isoxaflutole. Plant Physiol. Biochem., 38: 517-523

[0347] Ausubel, F. M.; Brent, R.; Kingston, R. E.; Moore, D. D.; Seidman, J. G.; Smith, J. A.; Struhl, K. (1995) Current protocols in molecular biology (volume 1-4). Wiley ed., Massachusetts General Hospital & Harward Medical School.

[0348] Bate, N. J.; Orr, J.; Ni, W.; Meromi, A.; Nadler-Hassar, T.; Doerner, P. W.; Dixon, R. A.; Lamb, C. J.; Elkind, Y. (1994) Quantitative relationship between phenylalanine ammonia-lyase levels and phenylpropanoid accumulation in transgenic tobacco identifies a rate-determining step in natural product synthesis. Proc. Natl. Acad. Sci. USA 91: 7608-12

[0349] Battersby, A. R.; Chrystal, E. J.; Staunton, J. (1980) Studies of enzyme-mediated reactions. Part 12. Stereochemical course of the decarboxylation of (2S)-tyrosine to tyramine by microbial, mammalian and plant systems. J. Chem. Soc. 1: 31-42

[0350] Bickel, H.; Palme, L.; Schultz, G. (1978) Incorporation of shikmate and other precursors into aromatic amino acids and prenylquinones of isolated spinach chloroplasts. Phytochemisty. 17: 119-124

[0351] Bickel, E; Buchholz, G.; Schultz, G. (1979) On the compartimentation of the biosynthesis of aromatic amino acids and prenylquinones in higher plants. In Advances in the biochemist and physiology of plant lipids, Appelqvist, L. A. Liljenberg, C., eds. Elsevier, Amsterdam pp 369-375

[0352] Biswas, I.; Gruss, A.; Ehrlich, S. D.; Maguin, E. (1993) High-efficiency gene inactivation and replacement system for Gram-positive bacteria. J. Bacteriol. 175: 3628-3535

[0353] Blakley, E. R. (1977) The catabolism of L-tyrosine by an Arthrobacter sp., Can. J. Microbiol. 23:1128-1139

[0354] Bligny, R.; Leguay, J. J. (1987) Techniques of cell cultures. Meth Enzymol. 148: 3-16

[0355] Boehringer Mannheim (1995) The DIG system user's guide for filter hybridization

[0356] Boldt, Y. R.; Sadowsky, M. J.; Ellis, L. B. M.; Que, L.; Wackett, L. P. (1995) A Manganese-dependent Dioxygenase from Arthrobacter globiformis CM-2 belongs to the major extradiol dioxygenase family. J. Bacteriol. 177: 1225-1232

[0357] Borresen, T; Klausen, N. K.; Larsen, L. M.; Sorensen, H. (1989) Purification and characterisation of tyrosine decarboxylase and aromatic-L-amino-acid decarboxylase. Biochem. Biophys. Acta 993:108-115

[0358] Bradford, M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254

[0359] Brouquisse, R.; James, F.; Pradet, A.; Raymond, P. (1992) Asparagine metabolism and nitrogen distribution during protein degradation in sugar-starved maize root tips. Planta. 188: 384-395

[0360] Callis, J. (1995) regulation of proteine degradation. Plant Cell. 7: 845-857

[0361] Campos-Garcia J., Najera R., Camarena L., Soberon-Chavez G. (2000) The Pseudomonas aeruginosa motR gene involved in regulation of bacterial motility. FEMS Microbiol Lett. 184:57-62

[0362] Chan, M. T.; Chao, Y. C.; Yu, S. M. (1994) Novel gene expression system for plant cells based on induction of alpha-amylase promoter by carbohydrate starvation. J. Biol Chem. 269:17635-17641

[0363] Chang, A. K.; Duggleby, R. G. (1997) Expression, purification and characterization of Arabidopsis thaliana acetohydroxyacid synthase. Biochem. J. 327: 161-169

[0364] Chevalier, C.; Bourgeois, E.; Just, D.; Raymond, P.; (1996) Metabolic regulation of asparagine synthetase gene expression in maize (Zea mays L.) root tips. Plant J. 9: 1-11

[0365] Chua, N. H. (1980) electrophoretic analysis of chloroplast proteins. Methods Enzymol. 69: 434-446

[0366] Coligan, J. E.; Dunn, B. M.; Ploegh, H. L.; Speicher, D. W.; Wingfield, P. T. Current protocols in protein science. Wiley ed.

[0367] Coligan, J. E. (1997) Chapter 11: Chemical analysis in Current Protocols in Protein Science. Coligan, J. E.; Dunn, B. M.; Ploegh, H. L.; Speicher, D. W.; Wingfield, P. T. (eds.) Wiley. Vol. 1.

[0368] David, C.; Daro, A.; Szalai, E.; Atarhouch, T.; Mergeay, M.(1996) Formation of polymeric pigments in the presence of bacteria and comparison with chemical oxidative coupling-II. Catabolism of tyrosine and hydroxyphenylacetic acid by Alcaligenes eutrophus CB34 and mutants. Eur. Polym. J., 32: 669-679

[0369] De Lorenzo V., Herero M., Jakubzik U., Timmis K. N. (1990) Mini-Tn5 trasposon drivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J Bacteriol 172: 6568-6572

[0370] D'Souza L M, Willson R C, Fox G E (2000) Expression of RNAs in Pseudomonas putida Curr Microbiol. 40: 91-95

[0371] Despeghel, J. P.; Delrot, S. (1983) Energetics of amino acids uptake by Vicia faba leaf tissue. Plant Physiol. 71: 1-6

[0372] Dey & Harborne (1997) Plant Biochemistry, page 389, PA P. M. Dey & J. B. Harborne, Academic Press

[0373] Fedi S., Brazil D., Dowling D. N., O'Gara F. (1996) Construction of a modified mini-Tn5 lacZY non-antibiotic marker cassette: ecological evaluation of a lacZY marked Pseudomonas strain in the sugarbeet rhizospherm FEMS Microbiol Lett. 135: 251-257

[0374] Feretti, L.; Sgaramella, V. (1981) Specific and reversible inhibition of the blunt end joining activity of the T4 DNA ligase. Nucleic Acid Res. 9:3695-3705

[0375] Ferrandez, A.; Garcia, J. L.; Diaz, E. (1997) Genetic characterization and expression in heterologous hosts of the 3-(3-hydroxyphenyl)-propionate catabolic pathway of Escherichia coli K12. J. Bacteriol. 179: 2573-2581

[0376] Filleur, S.; Daniel-Vedele, F. (1999) Expression analysis of a high affinity nitrate transporter isolated from Arabidopsis thaliana by differential display. Planta 207: 461-469

[0377] Flodin, C.; Whitfield, F. B. (1999) 4-hydroxybenzoic acid: a likely precursor of 2,4,6-tribromophenol in Ulva lactuca. Phytochemistry. 51:249-255

[0378] Flügge, U.-I. (1998) Metabolite transporters in plastids. Curr. Opinion Plant Biotech., 1: 201-206

[0379] Folch, J.; Lees, M.; Sloane-Stanley, G. H. (1957) A simple method for the isolation and purification of lipids from animal tissues. J Biol Chem 226:497-509

[0380] Frommer, W. B.; Kwart, M.; Hirner, B.; Fischer, W. N.; Hummel, S.; Ninnemann, O. (1994) Transporters for nitrogenous compounds in plants. Plant Mol. Biol. 26: 1651-1670

[0381] Gaines, C. G.; Byng, G. S.; Whitaker, R. J.; Jensen, R. A. (1982) L-tyrosine regulation and biosynthesis via argenate dehydrogenase in suspension-cultured cells of Nicotiana silvestri speg. et comes. Planta, 156: 233-240

[0382] Galan, B.; Diaz, E.; Prieto, M. A. (2000) Functional analysis of the small component of the 4-hydroxyphenylacetate 3-monooxygenase of Escherichia coli W: a prototype of a new flavin NAD(P)H reductase subfamily. J. Bacteriol. 182 627-636

[0383] Garcia, I.; Rodgers, M.; Lenne, C.; Rolland, A.; Sailland, A.; Matringe, M. (1997) Subcellular localisation and purification of a p-hydroxyphenylpyruvate dioxygenase from cultured carrot cells and characterisation of the corresponding cDNA. Biochem. J.; 325: 761

[0384] Garcia, I.; Rodgers, M.; Pèpin, R.; Ksieh, T.-F., Matringe, M. (1999) Characterization and subcellular compartmentation of recombinant 4-hydroxyphenylpyravate dioxygenase from Arabidopsis in transgenic tobacco. Plant Physiol. 119: 1507-1516

[0385] Gazzarini, S.; Lejay, L.; Gojon, A; Ninnemann, O.; Frommer, W. B.; von Wiren, N. (1999) Three functional transporters for constitutive, diurnally regulated and starvation-induced uptake of ammonium into Arabidopsis roots. Plant Cell. 11: 937-948

[0386] Genix, P.; Bligny, R.; Martin, J. B.; Douce, R. (1990) Transient accumulation of asparagine in sycamore cells after a long period of sucrose starvation. Plant Physiol. 94: 717-722

[0387] Georgalaki, M. D.; Sarantinopoulos, P.; Ferreira, E. S.; De Vuyst, L.; Kalantzopoulos, G.; Tsakalidou, E. (2000) Biochemical properties of Streptococcus macedonicus strains isolated from Greek Kasseri cheese. J. Appl. Microbiol. 88: 817-825

[0388] Goodchild, J. A.; Givan, C. V. (1990) Influence of ammonium and external pH on the amino and organic acid content of suspension culture cells of Acer pseudoplatanus L. Physiol. plant 78: 29-37

[0389] Goodwin & Mercer (1988) Introduction to plant biochemistry, 2^(nd) edition. Pergamon Press p. 356

[0390] Gout, E.; Bligny, R.; Genix, P.; Tissut, M.; Douce, R. (1992). Effect of glyphosate on plant cell metbolism. ³¹P and ¹³C NMR studies. Biochimie. 74: 875-882

[0391] Greenberg, D. M. ( ) Metabolic pathways. Amino acids and tetrapyrroles, 3^(rd) edition, Academic Press, vol. III: p. 148

[0392] Gross, D. (1975) Growth regulating substances of plant origin. Phytochemistry. 14: 2105-2112

[0393] Grunstein, M.; Hogness, D. S. (1975) Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc. Nalt. Acad. Sci. U.S.A. 72: 3961-3965

[0394] Hahlbrock, K.; Scheel, D.; (1989) Physiology and molecular biology of phenylpropanoid metabolism. Ann Rev. Plant Physiol. Plant Mol. Biol.; 40: 347-369

[0395] Hareland, W. A.; Crawford, R. L.; Chapman, P. J.; Dagley, S. (1975) Metabolic function and properties of 4-hydroxyphenylacetic acid 1-hydroxylase from Pseudomonas acidovorans. J. Bacteriol., 121: 272-285

[0396] Hess, J. L. (1993) Vitamine E, α-Tocophèrols. In Antioxidans in Higher Plants Edited by Alscher, R.; Hess, J.; Boca Raton: CRC: p.:111-134

[0397] Hill, C. M.; Duggleby, R. G. (1998) Mutagenesis of Escherichia coli acetohydroxyacid synthase isoenzyme II and characterization of three herbicide-insensitive forms. Biochem. J. 335: 653-661

[0398] Homeyer, U.; Litek, K.; Huchzermeyer, B.; Schultz, G. (1989) Uptake of phenylalanine into isolated barley vacuoles is driven by both tonoplast adenosine triphosphatase and pyrophosphatase. Plant Physiol. 89: 1388-1393

[0399] Jones, D.; Keddie, R. M. (1991) The genus Arthrobacter. In: The procaryotes (Balows, A; Trüper, H. G.; Dworkin, M; Harder, W.; Schleifer, K. H., eds.) 2nd eds., Springer-Verlag, New-York

[0400] Journet E. P., Bligny R., Douce R. (1986) Biochemical changes during sucrose deprivation in higher plant cells. J. Biol. Chem. 261: 3193-3199

[0401] Junge, K; Gosink, J. J.; Hoppe, H.-G.; Staley, J. T. (1998) Arthrobacter, Brachybacterium and Planococcus isolates identified from antarctic sea ice brine. Description of Planococcus mcmeekinii, sp. nov. System. Appl. Appl. Microbiol., 21: 306-314

[0402] Kaiser, G.; Martinoia, E.; Wiemken, A. (1982) Rapid appearance of photosynthetic products in the vacuoles isolated from barley mesophyll protoplasts by a new fast method. Z. Pflanzenphysiol. 107: 103-113

[0403] Keen, N. T., Tamai, S., Kobayashi, D., Trollinger, D., (1988), Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria, Gene, 70, 191-197

[0404] Kindl, H. (1969) Biosynthesis and metabolism of hydroxyphenylacetic acids in higher plants. Eur. J. Biochem. 7:340-347

[0405] Koch, C.; Schumann, P.; Stackebrandt, E. (1995) Reclassification of Micrococcus agilis (Ali-Cohen 1889) to the genus Arthrobacter as Arthrobacter agilis comb. nov. and emendation of the genus Arthrobacter. Int. J. Syst. Bacteriol. 45: 837-839

[0406] Kovach M E, Phillips R W, Elzer P H, Roop R M 2nd, Peterson K M (1994) pBBR1MCS: a broad-host-range cloning vector. Biotechiques 16: 800-802

[0407] Kovach M E, Elzer P H, Hill D S, Robertson G T, Farris M A, Roop R M 2nd, Peterson K M (1995) Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166: 175-176

[0408] Kruk, J.; Strzalka, K. (1998) Identification of plastoquinone-C in spinach and maple leaves by revere-phase high-performance liquid chromatography. Phytochemistry 49: 2267-2271

[0409] Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-683

[0410] Lamport, D. T. A.; Northcote, D. H. (1960) Hydroxyproline in primary cell walls of higher plants. Nature: 188: 665-666

[0411] Laursen, R. A. (1971) Solid-phase Edman degradation. An automatic peptide sequencer. Eur. J. Biochem. 20: 89-102.

[0412] Li, Z.-C; Bush, D. R. (1990) ΔpH-dependent amino acid transport into plasma membrane vesicles isolated from sugar beet leaves. I. Evidence for carrier-mediated, electrogenic flux through multiple transport systems. Plant Physiol. 94: 268-277

[0413] Li, Z.-C; Bush, D. R. (1991) ΔpH-dependent amino acid transport into plasma membrane vesicles isolated from sugar beet (Beta vulgaris L.) leaves. II. Evidence for multiple aliphatic, neutral amino acid symports. Plant Physiol. 96: 1338-1344

[0414] Liu, D.-L.; Xu, S.-X; Wang, W.-F. (1998) a novel lignan glucoside from Forsythia suspensa Vahl. J. Chin. Pharmaceut. Sci. 7: 49-51

[0415] Löffelhardt, W. (1977) The biosynthesis of phenylacetic acids in blue-green alga Anacystis nidulans: evidence for the involvement of a thylakoïd-bound L-amino acid oxidase. Z. Naturforsch. 32: 345-350

[0416] Luscombe, B. M.; Palett, K. E.; Loubierre, P.; Millet, J.-C.; Melgarejo, J.; Vrabel, T. E. (1995) RPA 201772 a novel herbicide for broad leaf and grass weeds control in maize and sugar cane, Proc. Brighton Crop Prot. Conf. Weeds, 1: 35

[0417] Luscombe, B. M.; Pallett, K. E.; (1996) Isoxaflutole for weed control in maize, Pesticide Outlook; December, 29

[0418] Lutterbach, R.; Stöckigt, J. (1994) in vivo investigation of plant cell metabolism by men of natural-abundance ¹³C-NMR spectroscopy. Helv. Chim. Acta, 77: 2153-2161

[0419] Lutterbach, R.; Stöckigt, J.; (1995), Dynamics of the biosynthesis of methylrsubin in plant cells employing in vivo ¹³C-NMR without labelling. Phytochemistry, 40: 801-806

[0420] MacLaighlin, P. J.; Weihrauch, J. L. (1979) Vitamine E content of foods. J. Am. Diet. Assoc. 75: 647-665

[0421] Maniatis, T.; Fritsch, E. F.; Sambrook, J. (1982) Molecular cloning—A laboratory manual eds Cold Spring Harbor Laboratory

[0422] Martin, M.; Gibello, A.; Fernandez, J.; Ferrer, E.; Garrido-Pertierra, A. (1991) Catabolism of 3- and 4-hydroxyphenylacetic acid by Klebsiella pneumoniae. J. Gen. Microbiol. 132: 621-628.

[0423] Mayer, M. P.; Beyer, P.; Kleinig, H. (1990) Quinone compounds are able to replace molecular oxygen as terminal electron acceptor in phytoen desaturation in chromoplasts of Narcissus pseudonarcissus L. Eur. J. Biochem. 191: 359-363

[0424] Mayer, M. P.; Nievelstein, V.; Beyer, P. (1992) Purification and characterization of a NADPH dependent oxidoreductase from chromoplasts of Narcissus pseudonarcissus: a redox-mediator possibly involved in carotene desaturation. Plant Physiol. Biochem. 30: 389-398

[0425] Mazelis, M. (1980) Amino acid metabolism In “the biochemistry of plants” (Stumpf, P K, Conn, E E; eds.), vol.5: amino acids and derivatives. Academic press, London, New York, pp: 1-55

[0426] Michal, G.—ed.—(1999) Biochemical Pathways, An atlas of biochemistry and molecular biology, Wiley & Spektrum eds., p. 60

[0427] Miflin, B. J.; Lea, P. J. (1982) Ammonium assimilation and amino acid metabolism. In A. B. Boulter, B. Parthiers, eds, Encyclopedia of Plant Physiology, Vol. 14, Nucleic Acids and Proteins in Plants 1. Springer Verlag, Berlin PP: 5-64

[0428] Moreno-Arribas, V.; Lonvaud-Funel, A. (1999) Tyrosine decarboxylase activity of Lactobacillus brevis IOEB 9809 isolated from wine and L. brevis ATCC 367. FEMS Microbiology Letters. 180: 55-60

[0429] Moreno-Arribas, V.; Torlois, S.; Joyeux, A.; Bertrand, A.; Lonvaud-Funel, A. (2000) Isolation, properties and behaviour of tyramine-producing lactic acid bacteria from wine. J. Appl. Microbiol. 88: 584593

[0430] Morot-Gaudry, J. F. (1997) Assimilation de l'azote chez les plantes. Aspects physiologique, biochimique et molèculaire. INRA Editions.

[0431] Mouillon, J. M.; Aubert, S.; Bourguignon, J.; Gout, E.; Douce, R.; Rebeillè, F. (1999)

[0432] Glycine and serine catabolism in non-photosynthetic higher plant cells: their role in C1 metabolism Plant J. 20: 197-205

[0433] Murashige, T.; Skoog (1962) A revised medium for rapid growth and bio assays with tobacco tissue cultures. Physiol. Plant. 15: 473

[0434] Negrel, J.; Javelle, F.; (1995); Induction of phenylpropanoid and tyramine metabolism in pectinase or pronase elicited cell suspension cultures of tobacco (Nicotiana tabacum); Physiologia Plantarum, 95: 569-574

[0435] Nester, E. W.; Montoya, A. L. (1976) An enzyme common to histidine and aromatic amino acid biosynthesis in Bacillus subtilis. J. Bacteriol. 126: 699-705

[0436] Norris, S. R.; Barette, T. R.; DellaPenna, D. (1995) Genetic dissection of carotenoid synthesis in Arabidopsis defines plastoquinone as an essential component of phytoene desaturation Plant Cell 7: 2139-2149

[0437] Pallett, K. E.; Little, J. P.; Sheekey, M.; Veerasekaran, P. (1998) The mode of action of Isoxaflutole. I. Physiological effects, metabolism and selectivity. Pestic. Biochem Physiol. 62: 113-124

[0438] Prieto, M. A.; Perez-Randa, A.; Garcia, J. L. (1993) Characterization of an Escherichia coli aromatic hydroxylase with a broad substrate range. J. Bacteriol. 175: 2162-2167

[0439] Prieto, M. A.; Garcia, J. L.; (1994) Molecular characterization of 4-hydroxyphenylacetate 3-hydroxylase of Escherichia coli. J. Biol. Chem. 269: 22823-22829

[0440] Prieto, M. A.; Diaz, E.; Garcia, J. L. (1996) Molecular characterization of the 4-hydroxyphenylacetate catabolic pathway of Escherichia coil W: engineering a mobile aromatic degradative cluster. J. Bacteriol. 178: 111-120

[0441] Prieto M. A., Kellerhals M. B., Bozzato G. B., Radnovic D., Witholt B., Kessler B. (1999) Engineering of stable reombinant bacteria for production of chiral medium-chain-length poly-3-hydroxyakanoates. Appl. Environ Microbiol. 65: 3265-3271

[0442] Roberts, J. K. M. (2000) NMR adventures in the metabolic labyrinth within plants. Trends Plant Sci. 5: 30-34

[0443] Roby, C.; Martin, J. B.; Bligay, R.; Douce, R. (1987) Biochemical changes during sucrose deprivation in higher plant cells. Phosphos-31 nuclear resonance magnetic studies. J. Biol. Chem. 262: 5000-5007

[0444] Sailland, A.; Matringe, M.; Rolland, A.; Pallett, K. (1995) Gène de l'hydroxy-phényl pyruvate dioxygénase et obtention de plantes contenant ce gène résistantes aux herbicides [Hydroxyphenylpyruvate dioxygenase gene and production of herbicide-resistant plants containing this gene]. WO 96/385567

[0445] Sailland, A., Derose, R. (1999) Method for enzymatic preparation of homogentisate. WO9934008 A 19990708

[0446] Sambrok; Fritsch; Maniatis. Molecular cloning. A laboratory manual, 2^(nd) edition

[0447] Schroeder, C.; Sommer, J.; Humpfer, E.; Stöckigt, J. (1997) Inverse correlated ¹H-¹³C in vivo NMR as a probe to follow the metabolism of unlabelled vanillin by plant cell cultures. Tetrahedron, 53: 927-934

[0448] Schoenle, E. J.; Adams, L. D.; Sammons, D. W. (1984) Insulin-induced rapid decrease of a major protein in fat cell plasma membranes. J. Biol. Chem. 259: 12112-12116

[0449] Shachar-Hill, Y.; Pfeffer, P. E.; Germann, M. W. (1996) Following plant metabolism in vivo and in extracts with heteronuclear two-dimensional nuclear magnetic resonance spectroscopy. Analytic. Biochem., 243: 110-118

[0450] Singer, M.; Berg, P. (1992) Genes & Genomes. Ed. VIGOT, Paris

[0451] Sparnins, V. L.; Dagley, S. (1975) Alternative routes of aromatic catabolism in Pseudomonas acidovorans and Pseudomonas putida: Gallic acid as a substrate and inhibitor of dioxygenases. J. Bacteriol. 124: 1374-1381

[0452] Stafford, H. A.; (1994) Anthocyanins and betalains: evolution of the mutually exclusive pathways. Plant Sci; 101: 91-98

[0453] Suemori, A.; Nakajima, K.; Kurane, R.; Nakamura, Y. (1995) L-Phenylalanine and L-Tyrosine degradative pathways in Rhodococcus erythropolis. Report Nat. Inst. Biosci. Hum. Tech. 3: 33-36

[0454] Suemori, A.; Nakajima, K.; Kurane, R.; Nakamura, Y. (1996) Purification and characterization of o-hydroxyphenylacetate 5-hydroxylase, m-hydroxyphenylacetate 6-hydroxylase and p-hydroxyphenylacetate 1-hydroxylase from Rhodococcus erythropolis. Journal of Fermentation and Bioengineering, 81: 133-137

[0455] Swiatek, L.; Grabias, B.; Kalemba, D. (1998) Phenolic acids in certain medicinal plants of the genus Artemisia. Pharm. Pharmacol. Lett. 4:158-160

[0456] Swiatek, L. (1977) kwasy fenolowe I Glukozydy irydoidowe w niektorych krajowych gatunkach leczniczych z rodzaju Plantago. Herba Polonica XXIII (3): 201-209

[0457] Takizawa, N.; Yokoyama, H.; Yanagihara, K.; Hatta, T.; Kiyohara, H. (1995) A locus of Pseudomonas pickettii DTP0602. had, that encodes 2,4,6-trichlorophenol 4-dechlorinase with hydroxylase activity, and hydroxylation of various chlorophenols by the enzyme. J. Ferment. Bioeng. 80: 318-326

[0458] Trieu-Cuot, P.; Carlier, C.; Poyart-Salmeron, C.; Courvalin, P. (1991) An integrative vector exploiting the transposition properties of Tn1545 for insertional mutagenesis and cloning of genes from Gram-positive bacteria. Gene 106: 21-27

[0459] Tseng, T. C.; Tsai, T. H.; Lue, M. Y.; Lee, H. T. (1995) Identification of sucrose-regulated genes in cultured rice cells using mRNA differential display. Gene. 161: 179-1782

[0460] Vertes, A.; Asai, Y.; Inui, N; Kobayashi, M; Kurusu, Y.; Yukawa, H., (1994) Transposon mutagenesis of Coryneform bacteria, Mol. Gen Genet., 245, 397-405

[0461] Vierstra, R. D. (1993) Protein degradation in plants. Ann. Rev. Plant Physiol. Plant Mol. Biol. 44: 385-410

[0462] Viviani; F.; Little, J.; Pallett, K. E. (1998) Mode of action of Isoxaflutole—2-Characterisation of the inhibition of the carrot 4-hydroxyphenylpyuvate dioxygenase by the diketonitrile derivative of isoxaflutole; Pestic. Biochem. Physiol. 62: 125-134

[0463] Whistance, G. R.; Threlfall, D. R. (1970) Biosynthesis of phytoquinones. Homogentisic acid: a precursor of plastoquinones, tocopherols and alpha-tocopherolquinone in higher plants, green algae and blue-green algae. Biochem J. 117: 593-600

[0464] Xun, L. Y. (1996) Purification and characterization of chlorophenol 4-monooxygenase from Burkholderia cepacia AC1100. J. Bacteriol. 178: 2645-2649

[0465] Xun, L. & Sandvik, E. R. (2000) Characterization of 4-hydroxyphenylacetate 3-hydroxylase (HpaB) of Escherichia coli as a reduced Flavin Adenine Dinucleotide-utilizing monooxygenase. Appl Env. Microbiol 66: 481-486

1 22 1 1683 DNA Arthrobacter globiformis CDS (1)..(1683) 1 atg act tca ctt aca gtg tcc ggc cgg gtg gcg cag gtc ctc agc agc 48 Met Thr Ser Leu Thr Val Ser Gly Arg Val Ala Gln Val Leu Ser Ser 1 5 10 15 tat gtc agc gat gtg ttc ggt gtg atg ggc aac gga aac gtc tac ttc 96 Tyr Val Ser Asp Val Phe Gly Val Met Gly Asn Gly Asn Val Tyr Phe 20 25 30 ctg gac gcc gcc gag aag gag ggc ctc cgc ttc acg gcc gta cgc cat 144 Leu Asp Ala Ala Glu Lys Glu Gly Leu Arg Phe Thr Ala Val Arg His 35 40 45 gaa ggt gcc gcc atc gcg gcg gcg gac gcc tac tat cgg gca tcc ggg 192 Glu Gly Ala Ala Ile Ala Ala Ala Asp Ala Tyr Tyr Arg Ala Ser Gly 50 55 60 cgc ctg gcg gcg ggg acc acc acc tac ggc ccc ggt tac acc aac gcc 240 Arg Leu Ala Ala Gly Thr Thr Thr Tyr Gly Pro Gly Tyr Thr Asn Ala 65 70 75 80 ctg acg gcc ctc gcc gag gcg gtc cag gcg cag atc ccc gtg gtg ctc 288 Leu Thr Ala Leu Ala Glu Ala Val Gln Ala Gln Ile Pro Val Val Leu 85 90 95 gtc acc ggg gac gcc ccg agc agc ggc gcc cgg cct tgg gac gtg gac 336 Val Thr Gly Asp Ala Pro Ser Ser Gly Ala Arg Pro Trp Asp Val Asp 100 105 110 cag gcc gcg atc gcc gcc ggg ctg ggg gcg gcg acc ttc acg gtc acc 384 Gln Ala Ala Ile Ala Ala Gly Leu Gly Ala Ala Thr Phe Thr Val Thr 115 120 125 cgt gaa gcc gca ggc tcc atc acg cag gaa gcg gtg gag tac gca ctt 432 Arg Glu Ala Ala Gly Ser Ile Thr Gln Glu Ala Val Glu Tyr Ala Leu 130 135 140 gcc cgg cgg acc gcc gtc gtg atc gcc gtt cca tac gac ctg tcg gcc 480 Ala Arg Arg Thr Ala Val Val Ile Ala Val Pro Tyr Asp Leu Ser Ala 145 150 155 160 ctt gag gcg gcg gag gaa gat ctt ccc gtg ccg ccg gcg gcc tcg gtt 528 Leu Glu Ala Ala Glu Glu Asp Leu Pro Val Pro Pro Ala Ala Ser Val 165 170 175 ccg gac gcc atc ggc ggc gga ctc gga cgg gcg gcc gaa gtg cgg gcg 576 Pro Asp Ala Ile Gly Gly Gly Leu Gly Arg Ala Ala Glu Val Arg Ala 180 185 190 gcc gaa ttg ctg gcg ggc gcg aag cgg ccg ctc atc ctt gcc ggc cgc 624 Ala Glu Leu Leu Ala Gly Ala Lys Arg Pro Leu Ile Leu Ala Gly Arg 195 200 205 ggt gcg cac ctc gca gga gcc ggc ccc gaa ctc cgg gaa ctc gcc gac 672 Gly Ala His Leu Ala Gly Ala Gly Pro Glu Leu Arg Glu Leu Ala Asp 210 215 220 cgc ctc ggc gcg ctc acg gcc ggc acc gca ctg gcg ctg aac ctg ctg 720 Arg Leu Gly Ala Leu Thr Ala Gly Thr Ala Leu Ala Leu Asn Leu Leu 225 230 235 240 cag ggc gag ggg tac ctc ggc gtc gcg ggc ggc ttc ggc acg gat acc 768 Gln Gly Glu Gly Tyr Leu Gly Val Ala Gly Gly Phe Gly Thr Asp Thr 245 250 255 gcc gcc ggg ctc atg ggc gag gcg gac gtg gtg ctc gtg gcg gga gcc 816 Ala Ala Gly Leu Met Gly Glu Ala Asp Val Val Leu Val Ala Gly Ala 260 265 270 agc ctg acc ccc ttc acc atg cgc ttc ggc cac ctg atc ggc ccg gac 864 Ser Leu Thr Pro Phe Thr Met Arg Phe Gly His Leu Ile Gly Pro Asp 275 280 285 gcc acc gtg atc cag atc gac acc gcc atg gag ccg acg gac ccg cgg 912 Ala Thr Val Ile Gln Ile Asp Thr Ala Met Glu Pro Thr Asp Pro Arg 290 295 300 gtg gac ctg ttt gtc agt gcg gac gcg aag gcc gct gcc ggc cgg atc 960 Val Asp Leu Phe Val Ser Ala Asp Ala Lys Ala Ala Ala Gly Arg Ile 305 310 315 320 ctc cgg ctg ctg gat gac gcc gcc ggg gcc aat gcg tcg aag gcc tgg 1008 Leu Arg Leu Leu Asp Asp Ala Ala Gly Ala Asn Ala Ser Lys Ala Trp 325 330 335 cgc gcg gaa gca ctc aag cgt ctg gcc gaa gga ccc tgc cac cac ccc 1056 Arg Ala Glu Ala Leu Lys Arg Leu Ala Glu Gly Pro Cys His His Pro 340 345 350 ggc acc gca gag acc acg gac ggc cgc ctt gac ccc cgg gcg ctt gct 1104 Gly Thr Ala Glu Thr Thr Asp Gly Arg Leu Asp Pro Arg Ala Leu Ala 355 360 365 tcg gca ctg gat gcc gtc ctg ccg gaa cgc cgc acc gtg gtc cag gac 1152 Ser Ala Leu Asp Ala Val Leu Pro Glu Arg Arg Thr Val Val Gln Asp 370 375 380 ggc ggg cac ttc ctg ggc tgg gca ccc atg tac tgg cgc atc ccc cgt 1200 Gly Gly His Phe Leu Gly Trp Ala Pro Met Tyr Trp Arg Ile Pro Arg 385 390 395 400 cct cag gac ctg gtc atg gtg ggg acc gcg tac cag tcg atc ggg ctt 1248 Pro Gln Asp Leu Val Met Val Gly Thr Ala Tyr Gln Ser Ile Gly Leu 405 410 415 ggc ctg gcc agc gcc gtg ggg gcg tcc cgg gcc gtg gac gac ggc aat 1296 Gly Leu Ala Ser Ala Val Gly Ala Ser Arg Ala Val Asp Asp Gly Asn 420 425 430 atc ctg gtg ctg gcg gcg ggc gac ggc gga ttc ctg atg ggc ctg tcc 1344 Ile Leu Val Leu Ala Ala Gly Asp Gly Gly Phe Leu Met Gly Leu Ser 435 440 445 gac ctg gaa tcg ctc gtg ggc gcg gcg agc agc gcc gtc gtg gtg atc 1392 Asp Leu Glu Ser Leu Val Gly Ala Ala Ser Ser Ala Val Val Val Ile 450 455 460 tac aac gac gcc gcc tac ggg gcc gag atc cat cag tac ggc tca cgg 1440 Tyr Asn Asp Ala Ala Tyr Gly Ala Glu Ile His Gln Tyr Gly Ser Arg 465 470 475 480 ggg ctc acc gaa aag ccc atg ctg atc ccc gaa gtg gac ttc agc ggg 1488 Gly Leu Thr Glu Lys Pro Met Leu Ile Pro Glu Val Asp Phe Ser Gly 485 490 495 att gcc cgc gcg atc ggg gcg gaa tcc gca atc atc cgc aag ctg tcg 1536 Ile Ala Arg Ala Ile Gly Ala Glu Ser Ala Ile Ile Arg Lys Leu Ser 500 505 510 gac ctc tcc gcg ctc acg gac tgg atc gag gcc ggc gcc agg gga acc 1584 Asp Leu Ser Ala Leu Thr Asp Trp Ile Glu Ala Gly Ala Arg Gly Thr 515 520 525 ttc gtg gcc gac tgc cgc atc acc tca agc gtc cgg gcc ccg tgg ctg 1632 Phe Val Ala Asp Cys Arg Ile Thr Ser Ser Val Arg Ala Pro Trp Leu 530 535 540 agc gaa tgg atg agg gcc tcg caa gcg gcg aag gag gcg gtg gcg ggc 1680 Ser Glu Trp Met Arg Ala Ser Gln Ala Ala Lys Glu Ala Val Ala Gly 545 550 555 560 tag 1683 2 560 PRT Arthrobacter globiformis 2 Met Thr Ser Leu Thr Val Ser Gly Arg Val Ala Gln Val Leu Ser Ser 1 5 10 15 Tyr Val Ser Asp Val Phe Gly Val Met Gly Asn Gly Asn Val Tyr Phe 20 25 30 Leu Asp Ala Ala Glu Lys Glu Gly Leu Arg Phe Thr Ala Val Arg His 35 40 45 Glu Gly Ala Ala Ile Ala Ala Ala Asp Ala Tyr Tyr Arg Ala Ser Gly 50 55 60 Arg Leu Ala Ala Gly Thr Thr Thr Tyr Gly Pro Gly Tyr Thr Asn Ala 65 70 75 80 Leu Thr Ala Leu Ala Glu Ala Val Gln Ala Gln Ile Pro Val Val Leu 85 90 95 Val Thr Gly Asp Ala Pro Ser Ser Gly Ala Arg Pro Trp Asp Val Asp 100 105 110 Gln Ala Ala Ile Ala Ala Gly Leu Gly Ala Ala Thr Phe Thr Val Thr 115 120 125 Arg Glu Ala Ala Gly Ser Ile Thr Gln Glu Ala Val Glu Tyr Ala Leu 130 135 140 Ala Arg Arg Thr Ala Val Val Ile Ala Val Pro Tyr Asp Leu Ser Ala 145 150 155 160 Leu Glu Ala Ala Glu Glu Asp Leu Pro Val Pro Pro Ala Ala Ser Val 165 170 175 Pro Asp Ala Ile Gly Gly Gly Leu Gly Arg Ala Ala Glu Val Arg Ala 180 185 190 Ala Glu Leu Leu Ala Gly Ala Lys Arg Pro Leu Ile Leu Ala Gly Arg 195 200 205 Gly Ala His Leu Ala Gly Ala Gly Pro Glu Leu Arg Glu Leu Ala Asp 210 215 220 Arg Leu Gly Ala Leu Thr Ala Gly Thr Ala Leu Ala Leu Asn Leu Leu 225 230 235 240 Gln Gly Glu Gly Tyr Leu Gly Val Ala Gly Gly Phe Gly Thr Asp Thr 245 250 255 Ala Ala Gly Leu Met Gly Glu Ala Asp Val Val Leu Val Ala Gly Ala 260 265 270 Ser Leu Thr Pro Phe Thr Met Arg Phe Gly His Leu Ile Gly Pro Asp 275 280 285 Ala Thr Val Ile Gln Ile Asp Thr Ala Met Glu Pro Thr Asp Pro Arg 290 295 300 Val Asp Leu Phe Val Ser Ala Asp Ala Lys Ala Ala Ala Gly Arg Ile 305 310 315 320 Leu Arg Leu Leu Asp Asp Ala Ala Gly Ala Asn Ala Ser Lys Ala Trp 325 330 335 Arg Ala Glu Ala Leu Lys Arg Leu Ala Glu Gly Pro Cys His His Pro 340 345 350 Gly Thr Ala Glu Thr Thr Asp Gly Arg Leu Asp Pro Arg Ala Leu Ala 355 360 365 Ser Ala Leu Asp Ala Val Leu Pro Glu Arg Arg Thr Val Val Gln Asp 370 375 380 Gly Gly His Phe Leu Gly Trp Ala Pro Met Tyr Trp Arg Ile Pro Arg 385 390 395 400 Pro Gln Asp Leu Val Met Val Gly Thr Ala Tyr Gln Ser Ile Gly Leu 405 410 415 Gly Leu Ala Ser Ala Val Gly Ala Ser Arg Ala Val Asp Asp Gly Asn 420 425 430 Ile Leu Val Leu Ala Ala Gly Asp Gly Gly Phe Leu Met Gly Leu Ser 435 440 445 Asp Leu Glu Ser Leu Val Gly Ala Ala Ser Ser Ala Val Val Val Ile 450 455 460 Tyr Asn Asp Ala Ala Tyr Gly Ala Glu Ile His Gln Tyr Gly Ser Arg 465 470 475 480 Gly Leu Thr Glu Lys Pro Met Leu Ile Pro Glu Val Asp Phe Ser Gly 485 490 495 Ile Ala Arg Ala Ile Gly Ala Glu Ser Ala Ile Ile Arg Lys Leu Ser 500 505 510 Asp Leu Ser Ala Leu Thr Asp Trp Ile Glu Ala Gly Ala Arg Gly Thr 515 520 525 Phe Val Ala Asp Cys Arg Ile Thr Ser Ser Val Arg Ala Pro Trp Leu 530 535 540 Ser Glu Trp Met Arg Ala Ser Gln Ala Ala Lys Glu Ala Val Ala Gly 545 550 555 560 3 1944 DNA Artificial CDS (55)..(1737) A. globiformis HPPO mutant 3 ccgacgtcgc atgctcccgg ccgccatggc ggccgcggga attcgattga attc atg 57 Met 1 act tca ctt aca gtg tcc ggc cgg gtg gcg cag gtc ctc agc agc tat 105 Thr Ser Leu Thr Val Ser Gly Arg Val Ala Gln Val Leu Ser Ser Tyr 5 10 15 gtc agc gat gtg ttc ggt gtg atg ggc aac gga aac gtc tac ttc ctg 153 Val Ser Asp Val Phe Gly Val Met Gly Asn Gly Asn Val Tyr Phe Leu 20 25 30 gac gcc gcc gag aag gag ggc ctc cgc ttc acg gcc gta cgc cat gaa 201 Asp Ala Ala Glu Lys Glu Gly Leu Arg Phe Thr Ala Val Arg His Glu 35 40 45 ggt gcc gcc atc gcg gcg gcg gac gcc tac tat cgg gca tcc ggg cgc 249 Gly Ala Ala Ile Ala Ala Ala Asp Ala Tyr Tyr Arg Ala Ser Gly Arg 50 55 60 65 ctg gcg gcg ggg acc acc acc tac ggc ccc ggt tac acc aac gcc ctg 297 Leu Ala Ala Gly Thr Thr Thr Tyr Gly Pro Gly Tyr Thr Asn Ala Leu 70 75 80 acg gcc ctc gcc gag gcg gtc cag gcg cag atc ccc gtg gtg ctc gtc 345 Thr Ala Leu Ala Glu Ala Val Gln Ala Gln Ile Pro Val Val Leu Val 85 90 95 acc ggg gac gcc ccg agc agc ggc gcc cgg cct tgg gac gtg gac cag 393 Thr Gly Asp Ala Pro Ser Ser Gly Ala Arg Pro Trp Asp Val Asp Gln 100 105 110 gcc gcg atc gcc gcc ggg ctg ggg gcg gcg acc ttc acg gtc acc cgt 441 Ala Ala Ile Ala Ala Gly Leu Gly Ala Ala Thr Phe Thr Val Thr Arg 115 120 125 gaa gcc gca ggc tcc atc acg cag gaa gcg gtg gag tac gca ctt gcc 489 Glu Ala Ala Gly Ser Ile Thr Gln Glu Ala Val Glu Tyr Ala Leu Ala 130 135 140 145 cgg cgg acc gcc gtc gtg atc gcc gtt cca tac gac ctg tcg gcc ctt 537 Arg Arg Thr Ala Val Val Ile Ala Val Pro Tyr Asp Leu Ser Ala Leu 150 155 160 gag gcg gcg gag gaa gat ctt ccc gtg ccg ccg gcg gcc tcg gtt ccg 585 Glu Ala Ala Glu Glu Asp Leu Pro Val Pro Pro Ala Ala Ser Val Pro 165 170 175 gac gcc atc ggc ggc gga ctc gga cgg gcg gcc gaa gtg cgg gcg gcc 633 Asp Ala Ile Gly Gly Gly Leu Gly Arg Ala Ala Glu Val Arg Ala Ala 180 185 190 gaa ttg ctg gcg ggc gcg aag cgg ccg ctc atc ctt gcc ggc cgc ggt 681 Glu Leu Leu Ala Gly Ala Lys Arg Pro Leu Ile Leu Ala Gly Arg Gly 195 200 205 gcg cac ctc gca gga acc ggc ccc gaa ctc cgg gaa ctc gcc gac cgc 729 Ala His Leu Ala Gly Thr Gly Pro Glu Leu Arg Glu Leu Ala Asp Arg 210 215 220 225 ctc ggc gcg ctc acg gcc ggc acc gca ctg gcg ctg aac ctg ctg cag 777 Leu Gly Ala Leu Thr Ala Gly Thr Ala Leu Ala Leu Asn Leu Leu Gln 230 235 240 ggc gag ggg tac ctc ggc gtc gcg ggc ggc ttc ggc acg gat acc gcc 825 Gly Glu Gly Tyr Leu Gly Val Ala Gly Gly Phe Gly Thr Asp Thr Ala 245 250 255 gcc ggg ctc atg ggc gag gcg gac gtg gtg ctc gtg gcg gga gcc agc 873 Ala Gly Leu Met Gly Glu Ala Asp Val Val Leu Val Ala Gly Ala Ser 260 265 270 ctg acc ccc ttc acc atg cgc ttc ggc cac ctg atc ggc ccg gac gcc 921 Leu Thr Pro Phe Thr Met Arg Phe Gly His Leu Ile Gly Pro Asp Ala 275 280 285 acc gtg atc cag atc gac acc gcc atg gag ccg acg gac ccg cgg gtg 969 Thr Val Ile Gln Ile Asp Thr Ala Met Glu Pro Thr Asp Pro Arg Val 290 295 300 305 gac ctg ttt gtc agt gcg gac gcg aag gcc gct gcc ggc cgg atc ctc 1017 Asp Leu Phe Val Ser Ala Asp Ala Lys Ala Ala Ala Gly Arg Ile Leu 310 315 320 cgg ctg ctg gat gac gcc gcc ggg gcc aat gcg tcg aag gcc tgg cgc 1065 Arg Leu Leu Asp Asp Ala Ala Gly Ala Asn Ala Ser Lys Ala Trp Arg 325 330 335 gcg gaa gca ctc aag cgt ctg gcc gaa gga ccc tgc cac cac ccc ggc 1113 Ala Glu Ala Leu Lys Arg Leu Ala Glu Gly Pro Cys His His Pro Gly 340 345 350 acc gca gag acc acg gac ggc cgc ctt gac ccc cgg gcg ctt gct tcg 1161 Thr Ala Glu Thr Thr Asp Gly Arg Leu Asp Pro Arg Ala Leu Ala Ser 355 360 365 gca ctg gat gcc gtc ctg ccg gaa cgc cgc acc gtg gtc cag gac ggc 1209 Ala Leu Asp Ala Val Leu Pro Glu Arg Arg Thr Val Val Gln Asp Gly 370 375 380 385 ggg cac ttc ctg ggc tgg gca ccc atg tac tgg cgc atc ccc cgt cct 1257 Gly His Phe Leu Gly Trp Ala Pro Met Tyr Trp Arg Ile Pro Arg Pro 390 395 400 cag gac ctg gtc atg gtg ggg acc gcg tac cag tcg atc ggg ctt ggc 1305 Gln Asp Leu Val Met Val Gly Thr Ala Tyr Gln Ser Ile Gly Leu Gly 405 410 415 ctg gcc agc gcc gtg ggg gcg tcc cgg gcc gtg gac gac ggc aat atc 1353 Leu Ala Ser Ala Val Gly Ala Ser Arg Ala Val Asp Asp Gly Asn Ile 420 425 430 ctg gtg ctg gcg gcg ggc gac ggc gga ttc ctg atg ggc ctg tcc gac 1401 Leu Val Leu Ala Ala Gly Asp Gly Gly Phe Leu Met Gly Leu Ser Asp 435 440 445 ctg gaa tcg ctc gtg ggc gcg gcg agc agc gcc gtc gtg gtg atc tac 1449 Leu Glu Ser Leu Val Gly Ala Ala Ser Ser Ala Val Val Val Ile Tyr 450 455 460 465 aac gac gcc gcc tac ggg gcc gag atc cat cag tac ggc tca cgg ggg 1497 Asn Asp Ala Ala Tyr Gly Ala Glu Ile His Gln Tyr Gly Ser Arg Gly 470 475 480 ctc acc gaa aag ccc atg ctg atc ccc gaa gtg gac ttc agc ggg att 1545 Leu Thr Glu Lys Pro Met Leu Ile Pro Glu Val Asp Phe Ser Gly Ile 485 490 495 gcc cgc gcg atc ggg gcg gaa tcc gca atc atc cgc aag ctg tcg gac 1593 Ala Arg Ala Ile Gly Ala Glu Ser Ala Ile Ile Arg Lys Leu Ser Asp 500 505 510 ctc tcc gcg ctc acg gac tgg atc gag gcc ggc gcc agg gga acc ttc 1641 Leu Ser Ala Leu Thr Asp Trp Ile Glu Ala Gly Ala Arg Gly Thr Phe 515 520 525 gtg gcc gac tgc cgc atc acc tca agc gtc cgg gcc ccg tgg ctg agc 1689 Val Ala Asp Cys Arg Ile Thr Ser Ser Val Arg Ala Pro Trp Leu Ser 530 535 540 545 gaa tgg atg agg gcc tcg caa gcg gcg aag gag gcg gtg gcg ggc tag 1737 Glu Trp Met Arg Ala Ser Gln Ala Ala Lys Glu Ala Val Ala Gly 550 555 560 ggccggcctc gtcgaaatgc cgccctccaa cccaactcag taccagctca gggcgttctc 1797 agggctggga acgccctgag ctgctactca tttgttcgaa ctcgagaatt caatcactag 1857 tgaattcgcg gccgcctgca ggtcgaccat atgggagagc tcccaacgcg ttggatgcat 1917 agcttgagta ttctatagtg tcaccta 1944 4 560 PRT Artificial A. Globiformis HPPO mutant 4 Met Thr Ser Leu Thr Val Ser Gly Arg Val Ala Gln Val Leu Ser Ser 1 5 10 15 Tyr Val Ser Asp Val Phe Gly Val Met Gly Asn Gly Asn Val Tyr Phe 20 25 30 Leu Asp Ala Ala Glu Lys Glu Gly Leu Arg Phe Thr Ala Val Arg His 35 40 45 Glu Gly Ala Ala Ile Ala Ala Ala Asp Ala Tyr Tyr Arg Ala Ser Gly 50 55 60 Arg Leu Ala Ala Gly Thr Thr Thr Tyr Gly Pro Gly Tyr Thr Asn Ala 65 70 75 80 Leu Thr Ala Leu Ala Glu Ala Val Gln Ala Gln Ile Pro Val Val Leu 85 90 95 Val Thr Gly Asp Ala Pro Ser Ser Gly Ala Arg Pro Trp Asp Val Asp 100 105 110 Gln Ala Ala Ile Ala Ala Gly Leu Gly Ala Ala Thr Phe Thr Val Thr 115 120 125 Arg Glu Ala Ala Gly Ser Ile Thr Gln Glu Ala Val Glu Tyr Ala Leu 130 135 140 Ala Arg Arg Thr Ala Val Val Ile Ala Val Pro Tyr Asp Leu Ser Ala 145 150 155 160 Leu Glu Ala Ala Glu Glu Asp Leu Pro Val Pro Pro Ala Ala Ser Val 165 170 175 Pro Asp Ala Ile Gly Gly Gly Leu Gly Arg Ala Ala Glu Val Arg Ala 180 185 190 Ala Glu Leu Leu Ala Gly Ala Lys Arg Pro Leu Ile Leu Ala Gly Arg 195 200 205 Gly Ala His Leu Ala Gly Thr Gly Pro Glu Leu Arg Glu Leu Ala Asp 210 215 220 Arg Leu Gly Ala Leu Thr Ala Gly Thr Ala Leu Ala Leu Asn Leu Leu 225 230 235 240 Gln Gly Glu Gly Tyr Leu Gly Val Ala Gly Gly Phe Gly Thr Asp Thr 245 250 255 Ala Ala Gly Leu Met Gly Glu Ala Asp Val Val Leu Val Ala Gly Ala 260 265 270 Ser Leu Thr Pro Phe Thr Met Arg Phe Gly His Leu Ile Gly Pro Asp 275 280 285 Ala Thr Val Ile Gln Ile Asp Thr Ala Met Glu Pro Thr Asp Pro Arg 290 295 300 Val Asp Leu Phe Val Ser Ala Asp Ala Lys Ala Ala Ala Gly Arg Ile 305 310 315 320 Leu Arg Leu Leu Asp Asp Ala Ala Gly Ala Asn Ala Ser Lys Ala Trp 325 330 335 Arg Ala Glu Ala Leu Lys Arg Leu Ala Glu Gly Pro Cys His His Pro 340 345 350 Gly Thr Ala Glu Thr Thr Asp Gly Arg Leu Asp Pro Arg Ala Leu Ala 355 360 365 Ser Ala Leu Asp Ala Val Leu Pro Glu Arg Arg Thr Val Val Gln Asp 370 375 380 Gly Gly His Phe Leu Gly Trp Ala Pro Met Tyr Trp Arg Ile Pro Arg 385 390 395 400 Pro Gln Asp Leu Val Met Val Gly Thr Ala Tyr Gln Ser Ile Gly Leu 405 410 415 Gly Leu Ala Ser Ala Val Gly Ala Ser Arg Ala Val Asp Asp Gly Asn 420 425 430 Ile Leu Val Leu Ala Ala Gly Asp Gly Gly Phe Leu Met Gly Leu Ser 435 440 445 Asp Leu Glu Ser Leu Val Gly Ala Ala Ser Ser Ala Val Val Val Ile 450 455 460 Tyr Asn Asp Ala Ala Tyr Gly Ala Glu Ile His Gln Tyr Gly Ser Arg 465 470 475 480 Gly Leu Thr Glu Lys Pro Met Leu Ile Pro Glu Val Asp Phe Ser Gly 485 490 495 Ile Ala Arg Ala Ile Gly Ala Glu Ser Ala Ile Ile Arg Lys Leu Ser 500 505 510 Asp Leu Ser Ala Leu Thr Asp Trp Ile Glu Ala Gly Ala Arg Gly Thr 515 520 525 Phe Val Ala Asp Cys Arg Ile Thr Ser Ser Val Arg Ala Pro Trp Leu 530 535 540 Ser Glu Trp Met Arg Ala Ser Gln Ala Ala Lys Glu Ala Val Ala Gly 545 550 555 560 5 1962 DNA Artificial CDS (111)..(1793) A. globiformis HPPO mutant 5 aggtgacact atagaatact caagctatgc atccaacgcg ttgggagctc tcccatatgg 60 tcgacctgca ggcggccgcg aattcactag tgattggaag gatccggtgc atg act 116 Met Thr 1 tca ctt aca gtg tcc ggc cgg gtg gcg cag gtc ctc agc agc tat gtc 164 Ser Leu Thr Val Ser Gly Arg Val Ala Gln Val Leu Ser Ser Tyr Val 5 10 15 agc gat gtg ttc ggt gtg atg ggc aac gga aac gtc tac ttc ctg gac 212 Ser Asp Val Phe Gly Val Met Gly Asn Gly Asn Val Tyr Phe Leu Asp 20 25 30 gcc gcc gag aag gag ggc ctc cgc ttc acg gcc gta cgc cat gaa ggt 260 Ala Ala Glu Lys Glu Gly Leu Arg Phe Thr Ala Val Arg His Glu Gly 35 40 45 50 gcc gcc atc gcg gcg gcg gac gcc tac tat cgg gca tcc ggg cgc ctg 308 Ala Ala Ile Ala Ala Ala Asp Ala Tyr Tyr Arg Ala Ser Gly Arg Leu 55 60 65 gcg gcg ggg acc acc acc tac ggc ccc ggt tac acc aac gcc ctg acg 356 Ala Ala Gly Thr Thr Thr Tyr Gly Pro Gly Tyr Thr Asn Ala Leu Thr 70 75 80 gcc ctc gcc gag gcg gtc cag gcg cag atc ccc gtg gtg ctc gtc acc 404 Ala Leu Ala Glu Ala Val Gln Ala Gln Ile Pro Val Val Leu Val Thr 85 90 95 ggg gac gcc ccg agc agc ggc gcc cgg cct tgg gac gtg gac cag gcc 452 Gly Asp Ala Pro Ser Ser Gly Ala Arg Pro Trp Asp Val Asp Gln Ala 100 105 110 gcg atc gcc ggc ggg ctg ggg gcg gcg acc ttc acg gtc acc cgt gaa 500 Ala Ile Ala Gly Gly Leu Gly Ala Ala Thr Phe Thr Val Thr Arg Glu 115 120 125 130 gcc gca ggc tcc atc acg cag gaa gcg gtg gag tac gca ctt gcc cgg 548 Ala Ala Gly Ser Ile Thr Gln Glu Ala Val Glu Tyr Ala Leu Ala Arg 135 140 145 cgg acc gcc gtc gtg atc gcc gtt cca tac gac ctg tcg gcc ctt gag 596 Arg Thr Ala Val Val Ile Ala Val Pro Tyr Asp Leu Ser Ala Leu Glu 150 155 160 gcg gca gag gaa gat ctt ccc gtg ccg ccg gcg gcc tcg gtt ccg gac 644 Ala Ala Glu Glu Asp Leu Pro Val Pro Pro Ala Ala Ser Val Pro Asp 165 170 175 gcc atc ggc ggc gga ctc gga cgg gcg gcc gaa gtg cgg gcg gcc gaa 692 Ala Ile Gly Gly Gly Leu Gly Arg Ala Ala Glu Val Arg Ala Ala Glu 180 185 190 ttg ctg gcg ggc gcg aag cgg ccg ctc atc ctt gcc ggc cgc ggt gcg 740 Leu Leu Ala Gly Ala Lys Arg Pro Leu Ile Leu Ala Gly Arg Gly Ala 195 200 205 210 cac ctc gca gga gcc ggc ccc gaa ctc cgg gaa ctc gcc gac cgc ctc 788 His Leu Ala Gly Ala Gly Pro Glu Leu Arg Glu Leu Ala Asp Arg Leu 215 220 225 ggc gcg ctc acg gcc ggc acc gca ctg gcg ctg aac ctg ctg cag ggc 836 Gly Ala Leu Thr Ala Gly Thr Ala Leu Ala Leu Asn Leu Leu Gln Gly 230 235 240 gag ggg tac ctc ggc gtc gcg ggc ggc ttc ggc acg gat acc gcc gcc 884 Glu Gly Tyr Leu Gly Val Ala Gly Gly Phe Gly Thr Asp Thr Ala Ala 245 250 255 ggg ctc atg ggc gag gcg gac gtg gtg ctc gtg gcg gga gcc agc ctg 932 Gly Leu Met Gly Glu Ala Asp Val Val Leu Val Ala Gly Ala Ser Leu 260 265 270 acc ccc ttc acc atg cgc ttc ggc cac ctg atc ggc ccg gac gcc acc 980 Thr Pro Phe Thr Met Arg Phe Gly His Leu Ile Gly Pro Asp Ala Thr 275 280 285 290 gtg atc cag atc gac acc gcc atg gag ccg acg gac ccg cgg gtg gac 1028 Val Ile Gln Ile Asp Thr Ala Met Glu Pro Thr Asp Pro Arg Val Asp 295 300 305 ctg ttt gtc agt gcg gac gcg aag gcc gct gcc ggc cgg atc ctc cgg 1076 Leu Phe Val Ser Ala Asp Ala Lys Ala Ala Ala Gly Arg Ile Leu Arg 310 315 320 ctg ctg gat gac gcc gcc ggg gcc aat gcg tcg aag gcc tgg cgc gcg 1124 Leu Leu Asp Asp Ala Ala Gly Ala Asn Ala Ser Lys Ala Trp Arg Ala 325 330 335 gaa gca ctc aag cgt ctg gcc gaa gga ccc tgc cac cac ccc ggc acc 1172 Glu Ala Leu Lys Arg Leu Ala Glu Gly Pro Cys His His Pro Gly Thr 340 345 350 gca gag acc acg gac ggc cgc ctt gac ccc cgg gcg ctt gct tcg gca 1220 Ala Glu Thr Thr Asp Gly Arg Leu Asp Pro Arg Ala Leu Ala Ser Ala 355 360 365 370 ctg gat gcc gtc ctg ccg gaa cgc cgc acc gtg gtc cag gac ggc ggg 1268 Leu Asp Ala Val Leu Pro Glu Arg Arg Thr Val Val Gln Asp Gly Gly 375 380 385 cac ttc ctg ggc tgg gca ccc atg tac tgg cgc atc ccc cgt cct cag 1316 His Phe Leu Gly Trp Ala Pro Met Tyr Trp Arg Ile Pro Arg Pro Gln 390 395 400 gac ctg gtc atg gtg ggg acc gcg tac cag tcg atc ggg ctt ggc ctg 1364 Asp Leu Val Met Val Gly Thr Ala Tyr Gln Ser Ile Gly Leu Gly Leu 405 410 415 gcc agc gcc gtg ggg gcg tcc cgg gcc gtg gac gac ggc aat atc ctg 1412 Ala Ser Ala Val Gly Ala Ser Arg Ala Val Asp Asp Gly Asn Ile Leu 420 425 430 gtg ctg gcg gcg ggc gac ggc gga ttc ctg atg ggc ctg tcc gac ctg 1460 Val Leu Ala Ala Gly Asp Gly Gly Phe Leu Met Gly Leu Ser Asp Leu 435 440 445 450 gaa tcg ctc gtg ggc gcg gcg agc agc gcc gtc gtg gtg atc tac aac 1508 Glu Ser Leu Val Gly Ala Ala Ser Ser Ala Val Val Val Ile Tyr Asn 455 460 465 gat gcc gcc tac ggg gcc gag atc cat cag tac ggc tca cgg ggg ctc 1556 Asp Ala Ala Tyr Gly Ala Glu Ile His Gln Tyr Gly Ser Arg Gly Leu 470 475 480 acc gaa aag ccc atg ctg atc ccc gaa gtg gac ttc agc ggg att gcc 1604 Thr Glu Lys Pro Met Leu Ile Pro Glu Val Asp Phe Ser Gly Ile Ala 485 490 495 cgc gcg atc ggg gcg gaa tcc gca atc atc cgc aag ctg tcg gac ctc 1652 Arg Ala Ile Gly Ala Glu Ser Ala Ile Ile Arg Lys Leu Ser Asp Leu 500 505 510 tcc gcg ctc acg gac tgg atc gag gcc ggc gcc agg gga acc ttc gtg 1700 Ser Ala Leu Thr Asp Trp Ile Glu Ala Gly Ala Arg Gly Thr Phe Val 515 520 525 530 gcc gac tgc cgc atc acc tca agc gtc cgg gcc ccg tgg ctg agc gaa 1748 Ala Asp Cys Arg Ile Thr Ser Ser Val Arg Ala Pro Trp Leu Ser Glu 535 540 545 tgg atg agg gcc tcg caa gcg gcg aag gag gcg gtg gcg ggc tag 1793 Trp Met Arg Ala Ser Gln Ala Ala Lys Glu Ala Val Ala Gly 550 555 560 ggccggcctc gtcgaaatgc cgccctccaa cccaactcag taccagctca gggcgttctc 1853 agggctggga acgccctgag ctgctactca gtttgttcga actcgagaat tcaatcgaat 1913 tcccgcggcc gccatggcgg ccgggagcat gcgacgtcgg gcccattcg 1962 6 560 PRT Artificial A. Globiformis HPPO mutant 6 Met Thr Ser Leu Thr Val Ser Gly Arg Val Ala Gln Val Leu Ser Ser 1 5 10 15 Tyr Val Ser Asp Val Phe Gly Val Met Gly Asn Gly Asn Val Tyr Phe 20 25 30 Leu Asp Ala Ala Glu Lys Glu Gly Leu Arg Phe Thr Ala Val Arg His 35 40 45 Glu Gly Ala Ala Ile Ala Ala Ala Asp Ala Tyr Tyr Arg Ala Ser Gly 50 55 60 Arg Leu Ala Ala Gly Thr Thr Thr Tyr Gly Pro Gly Tyr Thr Asn Ala 65 70 75 80 Leu Thr Ala Leu Ala Glu Ala Val Gln Ala Gln Ile Pro Val Val Leu 85 90 95 Val Thr Gly Asp Ala Pro Ser Ser Gly Ala Arg Pro Trp Asp Val Asp 100 105 110 Gln Ala Ala Ile Ala Gly Gly Leu Gly Ala Ala Thr Phe Thr Val Thr 115 120 125 Arg Glu Ala Ala Gly Ser Ile Thr Gln Glu Ala Val Glu Tyr Ala Leu 130 135 140 Ala Arg Arg Thr Ala Val Val Ile Ala Val Pro Tyr Asp Leu Ser Ala 145 150 155 160 Leu Glu Ala Ala Glu Glu Asp Leu Pro Val Pro Pro Ala Ala Ser Val 165 170 175 Pro Asp Ala Ile Gly Gly Gly Leu Gly Arg Ala Ala Glu Val Arg Ala 180 185 190 Ala Glu Leu Leu Ala Gly Ala Lys Arg Pro Leu Ile Leu Ala Gly Arg 195 200 205 Gly Ala His Leu Ala Gly Ala Gly Pro Glu Leu Arg Glu Leu Ala Asp 210 215 220 Arg Leu Gly Ala Leu Thr Ala Gly Thr Ala Leu Ala Leu Asn Leu Leu 225 230 235 240 Gln Gly Glu Gly Tyr Leu Gly Val Ala Gly Gly Phe Gly Thr Asp Thr 245 250 255 Ala Ala Gly Leu Met Gly Glu Ala Asp Val Val Leu Val Ala Gly Ala 260 265 270 Ser Leu Thr Pro Phe Thr Met Arg Phe Gly His Leu Ile Gly Pro Asp 275 280 285 Ala Thr Val Ile Gln Ile Asp Thr Ala Met Glu Pro Thr Asp Pro Arg 290 295 300 Val Asp Leu Phe Val Ser Ala Asp Ala Lys Ala Ala Ala Gly Arg Ile 305 310 315 320 Leu Arg Leu Leu Asp Asp Ala Ala Gly Ala Asn Ala Ser Lys Ala Trp 325 330 335 Arg Ala Glu Ala Leu Lys Arg Leu Ala Glu Gly Pro Cys His His Pro 340 345 350 Gly Thr Ala Glu Thr Thr Asp Gly Arg Leu Asp Pro Arg Ala Leu Ala 355 360 365 Ser Ala Leu Asp Ala Val Leu Pro Glu Arg Arg Thr Val Val Gln Asp 370 375 380 Gly Gly His Phe Leu Gly Trp Ala Pro Met Tyr Trp Arg Ile Pro Arg 385 390 395 400 Pro Gln Asp Leu Val Met Val Gly Thr Ala Tyr Gln Ser Ile Gly Leu 405 410 415 Gly Leu Ala Ser Ala Val Gly Ala Ser Arg Ala Val Asp Asp Gly Asn 420 425 430 Ile Leu Val Leu Ala Ala Gly Asp Gly Gly Phe Leu Met Gly Leu Ser 435 440 445 Asp Leu Glu Ser Leu Val Gly Ala Ala Ser Ser Ala Val Val Val Ile 450 455 460 Tyr Asn Asp Ala Ala Tyr Gly Ala Glu Ile His Gln Tyr Gly Ser Arg 465 470 475 480 Gly Leu Thr Glu Lys Pro Met Leu Ile Pro Glu Val Asp Phe Ser Gly 485 490 495 Ile Ala Arg Ala Ile Gly Ala Glu Ser Ala Ile Ile Arg Lys Leu Ser 500 505 510 Asp Leu Ser Ala Leu Thr Asp Trp Ile Glu Ala Gly Ala Arg Gly Thr 515 520 525 Phe Val Ala Asp Cys Arg Ile Thr Ser Ser Val Arg Ala Pro Trp Leu 530 535 540 Ser Glu Trp Met Arg Ala Ser Gln Ala Ala Lys Glu Ala Val Ala Gly 545 550 555 560 7 1692 DNA Pseudomonas acidivorans CDS (1)..(1692) 7 atg tcc cac ccc gcc atc tcc ctg caa gcg ctg cgc ggc agc ggc gca 48 Met Ser His Pro Ala Ile Ser Leu Gln Ala Leu Arg Gly Ser Gly Ala 1 5 10 15 gac ata cag tcc atc cac atc ccc tac gag cgc cat gcc gac cag gac 96 Asp Ile Gln Ser Ile His Ile Pro Tyr Glu Arg His Ala Asp Gln Asp 20 25 30 gcc ggt gcg gac acg ccc gcc cgg cat ccc gtc gtc atc gtc ggc gcc 144 Ala Gly Ala Asp Thr Pro Ala Arg His Pro Val Val Ile Val Gly Ala 35 40 45 ggc ccc gtg ggc ctg tcg ctg gcc atc gac ctg gcc cag cgc ggc cag 192 Gly Pro Val Gly Leu Ser Leu Ala Ile Asp Leu Ala Gln Arg Gly Gln 50 55 60 cgc gtg gtg ctg ctg gac aac gac tgc cgg ctg tcc acg ggc tcg cgc 240 Arg Val Val Leu Leu Asp Asn Asp Cys Arg Leu Ser Thr Gly Ser Arg 65 70 75 80 gcc atc tgc ttt tcc aag cgc acg ctg gag atc tgg gac cgc ctg ggc 288 Ala Ile Cys Phe Ser Lys Arg Thr Leu Glu Ile Trp Asp Arg Leu Gly 85 90 95 gtg ggc cag ccc atg gtg gac aag ggc gtg tcc tgg aac ctg ggc aag 336 Val Gly Gln Pro Met Val Asp Lys Gly Val Ser Trp Asn Leu Gly Lys 100 105 110 gtc ttc ttc aag gac cag ccg ctg tac cgc ttc gac ctg ctg ccc gag 384 Val Phe Phe Lys Asp Gln Pro Leu Tyr Arg Phe Asp Leu Leu Pro Glu 115 120 125 gac ggc cac gag cgc ccg gcc ttc atc aac ctg cag cag tac tac gcc 432 Asp Gly His Glu Arg Pro Ala Phe Ile Asn Leu Gln Gln Tyr Tyr Ala 130 135 140 gag gcc tat ctg gtc gag cgc gca ctg cag ctg ccg ctg atc gac ctg 480 Glu Ala Tyr Leu Val Glu Arg Ala Leu Gln Leu Pro Leu Ile Asp Leu 145 150 155 160 cgc tgg cac agc aag gtc acg gca ctg gag ccg cag gcc gag ggc gcg 528 Arg Trp His Ser Lys Val Thr Ala Leu Glu Pro Gln Ala Glu Gly Ala 165 170 175 ctg ctg acc gtg gag acg cct gac ggc agc tac cgc atc gat gcg caa 576 Leu Leu Thr Val Glu Thr Pro Asp Gly Ser Tyr Arg Ile Asp Ala Gln 180 185 190 tgg gtc ctg gcc tgc gat ggc tcg cgc tcg ccg ctg cgc ggc ctg ctg 624 Trp Val Leu Ala Cys Asp Gly Ser Arg Ser Pro Leu Arg Gly Leu Leu 195 200 205 ggc cag gaa agc cat ggc cgc atc ttc cgc gac cgc ttc ctg atc gcc 672 Gly Gln Glu Ser His Gly Arg Ile Phe Arg Asp Arg Phe Leu Ile Ala 210 215 220 gac gtg aag atg cac gcc gaa ttc ccc acc gag cgc tgg ttc tgg ttc 720 Asp Val Lys Met His Ala Glu Phe Pro Thr Glu Arg Trp Phe Trp Phe 225 230 235 240 gac ccg ccc ttc cac ccg ggc cag agc gtg ctg ctg cac cgc cag ccc 768 Asp Pro Pro Phe His Pro Gly Gln Ser Val Leu Leu His Arg Gln Pro 245 250 255 gac gat gtc tgg cgc atc gac ttc cag ctg ggc tgg gac gcg gac ccc 816 Asp Asp Val Trp Arg Ile Asp Phe Gln Leu Gly Trp Asp Ala Asp Pro 260 265 270 gag gaa gag aaa aag ccc gag aac atc gtg ccg cgc atc cgc gcc ctg 864 Glu Glu Glu Lys Lys Pro Glu Asn Ile Val Pro Arg Ile Arg Ala Leu 275 280 285 ctg ggc aag gac gcg ccc ttc gag ctg gaa tgg gcc agc gtc tac acc 912 Leu Gly Lys Asp Ala Pro Phe Glu Leu Glu Trp Ala Ser Val Tyr Thr 290 295 300 ttc gcc tgc ctg cgc atg gac cgc ttc gtc cat ggc cgc gtg gtc ttt 960 Phe Ala Cys Leu Arg Met Asp Arg Phe Val His Gly Arg Val Val Phe 305 310 315 320 gcg ggc gac agc gcc cac ggc gtc tcg ccg ttt ggc gca cgc ggc gcc 1008 Ala Gly Asp Ser Ala His Gly Val Ser Pro Phe Gly Ala Arg Gly Ala 325 330 335 aac agc ggc gtg cag gat gcc gag aac ctg gca tgg aag ctg gac cgc 1056 Asn Ser Gly Val Gln Asp Ala Glu Asn Leu Ala Trp Lys Leu Asp Arg 340 345 350 gtg ctg cgc ggc cag gcc gat gcc tcg ctg atc gcc acc tac ggc gcc 1104 Val Leu Arg Gly Gln Ala Asp Ala Ser Leu Ile Ala Thr Tyr Gly Ala 355 360 365 gag cgc gaa tac gcg gcc gac gag aac atc cgc aac tcc acg cgc gcc 1152 Glu Arg Glu Tyr Ala Ala Asp Glu Asn Ile Arg Asn Ser Thr Arg Ala 370 375 380 acc gac ttc atc acg ccc aag agc gag atc agc cgc ctg ttt cgc gac 1200 Thr Asp Phe Ile Thr Pro Lys Ser Glu Ile Ser Arg Leu Phe Arg Asp 385 390 395 400 gcc gtg ctg gac ctg gcg cgc gac cat gaa ttc gcg cgc cgc atc gtc 1248 Ala Val Leu Asp Leu Ala Arg Asp His Glu Phe Ala Arg Arg Ile Val 405 410 415 aac agc ggg cgg ctg tcc gtg ccg gcc acg ctg cac ggc tcc gcg ctc 1296 Asn Ser Gly Arg Leu Ser Val Pro Ala Thr Leu His Gly Ser Ala Leu 420 425 430 aac acg cct gac acc gac acc ttc gac gga acg cag ctg ccc ggc gcc 1344 Asn Thr Pro Asp Thr Asp Thr Phe Asp Gly Thr Gln Leu Pro Gly Ala 435 440 445 gtg ctg gcc gat gcg ccc atg cgc cgg ccc ggc gca gac ggc acg gcc 1392 Val Leu Ala Asp Ala Pro Met Arg Arg Pro Gly Ala Asp Gly Thr Ala 450 455 460 tgg ctg ctg cgc gca ctg gga ccg gac ttc acg ctg ctg cac ttc gac 1440 Trp Leu Leu Arg Ala Leu Gly Pro Asp Phe Thr Leu Leu His Phe Asp 465 470 475 480 ccc acg ccc gcc tgg gcg cag gcg ctg ccc ggc gtg ctc aac ctg tcc 1488 Pro Thr Pro Ala Trp Ala Gln Ala Leu Pro Gly Val Leu Asn Leu Ser 485 490 495 atc gcg gcc gag ggc gag gcc cat gcg cca gac gcc gac ctc atc gat 1536 Ile Ala Ala Glu Gly Glu Ala His Ala Pro Asp Ala Asp Leu Ile Asp 500 505 510 gcg cgc ggc ctg gcg gcc aaa cgc ctg gat gca cgc ccc ggc acc agc 1584 Ala Arg Gly Leu Ala Ala Lys Arg Leu Asp Ala Arg Pro Gly Thr Ser 515 520 525 tac ctg ctg cgg cct gac cag cat gtc tgc gcg cgc tgg cgc cgc ccc 1632 Tyr Leu Leu Arg Pro Asp Gln His Val Cys Ala Arg Trp Arg Arg Pro 530 535 540 gac gaa gcc agc gtg cgc gcc gcg ctg caa aga gcc tgc ggc gcc gcc 1680 Asp Glu Ala Ser Val Arg Ala Ala Leu Gln Arg Ala Cys Gly Ala Ala 545 550 555 560 gcc acg gcc tga 1692 Ala Thr Ala 8 563 PRT Pseudomonas acidivorans 8 Met Ser His Pro Ala Ile Ser Leu Gln Ala Leu Arg Gly Ser Gly Ala 1 5 10 15 Asp Ile Gln Ser Ile His Ile Pro Tyr Glu Arg His Ala Asp Gln Asp 20 25 30 Ala Gly Ala Asp Thr Pro Ala Arg His Pro Val Val Ile Val Gly Ala 35 40 45 Gly Pro Val Gly Leu Ser Leu Ala Ile Asp Leu Ala Gln Arg Gly Gln 50 55 60 Arg Val Val Leu Leu Asp Asn Asp Cys Arg Leu Ser Thr Gly Ser Arg 65 70 75 80 Ala Ile Cys Phe Ser Lys Arg Thr Leu Glu Ile Trp Asp Arg Leu Gly 85 90 95 Val Gly Gln Pro Met Val Asp Lys Gly Val Ser Trp Asn Leu Gly Lys 100 105 110 Val Phe Phe Lys Asp Gln Pro Leu Tyr Arg Phe Asp Leu Leu Pro Glu 115 120 125 Asp Gly His Glu Arg Pro Ala Phe Ile Asn Leu Gln Gln Tyr Tyr Ala 130 135 140 Glu Ala Tyr Leu Val Glu Arg Ala Leu Gln Leu Pro Leu Ile Asp Leu 145 150 155 160 Arg Trp His Ser Lys Val Thr Ala Leu Glu Pro Gln Ala Glu Gly Ala 165 170 175 Leu Leu Thr Val Glu Thr Pro Asp Gly Ser Tyr Arg Ile Asp Ala Gln 180 185 190 Trp Val Leu Ala Cys Asp Gly Ser Arg Ser Pro Leu Arg Gly Leu Leu 195 200 205 Gly Gln Glu Ser His Gly Arg Ile Phe Arg Asp Arg Phe Leu Ile Ala 210 215 220 Asp Val Lys Met His Ala Glu Phe Pro Thr Glu Arg Trp Phe Trp Phe 225 230 235 240 Asp Pro Pro Phe His Pro Gly Gln Ser Val Leu Leu His Arg Gln Pro 245 250 255 Asp Asp Val Trp Arg Ile Asp Phe Gln Leu Gly Trp Asp Ala Asp Pro 260 265 270 Glu Glu Glu Lys Lys Pro Glu Asn Ile Val Pro Arg Ile Arg Ala Leu 275 280 285 Leu Gly Lys Asp Ala Pro Phe Glu Leu Glu Trp Ala Ser Val Tyr Thr 290 295 300 Phe Ala Cys Leu Arg Met Asp Arg Phe Val His Gly Arg Val Val Phe 305 310 315 320 Ala Gly Asp Ser Ala His Gly Val Ser Pro Phe Gly Ala Arg Gly Ala 325 330 335 Asn Ser Gly Val Gln Asp Ala Glu Asn Leu Ala Trp Lys Leu Asp Arg 340 345 350 Val Leu Arg Gly Gln Ala Asp Ala Ser Leu Ile Ala Thr Tyr Gly Ala 355 360 365 Glu Arg Glu Tyr Ala Ala Asp Glu Asn Ile Arg Asn Ser Thr Arg Ala 370 375 380 Thr Asp Phe Ile Thr Pro Lys Ser Glu Ile Ser Arg Leu Phe Arg Asp 385 390 395 400 Ala Val Leu Asp Leu Ala Arg Asp His Glu Phe Ala Arg Arg Ile Val 405 410 415 Asn Ser Gly Arg Leu Ser Val Pro Ala Thr Leu His Gly Ser Ala Leu 420 425 430 Asn Thr Pro Asp Thr Asp Thr Phe Asp Gly Thr Gln Leu Pro Gly Ala 435 440 445 Val Leu Ala Asp Ala Pro Met Arg Arg Pro Gly Ala Asp Gly Thr Ala 450 455 460 Trp Leu Leu Arg Ala Leu Gly Pro Asp Phe Thr Leu Leu His Phe Asp 465 470 475 480 Pro Thr Pro Ala Trp Ala Gln Ala Leu Pro Gly Val Leu Asn Leu Ser 485 490 495 Ile Ala Ala Glu Gly Glu Ala His Ala Pro Asp Ala Asp Leu Ile Asp 500 505 510 Ala Arg Gly Leu Ala Ala Lys Arg Leu Asp Ala Arg Pro Gly Thr Ser 515 520 525 Tyr Leu Leu Arg Pro Asp Gln His Val Cys Ala Arg Trp Arg Arg Pro 530 535 540 Asp Glu Ala Ser Val Arg Ala Ala Leu Gln Arg Ala Cys Gly Ala Ala 545 550 555 560 Ala Thr Ala 9 966 DNA Pseudomonas acidivorans CDS (1)..(966) 9 atg acc acc aag acc ttt gcc tcc gcc gcc gac ctc gaa atc aag cag 48 Met Thr Thr Lys Thr Phe Ala Ser Ala Ala Asp Leu Glu Ile Lys Gln 1 5 10 15 gtc agc ttc gac aag ctc tcc gag cac gcc tat gcc tac acg gcc gaa 96 Val Ser Phe Asp Lys Leu Ser Glu His Ala Tyr Ala Tyr Thr Ala Glu 20 25 30 ggc gac ccc aac acc ggc atc atc att ggc gac gac gcg gtg atg gtg 144 Gly Asp Pro Asn Thr Gly Ile Ile Ile Gly Asp Asp Ala Val Met Val 35 40 45 atc gac acc cag gcc acg ccc gtc atg gcc cag gac gtg atc cgc cgc 192 Ile Asp Thr Gln Ala Thr Pro Val Met Ala Gln Asp Val Ile Arg Arg 50 55 60 atc cgt gag gtc acg gac aag ccc atc aag tac gtg acg ctg tcg cac 240 Ile Arg Glu Val Thr Asp Lys Pro Ile Lys Tyr Val Thr Leu Ser His 65 70 75 80 tac cac gcg gtg cgc gtg ctg ggc gcc tcg gcc ttc ttc gcg gaa ggc 288 Tyr His Ala Val Arg Val Leu Gly Ala Ser Ala Phe Phe Ala Glu Gly 85 90 95 gcc gaa cac atc att gcc agc cag gac acc tac gac ctc atc gtg gag 336 Ala Glu His Ile Ile Ala Ser Gln Asp Thr Tyr Asp Leu Ile Val Glu 100 105 110 cgc ggc gag cag gac aag gcc agc gag atc ggc cgc ttt ccc cgc ctg 384 Arg Gly Glu Gln Asp Lys Ala Ser Glu Ile Gly Arg Phe Pro Arg Leu 115 120 125 ttc cag aac gtg gaa agc gtg ccc gat ggc atg acc tgg ccc acc ctc 432 Phe Gln Asn Val Glu Ser Val Pro Asp Gly Met Thr Trp Pro Thr Leu 130 135 140 acc ttc acc ggc aag atg acg ctg tgg ctg ggc aag ctg gaa gtg cag 480 Thr Phe Thr Gly Lys Met Thr Leu Trp Leu Gly Lys Leu Glu Val Gln 145 150 155 160 atc ctg cag ctg ggc cgc ggc cac acc aag ggc gac acc gtg gtc tgg 528 Ile Leu Gln Leu Gly Arg Gly His Thr Lys Gly Asp Thr Val Val Trp 165 170 175 ctg ccc cag gac aag gtg ctg ttc agc ggc gac ctg gtg gag ttc ggc 576 Leu Pro Gln Asp Lys Val Leu Phe Ser Gly Asp Leu Val Glu Phe Gly 180 185 190 gcc acg ccc tat gcg ggc gat gcc tac ttc cag gac tgg ccg cac acg 624 Ala Thr Pro Tyr Ala Gly Asp Ala Tyr Phe Gln Asp Trp Pro His Thr 195 200 205 ctg gac gcc atc gcc gcc ctg cag ccc gaa aag ctc gtg ccc ggc cgg 672 Leu Asp Ala Ile Ala Ala Leu Gln Pro Glu Lys Leu Val Pro Gly Arg 210 215 220 ggc gcc gcg ctg cag acg ccg gcc gag gtg cag gcc ggc ctg gcc ggc 720 Gly Ala Ala Leu Gln Thr Pro Ala Glu Val Gln Ala Gly Leu Ala Gly 225 230 235 240 acg cgc gac ttc atc agc gac ctg tgg acc gag gtc aag gcc ggc gcc 768 Thr Arg Asp Phe Ile Ser Asp Leu Trp Thr Glu Val Lys Ala Gly Ala 245 250 255 gat gcc cag cag gac ctg cgc aag gtc tac gag gcc gcc ttc gcc aag 816 Asp Ala Gln Gln Asp Leu Arg Lys Val Tyr Glu Ala Ala Phe Ala Lys 260 265 270 ctg cag ccc aag tac ggc cag tgg gtg atc ttc aac cac tgc atg ccc 864 Leu Gln Pro Lys Tyr Gly Gln Trp Val Ile Phe Asn His Cys Met Pro 275 280 285 ttc gat gtg acc cgc gcc tat gac gag gca tcg ggc cac gcc gac cca 912 Phe Asp Val Thr Arg Ala Tyr Asp Glu Ala Ser Gly His Ala Asp Pro 290 295 300 cgc atc tgg acc gcc gag cgc gac cgc cag atg tgg ctg gcg ctc gaa 960 Arg Ile Trp Thr Ala Glu Arg Asp Arg Gln Met Trp Leu Ala Leu Glu 305 310 315 320 ggc tga 966 Gly 10 321 PRT Pseudomonas acidivorans 10 Met Thr Thr Lys Thr Phe Ala Ser Ala Ala Asp Leu Glu Ile Lys Gln 1 5 10 15 Val Ser Phe Asp Lys Leu Ser Glu His Ala Tyr Ala Tyr Thr Ala Glu 20 25 30 Gly Asp Pro Asn Thr Gly Ile Ile Ile Gly Asp Asp Ala Val Met Val 35 40 45 Ile Asp Thr Gln Ala Thr Pro Val Met Ala Gln Asp Val Ile Arg Arg 50 55 60 Ile Arg Glu Val Thr Asp Lys Pro Ile Lys Tyr Val Thr Leu Ser His 65 70 75 80 Tyr His Ala Val Arg Val Leu Gly Ala Ser Ala Phe Phe Ala Glu Gly 85 90 95 Ala Glu His Ile Ile Ala Ser Gln Asp Thr Tyr Asp Leu Ile Val Glu 100 105 110 Arg Gly Glu Gln Asp Lys Ala Ser Glu Ile Gly Arg Phe Pro Arg Leu 115 120 125 Phe Gln Asn Val Glu Ser Val Pro Asp Gly Met Thr Trp Pro Thr Leu 130 135 140 Thr Phe Thr Gly Lys Met Thr Leu Trp Leu Gly Lys Leu Glu Val Gln 145 150 155 160 Ile Leu Gln Leu Gly Arg Gly His Thr Lys Gly Asp Thr Val Val Trp 165 170 175 Leu Pro Gln Asp Lys Val Leu Phe Ser Gly Asp Leu Val Glu Phe Gly 180 185 190 Ala Thr Pro Tyr Ala Gly Asp Ala Tyr Phe Gln Asp Trp Pro His Thr 195 200 205 Leu Asp Ala Ile Ala Ala Leu Gln Pro Glu Lys Leu Val Pro Gly Arg 210 215 220 Gly Ala Ala Leu Gln Thr Pro Ala Glu Val Gln Ala Gly Leu Ala Gly 225 230 235 240 Thr Arg Asp Phe Ile Ser Asp Leu Trp Thr Glu Val Lys Ala Gly Ala 245 250 255 Asp Ala Gln Gln Asp Leu Arg Lys Val Tyr Glu Ala Ala Phe Ala Lys 260 265 270 Leu Gln Pro Lys Tyr Gly Gln Trp Val Ile Phe Asn His Cys Met Pro 275 280 285 Phe Asp Val Thr Arg Ala Tyr Asp Glu Ala Ser Gly His Ala Asp Pro 290 295 300 Arg Ile Trp Thr Ala Glu Arg Asp Arg Gln Met Trp Leu Ala Leu Glu 305 310 315 320 Gly 11 966 DNA Artificial CDS (1)..(966) P. acidovorans HPAC mutant 11 atg tcc acc aag acc ttt gcc tcc gcc gcc gac ctc gaa atc aag cag 48 Met Ser Thr Lys Thr Phe Ala Ser Ala Ala Asp Leu Glu Ile Lys Gln 1 5 10 15 gtc agc ttc gac aag ctc tcc gag cac gcc tat gcc tac acg gcc gaa 96 Val Ser Phe Asp Lys Leu Ser Glu His Ala Tyr Ala Tyr Thr Ala Glu 20 25 30 ggc gac ccc aac acc ggc atc atc att ggc gac gac gcg gtg atg gtg 144 Gly Asp Pro Asn Thr Gly Ile Ile Ile Gly Asp Asp Ala Val Met Val 35 40 45 atc gac acc cag gcc acg ccc gtc atg gcc cag gac gtg atc cgc cgc 192 Ile Asp Thr Gln Ala Thr Pro Val Met Ala Gln Asp Val Ile Arg Arg 50 55 60 atc cgt gag gtc acg gac aag ccc atc aag tac gtg acg ctg tcg cac 240 Ile Arg Glu Val Thr Asp Lys Pro Ile Lys Tyr Val Thr Leu Ser His 65 70 75 80 tac cac gcg gtg cgc gtg ctg ggc gcc tcg gcc ttc ttc gcg gaa ggc 288 Tyr His Ala Val Arg Val Leu Gly Ala Ser Ala Phe Phe Ala Glu Gly 85 90 95 gcc gaa cac atc att gcc agc cag gac acc tac gac ctc atc gtg gag 336 Ala Glu His Ile Ile Ala Ser Gln Asp Thr Tyr Asp Leu Ile Val Glu 100 105 110 cgc ggc gag cag gac aag gcc agc gag atc ggc cgc ttt ccc cgc ctg 384 Arg Gly Glu Gln Asp Lys Ala Ser Glu Ile Gly Arg Phe Pro Arg Leu 115 120 125 ttc cag aac gtg gaa agc gtg ccc gat ggc atg acc tgg ccc acc ctc 432 Phe Gln Asn Val Glu Ser Val Pro Asp Gly Met Thr Trp Pro Thr Leu 130 135 140 acc ttc acc ggc aag atg acg ctg tgg ctg ggc aag ctg gaa gtg cag 480 Thr Phe Thr Gly Lys Met Thr Leu Trp Leu Gly Lys Leu Glu Val Gln 145 150 155 160 atc ctg cag ctg ggc cgc ggc cac acc aag ggc gac acc gtg gtc tgg 528 Ile Leu Gln Leu Gly Arg Gly His Thr Lys Gly Asp Thr Val Val Trp 165 170 175 ctg ccc cag gac aag gtg ctg ttc agc ggc gac ctg gtg gag ttc ggc 576 Leu Pro Gln Asp Lys Val Leu Phe Ser Gly Asp Leu Val Glu Phe Gly 180 185 190 gcc acg ccc tat gcg ggc gat gcc tac ttc cag gac tgg ccg cac acg 624 Ala Thr Pro Tyr Ala Gly Asp Ala Tyr Phe Gln Asp Trp Pro His Thr 195 200 205 ctg gac acc atc gcc gcc ctg cag ccc gaa aag ctc gtg ccc ggc cgg 672 Leu Asp Thr Ile Ala Ala Leu Gln Pro Glu Lys Leu Val Pro Gly Arg 210 215 220 ggc gcc gcg ctg cag acg ccg gcc gag gtg cag gcc ggc ctg gcc ggc 720 Gly Ala Ala Leu Gln Thr Pro Ala Glu Val Gln Ala Gly Leu Ala Gly 225 230 235 240 acg cgc gac ttc atc agc gac ctg tgg acc gag gtc aag gcc ggc gcc 768 Thr Arg Asp Phe Ile Ser Asp Leu Trp Thr Glu Val Lys Ala Gly Ala 245 250 255 gat gcc cag cag gac ctg cgc aag gtc tac gag gcc gcc ttc gcc aag 816 Asp Ala Gln Gln Asp Leu Arg Lys Val Tyr Glu Ala Ala Phe Ala Lys 260 265 270 ctg cag ccc aag tac ggc cag tgg gtg atc ttc aac cac tgc atg ccc 864 Leu Gln Pro Lys Tyr Gly Gln Trp Val Ile Phe Asn His Cys Met Pro 275 280 285 ttc gat gtg acc cgc gcc tat gac gag gca tcg ggc cac gcc gac cca 912 Phe Asp Val Thr Arg Ala Tyr Asp Glu Ala Ser Gly His Ala Asp Pro 290 295 300 cgc atc tgg acc gcc gag cgc gac cgc cag atg tgg ctg gcg ctc gaa 960 Arg Ile Trp Thr Ala Glu Arg Asp Arg Gln Met Trp Leu Ala Leu Glu 305 310 315 320 ggc tga 966 Gly 12 321 PRT Artificial P. acidovorans HPAC mutant 12 Met Ser Thr Lys Thr Phe Ala Ser Ala Ala Asp Leu Glu Ile Lys Gln 1 5 10 15 Val Ser Phe Asp Lys Leu Ser Glu His Ala Tyr Ala Tyr Thr Ala Glu 20 25 30 Gly Asp Pro Asn Thr Gly Ile Ile Ile Gly Asp Asp Ala Val Met Val 35 40 45 Ile Asp Thr Gln Ala Thr Pro Val Met Ala Gln Asp Val Ile Arg Arg 50 55 60 Ile Arg Glu Val Thr Asp Lys Pro Ile Lys Tyr Val Thr Leu Ser His 65 70 75 80 Tyr His Ala Val Arg Val Leu Gly Ala Ser Ala Phe Phe Ala Glu Gly 85 90 95 Ala Glu His Ile Ile Ala Ser Gln Asp Thr Tyr Asp Leu Ile Val Glu 100 105 110 Arg Gly Glu Gln Asp Lys Ala Ser Glu Ile Gly Arg Phe Pro Arg Leu 115 120 125 Phe Gln Asn Val Glu Ser Val Pro Asp Gly Met Thr Trp Pro Thr Leu 130 135 140 Thr Phe Thr Gly Lys Met Thr Leu Trp Leu Gly Lys Leu Glu Val Gln 145 150 155 160 Ile Leu Gln Leu Gly Arg Gly His Thr Lys Gly Asp Thr Val Val Trp 165 170 175 Leu Pro Gln Asp Lys Val Leu Phe Ser Gly Asp Leu Val Glu Phe Gly 180 185 190 Ala Thr Pro Tyr Ala Gly Asp Ala Tyr Phe Gln Asp Trp Pro His Thr 195 200 205 Leu Asp Thr Ile Ala Ala Leu Gln Pro Glu Lys Leu Val Pro Gly Arg 210 215 220 Gly Ala Ala Leu Gln Thr Pro Ala Glu Val Gln Ala Gly Leu Ala Gly 225 230 235 240 Thr Arg Asp Phe Ile Ser Asp Leu Trp Thr Glu Val Lys Ala Gly Ala 245 250 255 Asp Ala Gln Gln Asp Leu Arg Lys Val Tyr Glu Ala Ala Phe Ala Lys 260 265 270 Leu Gln Pro Lys Tyr Gly Gln Trp Val Ile Phe Asn His Cys Met Pro 275 280 285 Phe Asp Val Thr Arg Ala Tyr Asp Glu Ala Ser Gly His Ala Asp Pro 290 295 300 Arg Ile Trp Thr Ala Glu Arg Asp Arg Gln Met Trp Leu Ala Leu Glu 305 310 315 320 Gly 13 966 DNA Artificial CDS (1)..(966) P. acidovorans HPAC mutant 13 atg tcc acc aag acc ttt gcc tcc gcc gcc gac ctc gaa atc aag cag 48 Met Ser Thr Lys Thr Phe Ala Ser Ala Ala Asp Leu Glu Ile Lys Gln 1 5 10 15 gtc agc ttc gac aag ctc tcc gag cac gcc tat gcc tac acg gcc gaa 96 Val Ser Phe Asp Lys Leu Ser Glu His Ala Tyr Ala Tyr Thr Ala Glu 20 25 30 ggc gac ccc aac acc ggc atc atc att ggc gac gac gcg gtg atg gtg 144 Gly Asp Pro Asn Thr Gly Ile Ile Ile Gly Asp Asp Ala Val Met Val 35 40 45 atc gac acc cag gcc acg ccc gtc atg gcc cag gac gtg atc cgc cgc 192 Ile Asp Thr Gln Ala Thr Pro Val Met Ala Gln Asp Val Ile Arg Arg 50 55 60 atc cgt gag gtc acg gac aag ccc atc aag tac gtg acg ctg tcg cac 240 Ile Arg Glu Val Thr Asp Lys Pro Ile Lys Tyr Val Thr Leu Ser His 65 70 75 80 tac cac gcg gtg cgc gtg ctg ggc gcc tcg gcc ttc ttc gcg gaa ggc 288 Tyr His Ala Val Arg Val Leu Gly Ala Ser Ala Phe Phe Ala Glu Gly 85 90 95 gcc gaa cac atc att gcc agc cag gac acc tac gac ctc atc gtg gag 336 Ala Glu His Ile Ile Ala Ser Gln Asp Thr Tyr Asp Leu Ile Val Glu 100 105 110 cgc ggc gag cag gac aag gcc agc gag atc ggc cgc ttt ccc cgc ctg 384 Arg Gly Glu Gln Asp Lys Ala Ser Glu Ile Gly Arg Phe Pro Arg Leu 115 120 125 ttc cag aac gtg gaa agc gtg ccc gat ggc atg acc tgg ccc acc ctc 432 Phe Gln Asn Val Glu Ser Val Pro Asp Gly Met Thr Trp Pro Thr Leu 130 135 140 acc ttc acc ggc aag atg acg ctg tgg ctg ggc aag ctg gaa gtg cag 480 Thr Phe Thr Gly Lys Met Thr Leu Trp Leu Gly Lys Leu Glu Val Gln 145 150 155 160 atc ctg cag ctg ggc cgc ggc cac acc aag ggc gac acc gtg gtc tgg 528 Ile Leu Gln Leu Gly Arg Gly His Thr Lys Gly Asp Thr Val Val Trp 165 170 175 ctg ccc cag gac aag gtg ctg ttc agc ggc gac ctg gtg gag ttc ggc 576 Leu Pro Gln Asp Lys Val Leu Phe Ser Gly Asp Leu Val Glu Phe Gly 180 185 190 gcc acg ccc tat gcg ggc gat gcc tac ttc cag gac tgg ccg cac acg 624 Ala Thr Pro Tyr Ala Gly Asp Ala Tyr Phe Gln Asp Trp Pro His Thr 195 200 205 ctg gac gcc atc gcc gcc ctg cag ccc gaa aag ctc gtg ccc ggc cgg 672 Leu Asp Ala Ile Ala Ala Leu Gln Pro Glu Lys Leu Val Pro Gly Arg 210 215 220 ggc gcc gcg ctg cag acg ccg gcc gag gtg cag gcc ggc ctg gcc ggc 720 Gly Ala Ala Leu Gln Thr Pro Ala Glu Val Gln Ala Gly Leu Ala Gly 225 230 235 240 acg cgc gac ttc atc agc gac ctg tgg acc gag gtc aag gcc ggc gcc 768 Thr Arg Asp Phe Ile Ser Asp Leu Trp Thr Glu Val Lys Ala Gly Ala 245 250 255 gat gcc cag cag gac ctg cgc aag gtc tac gag gcc gcc ttc gcc aag 816 Asp Ala Gln Gln Asp Leu Arg Lys Val Tyr Glu Ala Ala Phe Ala Lys 260 265 270 ctg cag ccc aag tac ggc cag tgg gtg atc ttc aac cac tgc atg ccc 864 Leu Gln Pro Lys Tyr Gly Gln Trp Val Ile Phe Asn His Cys Met Pro 275 280 285 ttc gat gtg acc cgc gcc tat gac gag gca tcg ggc cac gcc gac cca 912 Phe Asp Val Thr Arg Ala Tyr Asp Glu Ala Ser Gly His Ala Asp Pro 290 295 300 cgc atc tgg acc gcc gag cgc gac cgc cag atg tgg ctg gcg ctc gaa 960 Arg Ile Trp Thr Ala Glu Arg Asp Arg Gln Met Trp Leu Ala Leu Glu 305 310 315 320 ggc tga 966 Gly 14 321 PRT Artificial P. acidovorans HPAC mutant 14 Met Ser Thr Lys Thr Phe Ala Ser Ala Ala Asp Leu Glu Ile Lys Gln 1 5 10 15 Val Ser Phe Asp Lys Leu Ser Glu His Ala Tyr Ala Tyr Thr Ala Glu 20 25 30 Gly Asp Pro Asn Thr Gly Ile Ile Ile Gly Asp Asp Ala Val Met Val 35 40 45 Ile Asp Thr Gln Ala Thr Pro Val Met Ala Gln Asp Val Ile Arg Arg 50 55 60 Ile Arg Glu Val Thr Asp Lys Pro Ile Lys Tyr Val Thr Leu Ser His 65 70 75 80 Tyr His Ala Val Arg Val Leu Gly Ala Ser Ala Phe Phe Ala Glu Gly 85 90 95 Ala Glu His Ile Ile Ala Ser Gln Asp Thr Tyr Asp Leu Ile Val Glu 100 105 110 Arg Gly Glu Gln Asp Lys Ala Ser Glu Ile Gly Arg Phe Pro Arg Leu 115 120 125 Phe Gln Asn Val Glu Ser Val Pro Asp Gly Met Thr Trp Pro Thr Leu 130 135 140 Thr Phe Thr Gly Lys Met Thr Leu Trp Leu Gly Lys Leu Glu Val Gln 145 150 155 160 Ile Leu Gln Leu Gly Arg Gly His Thr Lys Gly Asp Thr Val Val Trp 165 170 175 Leu Pro Gln Asp Lys Val Leu Phe Ser Gly Asp Leu Val Glu Phe Gly 180 185 190 Ala Thr Pro Tyr Ala Gly Asp Ala Tyr Phe Gln Asp Trp Pro His Thr 195 200 205 Leu Asp Ala Ile Ala Ala Leu Gln Pro Glu Lys Leu Val Pro Gly Arg 210 215 220 Gly Ala Ala Leu Gln Thr Pro Ala Glu Val Gln Ala Gly Leu Ala Gly 225 230 235 240 Thr Arg Asp Phe Ile Ser Asp Leu Trp Thr Glu Val Lys Ala Gly Ala 245 250 255 Asp Ala Gln Gln Asp Leu Arg Lys Val Tyr Glu Ala Ala Phe Ala Lys 260 265 270 Leu Gln Pro Lys Tyr Gly Gln Trp Val Ile Phe Asn His Cys Met Pro 275 280 285 Phe Asp Val Thr Arg Ala Tyr Asp Glu Ala Ser Gly His Ala Asp Pro 290 295 300 Arg Ile Trp Thr Ala Glu Arg Asp Arg Gln Met Trp Leu Ala Leu Glu 305 310 315 320 Gly 15 3549 DNA Artificial promoter (1)..(928) 15 tgcatgccta ggtcgaggag aaatatgagt cgaggcatgg atacactaag ttcccctgaa 60 gtgagcatga tctttgatgc tgagatgatt cccagagcaa gatagtttgt gctgcaagtg 120 acacaattgt aatgaaacca ccactcaacg aatttacttg tggctttgac atgtcgtgtg 180 ctctgtttgt atttgtgagt gccggttggt aattattttt gttaatgtga ttttaaaacc 240 tcttatgtaa atagttactt tatctattga agtgtgttct tgtggtctat agtttctcaa 300 agggaaatta aaatgttgac atcccattta caattgataa cttggtatac acaaactttg 360 taaatttggt gatatttatg gtcgaaagaa ggcaataccc attgtatgtt ccaatatcaa 420 tatcaatacg ataacttgat aatactaaca tatgattgtc attgtttttc cagtatcaat 480 atacattaag ctactacaaa attagtataa atcactatat tataaatctt tttcggttgt 540 aacttgtaat tcgtgggttt ttaaaataaa agcatgtgaa aattttcaaa taatgtgatg 600 gcgcaatttt attttccgag ttccaaaata ttgccgcttc attaccctaa tttgtggcgc 660 cacatgtaaa acaaaagacg attcttagtg gctatcactg ccatcacgcg gatcactaat 720 atgaaccgtc gattaaaaca gatcgacggt ttatacatca ttttattgta cacacggatc 780 gatatctcag ccgttagatt taatatgcga tctgattgct caaaaaatag actctccgtc 840 tttgcctata aaaacaattt cacatctttc tcacccaaat ctactcttaa ccgttcttct 900 tcttctacag acatcaattt ctctcgactc tagaggatcc aagcttatcg atttcgaacc 960 cctc atg act tca ctt aca gtg tcc ggc cgg gtg gcg cag gtc ctc agc 1009 Met Thr Ser Leu Thr Val Ser Gly Arg Val Ala Gln Val Leu Ser 1 5 10 15 agc tat gtc agc gat gtg ttc ggt gtg atg ggc aac gga aac gtc tac 1057 Ser Tyr Val Ser Asp Val Phe Gly Val Met Gly Asn Gly Asn Val Tyr 20 25 30 ttc ctg gac gcc gcc gag aag gag ggc ctc cgc ttc acg gcc gta cgc 1105 Phe Leu Asp Ala Ala Glu Lys Glu Gly Leu Arg Phe Thr Ala Val Arg 35 40 45 cat gaa ggt gcc gcc atc gcg gcg gcg gac gcc tac tat cgg gca tcc 1153 His Glu Gly Ala Ala Ile Ala Ala Ala Asp Ala Tyr Tyr Arg Ala Ser 50 55 60 ggg cgc ctg gcg gcg ggg acc acc acc tac ggc ccc ggt tac acc aac 1201 Gly Arg Leu Ala Ala Gly Thr Thr Thr Tyr Gly Pro Gly Tyr Thr Asn 65 70 75 gcc ctg acg gcc ctc gcc gag gcg gtc cag gcg cag atc ccc gtg gtg 1249 Ala Leu Thr Ala Leu Ala Glu Ala Val Gln Ala Gln Ile Pro Val Val 80 85 90 95 ctc gtc acc ggg gac gcc ccg agc agc ggc gcc cgg cct tgg gac gtg 1297 Leu Val Thr Gly Asp Ala Pro Ser Ser Gly Ala Arg Pro Trp Asp Val 100 105 110 gac cag gcc gcg atc gcc gcc ggg ctg ggg gcg gcg acc ttc acg gtc 1345 Asp Gln Ala Ala Ile Ala Ala Gly Leu Gly Ala Ala Thr Phe Thr Val 115 120 125 acc cgt gaa gcc gca ggc tcc atc acg cag gaa gcg gtg gag tac gca 1393 Thr Arg Glu Ala Ala Gly Ser Ile Thr Gln Glu Ala Val Glu Tyr Ala 130 135 140 ctt gcc cgg cgg acc gcc gtc gtg atc gcc gtt cca tac gac ctg tcg 1441 Leu Ala Arg Arg Thr Ala Val Val Ile Ala Val Pro Tyr Asp Leu Ser 145 150 155 gcc ctt gag gcg gcg gag gaa gat ctt ccc gtg ccg ccg gcg gcc tcg 1489 Ala Leu Glu Ala Ala Glu Glu Asp Leu Pro Val Pro Pro Ala Ala Ser 160 165 170 175 gtt ccg gac gcc atc ggc ggc gga ctc gga cgg gcg gcc gaa gtg cgg 1537 Val Pro Asp Ala Ile Gly Gly Gly Leu Gly Arg Ala Ala Glu Val Arg 180 185 190 gcg gcc gaa ttg ctg gcg ggc gcg aag cgg ccg ctc atc ctt gcc ggc 1585 Ala Ala Glu Leu Leu Ala Gly Ala Lys Arg Pro Leu Ile Leu Ala Gly 195 200 205 cgc ggt gcg cac ctc gca gga acc ggc ccc gaa ctc cgg gaa ctc gcc 1633 Arg Gly Ala His Leu Ala Gly Thr Gly Pro Glu Leu Arg Glu Leu Ala 210 215 220 gac cgc ctc ggc gcg ctc acg gcc ggc acc gca ctg gcg ctg aac ctg 1681 Asp Arg Leu Gly Ala Leu Thr Ala Gly Thr Ala Leu Ala Leu Asn Leu 225 230 235 ctg cag ggc gag ggg tac ctc ggc gtc gcg ggc ggc ttc ggc acg gat 1729 Leu Gln Gly Glu Gly Tyr Leu Gly Val Ala Gly Gly Phe Gly Thr Asp 240 245 250 255 acc gcc gcc ggg ctc atg ggc gag gcg gac gtg gtg ctc gtg gcg gga 1777 Thr Ala Ala Gly Leu Met Gly Glu Ala Asp Val Val Leu Val Ala Gly 260 265 270 gcc agc ctg acc ccc ttc acc atg cgc ttc ggc cac ctg atc ggc ccg 1825 Ala Ser Leu Thr Pro Phe Thr Met Arg Phe Gly His Leu Ile Gly Pro 275 280 285 gac gcc acc gtg atc cag atc gac acc gcc atg gag ccg acg gac ccg 1873 Asp Ala Thr Val Ile Gln Ile Asp Thr Ala Met Glu Pro Thr Asp Pro 290 295 300 cgg gtg gac ctg ttt gtc agt gcg gac gcg aag gcc gct gcc ggc cgg 1921 Arg Val Asp Leu Phe Val Ser Ala Asp Ala Lys Ala Ala Ala Gly Arg 305 310 315 atc ctc cgg ctg ctg gat gac gcc gcc ggg gcc aat gcg tcg aag gcc 1969 Ile Leu Arg Leu Leu Asp Asp Ala Ala Gly Ala Asn Ala Ser Lys Ala 320 325 330 335 tgg cgc gcg gaa gca ctc aag cgt ctg gcc gaa gga ccc tgc cac cac 2017 Trp Arg Ala Glu Ala Leu Lys Arg Leu Ala Glu Gly Pro Cys His His 340 345 350 ccc ggc acc gca gag acc acg gac ggc cgc ctt gac ccc cgg gcg ctt 2065 Pro Gly Thr Ala Glu Thr Thr Asp Gly Arg Leu Asp Pro Arg Ala Leu 355 360 365 gct tcg gca ctg gat gcc gtc ctg ccg gaa cgc cgc acc gtg gtc cag 2113 Ala Ser Ala Leu Asp Ala Val Leu Pro Glu Arg Arg Thr Val Val Gln 370 375 380 gac ggc ggg cac ttc ctg ggc tgg gca ccc atg tac tgg cgc atc ccc 2161 Asp Gly Gly His Phe Leu Gly Trp Ala Pro Met Tyr Trp Arg Ile Pro 385 390 395 cgt cct cag gac ctg gtc atg gtg ggg acc gcg tac cag tcg atc ggg 2209 Arg Pro Gln Asp Leu Val Met Val Gly Thr Ala Tyr Gln Ser Ile Gly 400 405 410 415 ctt ggc ctg gcc agc gcc gtg ggg gcg tcc cgg gcc gtg gac gac ggc 2257 Leu Gly Leu Ala Ser Ala Val Gly Ala Ser Arg Ala Val Asp Asp Gly 420 425 430 aat atc ctg gtg ctg gcg gcg ggc gac ggc gga ttc ctg atg ggc ctg 2305 Asn Ile Leu Val Leu Ala Ala Gly Asp Gly Gly Phe Leu Met Gly Leu 435 440 445 tcc gac ctg gaa tcg ctc gtg ggc gcg gcg agc agc gcc gtc gtg gtg 2353 Ser Asp Leu Glu Ser Leu Val Gly Ala Ala Ser Ser Ala Val Val Val 450 455 460 atc tac aac gac gcc gcc tac ggg gcc gag atc cat cag tac ggc tca 2401 Ile Tyr Asn Asp Ala Ala Tyr Gly Ala Glu Ile His Gln Tyr Gly Ser 465 470 475 cgg ggg ctc acc gaa aag ccc atg ctg atc ccc gaa gtg gac ttc agc 2449 Arg Gly Leu Thr Glu Lys Pro Met Leu Ile Pro Glu Val Asp Phe Ser 480 485 490 495 ggg att gcc cgc gcg atc ggg gcg gaa tcc gca atc atc cgc aag ctg 2497 Gly Ile Ala Arg Ala Ile Gly Ala Glu Ser Ala Ile Ile Arg Lys Leu 500 505 510 tcg gac ctc tcc gcg ctc acg gac tgg atc gag gcc ggc gcc agg gga 2545 Ser Asp Leu Ser Ala Leu Thr Asp Trp Ile Glu Ala Gly Ala Arg Gly 515 520 525 acc ttc gtg gcc gac tgc cgc atc acc tca agc gtc cgg gcc ccg tgg 2593 Thr Phe Val Ala Asp Cys Arg Ile Thr Ser Ser Val Arg Ala Pro Trp 530 535 540 ctg agc gaa tgg atg agg gcc tcg caa gcg gcg aag gag gcg gtg gcg 2641 Leu Ser Glu Trp Met Arg Ala Ser Gln Ala Ala Lys Glu Ala Val Ala 545 550 555 ggc tag ggccggcctc gtcgaaatgc cgccctccaa cccaactcag taccagctca 2697 Gly 560 gggcgttctc agggctggga acgccctgag ctgctactca tttgttcgaa ctcgaggtcg 2757 acggtatcga taagcttgat atcgaattcc tgcagcccgg gggatccact aggggatccc 2817 ccgatccgcg tttgtgtttt ctgggtttct cacttaagcg tctgcgtttt acttttgtat 2877 tgggtttggc gtttagtagt ttgcggtagc gttcttgtta tgtgtaatta cgctttttct 2937 tcttgcttca gcagtttcgg ttgaaatata aatcgaatca agtttcactt tatcagcgtt 2997 gttttaaatt ttggcattaa attggtgaaa attgcttcaa ttttgtatct aaatagaaga 3057 gacaacatga aattcgactt ttgacctcaa atcttcgaac atttatttcc tgatttcacg 3117 atggatgagg ataacgaaag ggcggttcct atgtccggga aagttcccgt agaagacaat 3177 gagcaaagct actgaaacgc ggacacgacg tcgcattggt acggatatga gttaaaccga 3237 ctcaattcct ttattaagac ataaaccgat tttggttaaa gtgtaacagt gagctgatat 3297 aaaaccgaaa caaaccggta caagtttgat tgagcaactt gatgacaaac ttcagaattt 3357 tggttattga atgaaaatca tagtctaatc gtaaaaaatg tacagaagaa aagctagagc 3417 agaacaaaga ttctatattc tggttccaat ttatcatcgc tttaacgtcc ctcagatttg 3477 atcgggctgc aggaattcgg cctgactgat catttaaaca ctagttctag agcggccgcc 3537 accgcggtgg ag 3549 16 560 PRT Artificial Expression cassette 16 Met Thr Ser Leu Thr Val Ser Gly Arg Val Ala Gln Val Leu Ser Ser 1 5 10 15 Tyr Val Ser Asp Val Phe Gly Val Met Gly Asn Gly Asn Val Tyr Phe 20 25 30 Leu Asp Ala Ala Glu Lys Glu Gly Leu Arg Phe Thr Ala Val Arg His 35 40 45 Glu Gly Ala Ala Ile Ala Ala Ala Asp Ala Tyr Tyr Arg Ala Ser Gly 50 55 60 Arg Leu Ala Ala Gly Thr Thr Thr Tyr Gly Pro Gly Tyr Thr Asn Ala 65 70 75 80 Leu Thr Ala Leu Ala Glu Ala Val Gln Ala Gln Ile Pro Val Val Leu 85 90 95 Val Thr Gly Asp Ala Pro Ser Ser Gly Ala Arg Pro Trp Asp Val Asp 100 105 110 Gln Ala Ala Ile Ala Ala Gly Leu Gly Ala Ala Thr Phe Thr Val Thr 115 120 125 Arg Glu Ala Ala Gly Ser Ile Thr Gln Glu Ala Val Glu Tyr Ala Leu 130 135 140 Ala Arg Arg Thr Ala Val Val Ile Ala Val Pro Tyr Asp Leu Ser Ala 145 150 155 160 Leu Glu Ala Ala Glu Glu Asp Leu Pro Val Pro Pro Ala Ala Ser Val 165 170 175 Pro Asp Ala Ile Gly Gly Gly Leu Gly Arg Ala Ala Glu Val Arg Ala 180 185 190 Ala Glu Leu Leu Ala Gly Ala Lys Arg Pro Leu Ile Leu Ala Gly Arg 195 200 205 Gly Ala His Leu Ala Gly Thr Gly Pro Glu Leu Arg Glu Leu Ala Asp 210 215 220 Arg Leu Gly Ala Leu Thr Ala Gly Thr Ala Leu Ala Leu Asn Leu Leu 225 230 235 240 Gln Gly Glu Gly Tyr Leu Gly Val Ala Gly Gly Phe Gly Thr Asp Thr 245 250 255 Ala Ala Gly Leu Met Gly Glu Ala Asp Val Val Leu Val Ala Gly Ala 260 265 270 Ser Leu Thr Pro Phe Thr Met Arg Phe Gly His Leu Ile Gly Pro Asp 275 280 285 Ala Thr Val Ile Gln Ile Asp Thr Ala Met Glu Pro Thr Asp Pro Arg 290 295 300 Val Asp Leu Phe Val Ser Ala Asp Ala Lys Ala Ala Ala Gly Arg Ile 305 310 315 320 Leu Arg Leu Leu Asp Asp Ala Ala Gly Ala Asn Ala Ser Lys Ala Trp 325 330 335 Arg Ala Glu Ala Leu Lys Arg Leu Ala Glu Gly Pro Cys His His Pro 340 345 350 Gly Thr Ala Glu Thr Thr Asp Gly Arg Leu Asp Pro Arg Ala Leu Ala 355 360 365 Ser Ala Leu Asp Ala Val Leu Pro Glu Arg Arg Thr Val Val Gln Asp 370 375 380 Gly Gly His Phe Leu Gly Trp Ala Pro Met Tyr Trp Arg Ile Pro Arg 385 390 395 400 Pro Gln Asp Leu Val Met Val Gly Thr Ala Tyr Gln Ser Ile Gly Leu 405 410 415 Gly Leu Ala Ser Ala Val Gly Ala Ser Arg Ala Val Asp Asp Gly Asn 420 425 430 Ile Leu Val Leu Ala Ala Gly Asp Gly Gly Phe Leu Met Gly Leu Ser 435 440 445 Asp Leu Glu Ser Leu Val Gly Ala Ala Ser Ser Ala Val Val Val Ile 450 455 460 Tyr Asn Asp Ala Ala Tyr Gly Ala Glu Ile His Gln Tyr Gly Ser Arg 465 470 475 480 Gly Leu Thr Glu Lys Pro Met Leu Ile Pro Glu Val Asp Phe Ser Gly 485 490 495 Ile Ala Arg Ala Ile Gly Ala Glu Ser Ala Ile Ile Arg Lys Leu Ser 500 505 510 Asp Leu Ser Ala Leu Thr Asp Trp Ile Glu Ala Gly Ala Arg Gly Thr 515 520 525 Phe Val Ala Asp Cys Arg Ile Thr Ser Ser Val Arg Ala Pro Trp Leu 530 535 540 Ser Glu Trp Met Arg Ala Ser Gln Ala Ala Lys Glu Ala Val Ala Gly 545 550 555 560 17 2838 DNA Artificial promoter (1)..(807) 17 ggccccccct cgagcccaca gatggttaga gaggcttacg cagcaggtct catcaagacg 60 atctacccga gcaataatct ccaggaaatc aaataccttc ccaagaaggt taaagatgca 120 gtcaaaagat tcaggactaa ctgcatcaag aacacagaga aagatatatt tctcaagatc 180 agaagtacta ttccagtatg gacgattcaa ggcttgcttc acaaaccaag gcaagtaata 240 gagattggag tctctaaaaa ggtagttccc actgaatcaa aggccatgga gtcaaagatt 300 caaatagagg acctaacaga actcgccgta aagactggcg aacagttcat acagagtctc 360 ttacgactca atgacaagaa gaaaatcttc gtcaacatgg tggagcacga cacacttgtc 420 tactccaaaa atatcaaaga tacagtctca gaagaccaaa gggcaattga gacttttcaa 480 caaagggtaa tatccggaaa cctcctcgga ttccattgcc cagctatctg tcactttatt 540 gtgaagatag tggaaaagga aggtggctcc tacaaatgcc atcattgcga taaaggaaag 600 gccatcgttg aagatgcctc tgccgacagt ggtcccaaag atggaccccc acccacgagg 660 agcatcgtgg aaaaagaaga cgttccaacc acgtcttcaa agcaagtgga ttgatgtgat 720 atctccactg acgtaaggga tgacgcacaa tcccactatc cttcgcaaga cccttcctct 780 atataaggaa gttcatttca tttggagaga acacggggga ctctagagga tcagaggacg 840 aacaac atg tcc cac ccc gcc atc tcc ctg caa gcg ctg cgc ggc agc 888 Met Ser His Pro Ala Ile Ser Leu Gln Ala Leu Arg Gly Ser 1 5 10 ggc gca gac ata cag tcc atc cac atc ccc tac gag cgc cat gcc gac 936 Gly Ala Asp Ile Gln Ser Ile His Ile Pro Tyr Glu Arg His Ala Asp 15 20 25 30 cag gac gcc ggt gcg gac acg ccc gcc cgg cat ccc gtc gtc atc gtc 984 Gln Asp Ala Gly Ala Asp Thr Pro Ala Arg His Pro Val Val Ile Val 35 40 45 ggc gcc ggc ccc gtg ggc ctg tcg ctg gcc atc gac ctg gcc cag cgc 1032 Gly Ala Gly Pro Val Gly Leu Ser Leu Ala Ile Asp Leu Ala Gln Arg 50 55 60 ggc cag cgc gtg gtg ctg ctg gac aac gac tgc cgg ctg tcc acg ggc 1080 Gly Gln Arg Val Val Leu Leu Asp Asn Asp Cys Arg Leu Ser Thr Gly 65 70 75 tcg cgc gcc atc tgc ttt tcc aag cgc acg ctg gag atc tgg gac cgc 1128 Ser Arg Ala Ile Cys Phe Ser Lys Arg Thr Leu Glu Ile Trp Asp Arg 80 85 90 ctg ggc gtg ggc cag ccc atg gtg gac aag ggc gtg tcc tgg aac ctg 1176 Leu Gly Val Gly Gln Pro Met Val Asp Lys Gly Val Ser Trp Asn Leu 95 100 105 110 ggc aag gtc ttc ttc aag gac cag ccg ctg tac cgc ttc gac ctg ctg 1224 Gly Lys Val Phe Phe Lys Asp Gln Pro Leu Tyr Arg Phe Asp Leu Leu 115 120 125 ccc gag gac ggc cac gag cgc ccg gcc ttc atc aac ctg cag cag tac 1272 Pro Glu Asp Gly His Glu Arg Pro Ala Phe Ile Asn Leu Gln Gln Tyr 130 135 140 tac gcc gag gcc tat ctg gtc gag cgc gca ctg cag ctg ccg ctg atc 1320 Tyr Ala Glu Ala Tyr Leu Val Glu Arg Ala Leu Gln Leu Pro Leu Ile 145 150 155 gac ctg cgc tgg cac agc aag gtc acg gca ctg gag ccg cag gcc gag 1368 Asp Leu Arg Trp His Ser Lys Val Thr Ala Leu Glu Pro Gln Ala Glu 160 165 170 ggc gcg ctg ctg acc gtg gag acg cct gac ggc agc tac cgc atc gat 1416 Gly Ala Leu Leu Thr Val Glu Thr Pro Asp Gly Ser Tyr Arg Ile Asp 175 180 185 190 gcg caa tgg gtc ctg gcc tgc gat ggc tcg cgc tcg ccg ctg cgc ggc 1464 Ala Gln Trp Val Leu Ala Cys Asp Gly Ser Arg Ser Pro Leu Arg Gly 195 200 205 ctg ctg ggc cag gaa agc cat ggc cgc atc ttc cgc gac cgc ttc ctg 1512 Leu Leu Gly Gln Glu Ser His Gly Arg Ile Phe Arg Asp Arg Phe Leu 210 215 220 atc gcc gac gtg aag atg cac gcc gaa ttc ccc acc gag cgc tgg ttc 1560 Ile Ala Asp Val Lys Met His Ala Glu Phe Pro Thr Glu Arg Trp Phe 225 230 235 tgg ttc gac ccg ccc ttc cac ccg ggc cag agc gtg ctg ctg cac cgc 1608 Trp Phe Asp Pro Pro Phe His Pro Gly Gln Ser Val Leu Leu His Arg 240 245 250 cag ccc gac gat gtc tgg cgc atc gac ttc cag ctg ggc tgg gac gcg 1656 Gln Pro Asp Asp Val Trp Arg Ile Asp Phe Gln Leu Gly Trp Asp Ala 255 260 265 270 gac ccc gag gaa gag aaa aag ccc gag aac atc gtg ccg cgc atc cgc 1704 Asp Pro Glu Glu Glu Lys Lys Pro Glu Asn Ile Val Pro Arg Ile Arg 275 280 285 gcc ctg ctg ggc aag gac gcg ccc ttc gag ctg gaa tgg gcc agc gtc 1752 Ala Leu Leu Gly Lys Asp Ala Pro Phe Glu Leu Glu Trp Ala Ser Val 290 295 300 tac acc ttc gcc tgc ctg cgc atg gac cgc ttc gtc cat ggc cgc gtg 1800 Tyr Thr Phe Ala Cys Leu Arg Met Asp Arg Phe Val His Gly Arg Val 305 310 315 gtc ttt gcg ggc gac agc gcc cac ggc gtc tcg ccg ttt ggc gca cgc 1848 Val Phe Ala Gly Asp Ser Ala His Gly Val Ser Pro Phe Gly Ala Arg 320 325 330 ggc gcc aac agc ggc gtg cag gat gcc gag aac ctg gca tgg aag ctg 1896 Gly Ala Asn Ser Gly Val Gln Asp Ala Glu Asn Leu Ala Trp Lys Leu 335 340 345 350 gac cgc gtg ctg cgc ggc cag gcc gat gcc tcg ctg atc gcc acc tac 1944 Asp Arg Val Leu Arg Gly Gln Ala Asp Ala Ser Leu Ile Ala Thr Tyr 355 360 365 ggc gcc gag cgc gaa tac gcg gcc gac gag aac atc cgc aac tcc acg 1992 Gly Ala Glu Arg Glu Tyr Ala Ala Asp Glu Asn Ile Arg Asn Ser Thr 370 375 380 cgc gcc acc gac ttc atc acg ccc aag agc gag atc agc cgc ctg ttt 2040 Arg Ala Thr Asp Phe Ile Thr Pro Lys Ser Glu Ile Ser Arg Leu Phe 385 390 395 cgc gac gcc gtg ctg gac ctg gcg cgc gac cat gaa ttc gcg cgc cgc 2088 Arg Asp Ala Val Leu Asp Leu Ala Arg Asp His Glu Phe Ala Arg Arg 400 405 410 atc gtc aac agc ggg cgg ctg tcc gtg ccg gcc acg ctg cac ggc tcc 2136 Ile Val Asn Ser Gly Arg Leu Ser Val Pro Ala Thr Leu His Gly Ser 415 420 425 430 gcg ctc aac acg cct gac acc gac acc ttc gac gga acg cag ctg ccc 2184 Ala Leu Asn Thr Pro Asp Thr Asp Thr Phe Asp Gly Thr Gln Leu Pro 435 440 445 ggc gcc gtg ctg gcc gat gcg ccc atg cgc cgg ccc ggc gca gac ggc 2232 Gly Ala Val Leu Ala Asp Ala Pro Met Arg Arg Pro Gly Ala Asp Gly 450 455 460 acg gcc tgg ctg ctg cgc gca ctg gga ccg gac ttc acg ctg ctg cac 2280 Thr Ala Trp Leu Leu Arg Ala Leu Gly Pro Asp Phe Thr Leu Leu His 465 470 475 ttc gac ccc acg ccc gcc tgg gcg cag gcg ctg ccc ggc gtg ctc aac 2328 Phe Asp Pro Thr Pro Ala Trp Ala Gln Ala Leu Pro Gly Val Leu Asn 480 485 490 ctg tcc atc gcg gcc gag ggc gag gcc cat gcg cca gac gcc gac ctc 2376 Leu Ser Ile Ala Ala Glu Gly Glu Ala His Ala Pro Asp Ala Asp Leu 495 500 505 510 atc gat gcg cgc ggc ctg gcg gcc aaa cgc ctg gat gca cgc ccc ggc 2424 Ile Asp Ala Arg Gly Leu Ala Ala Lys Arg Leu Asp Ala Arg Pro Gly 515 520 525 acc agc tac ctg ctg cgg cct gac cag cat gtc tgc gcg cgc tgg cgc 2472 Thr Ser Tyr Leu Leu Arg Pro Asp Gln His Val Cys Ala Arg Trp Arg 530 535 540 cgc ccc gac gaa gcc agc gtg cgc gcc gcg ctg caa aga gcc tgc ggc 2520 Arg Pro Asp Glu Ala Ser Val Arg Ala Ala Leu Gln Arg Ala Cys Gly 545 550 555 gcc gcc gcc acg gcc tga acctcttaag cttatcgata ccgtcgacga 2568 Ala Ala Ala Thr Ala 560 atttccccga tcgttcaaac atttggcaat aaagtttctt aagattgaat cctgttgccg 2628 gtcttgcgat gattatcata taatttctgt tgaattacgt taagcatgta ataattaaca 2688 tgtaatgcat gacgttattt atgagatggg tttttatgat tagagtcccg caattataca 2748 tttaatacgc gatagaaaac aaaatatagc gcgcaaacta ggataaatta tcgcgcgcgg 2808 tgtcatctat gttcctaggt cgggaattgc 2838 18 563 PRT Artificial Expression Cassette 18 Met Ser His Pro Ala Ile Ser Leu Gln Ala Leu Arg Gly Ser Gly Ala 1 5 10 15 Asp Ile Gln Ser Ile His Ile Pro Tyr Glu Arg His Ala Asp Gln Asp 20 25 30 Ala Gly Ala Asp Thr Pro Ala Arg His Pro Val Val Ile Val Gly Ala 35 40 45 Gly Pro Val Gly Leu Ser Leu Ala Ile Asp Leu Ala Gln Arg Gly Gln 50 55 60 Arg Val Val Leu Leu Asp Asn Asp Cys Arg Leu Ser Thr Gly Ser Arg 65 70 75 80 Ala Ile Cys Phe Ser Lys Arg Thr Leu Glu Ile Trp Asp Arg Leu Gly 85 90 95 Val Gly Gln Pro Met Val Asp Lys Gly Val Ser Trp Asn Leu Gly Lys 100 105 110 Val Phe Phe Lys Asp Gln Pro Leu Tyr Arg Phe Asp Leu Leu Pro Glu 115 120 125 Asp Gly His Glu Arg Pro Ala Phe Ile Asn Leu Gln Gln Tyr Tyr Ala 130 135 140 Glu Ala Tyr Leu Val Glu Arg Ala Leu Gln Leu Pro Leu Ile Asp Leu 145 150 155 160 Arg Trp His Ser Lys Val Thr Ala Leu Glu Pro Gln Ala Glu Gly Ala 165 170 175 Leu Leu Thr Val Glu Thr Pro Asp Gly Ser Tyr Arg Ile Asp Ala Gln 180 185 190 Trp Val Leu Ala Cys Asp Gly Ser Arg Ser Pro Leu Arg Gly Leu Leu 195 200 205 Gly Gln Glu Ser His Gly Arg Ile Phe Arg Asp Arg Phe Leu Ile Ala 210 215 220 Asp Val Lys Met His Ala Glu Phe Pro Thr Glu Arg Trp Phe Trp Phe 225 230 235 240 Asp Pro Pro Phe His Pro Gly Gln Ser Val Leu Leu His Arg Gln Pro 245 250 255 Asp Asp Val Trp Arg Ile Asp Phe Gln Leu Gly Trp Asp Ala Asp Pro 260 265 270 Glu Glu Glu Lys Lys Pro Glu Asn Ile Val Pro Arg Ile Arg Ala Leu 275 280 285 Leu Gly Lys Asp Ala Pro Phe Glu Leu Glu Trp Ala Ser Val Tyr Thr 290 295 300 Phe Ala Cys Leu Arg Met Asp Arg Phe Val His Gly Arg Val Val Phe 305 310 315 320 Ala Gly Asp Ser Ala His Gly Val Ser Pro Phe Gly Ala Arg Gly Ala 325 330 335 Asn Ser Gly Val Gln Asp Ala Glu Asn Leu Ala Trp Lys Leu Asp Arg 340 345 350 Val Leu Arg Gly Gln Ala Asp Ala Ser Leu Ile Ala Thr Tyr Gly Ala 355 360 365 Glu Arg Glu Tyr Ala Ala Asp Glu Asn Ile Arg Asn Ser Thr Arg Ala 370 375 380 Thr Asp Phe Ile Thr Pro Lys Ser Glu Ile Ser Arg Leu Phe Arg Asp 385 390 395 400 Ala Val Leu Asp Leu Ala Arg Asp His Glu Phe Ala Arg Arg Ile Val 405 410 415 Asn Ser Gly Arg Leu Ser Val Pro Ala Thr Leu His Gly Ser Ala Leu 420 425 430 Asn Thr Pro Asp Thr Asp Thr Phe Asp Gly Thr Gln Leu Pro Gly Ala 435 440 445 Val Leu Ala Asp Ala Pro Met Arg Arg Pro Gly Ala Asp Gly Thr Ala 450 455 460 Trp Leu Leu Arg Ala Leu Gly Pro Asp Phe Thr Leu Leu His Phe Asp 465 470 475 480 Pro Thr Pro Ala Trp Ala Gln Ala Leu Pro Gly Val Leu Asn Leu Ser 485 490 495 Ile Ala Ala Glu Gly Glu Ala His Ala Pro Asp Ala Asp Leu Ile Asp 500 505 510 Ala Arg Gly Leu Ala Ala Lys Arg Leu Asp Ala Arg Pro Gly Thr Ser 515 520 525 Tyr Leu Leu Arg Pro Asp Gln His Val Cys Ala Arg Trp Arg Arg Pro 530 535 540 Asp Glu Ala Ser Val Arg Ala Ala Leu Gln Arg Ala Cys Gly Ala Ala 545 550 555 560 Ala Thr Ala 19 1839 DNA Artificial promoter (1)..(547) 19 ccccctcgag gtcgacggta ttgatcagct tccagaaggt aattatccaa gatgtagcat 60 caagaatcca atgtttacgg gaaaaactat ggaagtatta tgtgagctca gcaagaagca 120 gatcaatatg cggcacatat gcaacctatg ttcaaaaatg aagaatgtac agatacaaga 180 tcctatactg ccagaatacg aagaagaata cgtagaaatt gaaaaagaag aaccaggcga 240 agaaaagaat cttgaagacg taagcactga cgacaacaat gaaaagaaga agataaggtc 300 ggtgattgtg aaagagacat agaggacaca tgtaaggtgg aaaatgtaag ggcggaaagt 360 aaccttatca caaaggaatc ttatccccca ctacttatcc ttttatattt ttccgtgtca 420 tttttgccct tgagttttcc tatataagga accaagttcg gcatttgtga aaacaagaaa 480 aaatttggtg taagctattt tctttgaagt actgaggata caacttcaga gaaatttgta 540 agtttgtaga tctgaattcg atgcaggatg cac atg tcc acc aag acc ttt gcc 594 Met Ser Thr Lys Thr Phe Ala 1 5 tcc gcc gcc gac ctc gaa atc aag cag gtc agc ttc gac aag ctc tcc 642 Ser Ala Ala Asp Leu Glu Ile Lys Gln Val Ser Phe Asp Lys Leu Ser 10 15 20 gag cac gcc tat gcc tac acg gcc gaa ggc gac ccc aac acc ggc atc 690 Glu His Ala Tyr Ala Tyr Thr Ala Glu Gly Asp Pro Asn Thr Gly Ile 25 30 35 atc att ggc gac gac gcg gtg atg gtg atc gac acc cag gcc acg ccc 738 Ile Ile Gly Asp Asp Ala Val Met Val Ile Asp Thr Gln Ala Thr Pro 40 45 50 55 gtc atg gcc cag gac gtg atc cgc cgc atc cgt gag gtc acg gac aag 786 Val Met Ala Gln Asp Val Ile Arg Arg Ile Arg Glu Val Thr Asp Lys 60 65 70 ccc atc aag tac gtg acg ctg tcg cac tac cac gcg gtg cgc gtg ctg 834 Pro Ile Lys Tyr Val Thr Leu Ser His Tyr His Ala Val Arg Val Leu 75 80 85 ggc gcc tcg gcc ttc ttc gcg gaa ggc gcc gaa cac atc att gcc agc 882 Gly Ala Ser Ala Phe Phe Ala Glu Gly Ala Glu His Ile Ile Ala Ser 90 95 100 cag gac acc tac gac ctc atc gtg gag cgc ggc gag cag gac aag gcc 930 Gln Asp Thr Tyr Asp Leu Ile Val Glu Arg Gly Glu Gln Asp Lys Ala 105 110 115 agc gag atc ggc cgc ttt ccc cgc ctg ttc cag aac gtg gaa agc gtg 978 Ser Glu Ile Gly Arg Phe Pro Arg Leu Phe Gln Asn Val Glu Ser Val 120 125 130 135 ccc gat ggc atg acc tgg ccc acc ctc acc ttc acc ggc aag atg acg 1026 Pro Asp Gly Met Thr Trp Pro Thr Leu Thr Phe Thr Gly Lys Met Thr 140 145 150 ctg tgg ctg ggc aag ctg gaa gtg cag atc ctg cag ctg ggc cgc ggc 1074 Leu Trp Leu Gly Lys Leu Glu Val Gln Ile Leu Gln Leu Gly Arg Gly 155 160 165 cac acc aag ggc gac acc gtg gtc tgg ctg ccc cag gac aag gtg ctg 1122 His Thr Lys Gly Asp Thr Val Val Trp Leu Pro Gln Asp Lys Val Leu 170 175 180 ttc agc ggc gac ctg gtg gag ttc ggc gcc acg ccc tat gcg ggc gat 1170 Phe Ser Gly Asp Leu Val Glu Phe Gly Ala Thr Pro Tyr Ala Gly Asp 185 190 195 gcc tac ttc cag gac tgg ccg cac acg ctg gac gcc atc gcc gcc ctg 1218 Ala Tyr Phe Gln Asp Trp Pro His Thr Leu Asp Ala Ile Ala Ala Leu 200 205 210 215 cag ccc gaa aag ctc gtg ccc ggc cgg ggc gcc gcg ctg cag acg ccg 1266 Gln Pro Glu Lys Leu Val Pro Gly Arg Gly Ala Ala Leu Gln Thr Pro 220 225 230 gcc gag gtg cag gcc ggc ctg gcc ggc acg cgc gac ttc atc agc gac 1314 Ala Glu Val Gln Ala Gly Leu Ala Gly Thr Arg Asp Phe Ile Ser Asp 235 240 245 ctg tgg acc gag gtc aag gcc ggc gcc gat gcc cag cag gac ctg cgc 1362 Leu Trp Thr Glu Val Lys Ala Gly Ala Asp Ala Gln Gln Asp Leu Arg 250 255 260 aag gtc tac gag gcc gcc ttc gcc aag ctg cag ccc aag tac ggc cag 1410 Lys Val Tyr Glu Ala Ala Phe Ala Lys Leu Gln Pro Lys Tyr Gly Gln 265 270 275 tgg gtg atc ttc aac cac tgc atg ccc ttc gat gtg acc cgc gcc tat 1458 Trp Val Ile Phe Asn His Cys Met Pro Phe Asp Val Thr Arg Ala Tyr 280 285 290 295 gac gag gca tcg ggc cac gcc gac cca cgc atc tgg acc gcc gag cgc 1506 Asp Glu Ala Ser Gly His Ala Asp Pro Arg Ile Trp Thr Ala Glu Arg 300 305 310 gac cgc cag atg tgg ctg gcg ctc gaa ggc tga tgcaagctta tcgataccgt 1559 Asp Arg Gln Met Trp Leu Ala Leu Glu Gly 315 320 cgacgaattt ccccgatcgt tcaaacattt ggcaataaag tttcttaaga ttgaatcctg 1619 ttgccggtct tgcgatgatt atcatataat ttctgttgaa ttacgttaag catgtaataa 1679 ttaacatgta atgcatgacg ttatttatga gatgggtttt tatgattaga gtcccgcaat 1739 tatacattta atacgcgata gaaaacaaaa tatagcgcgc aaactaggat aaattatcgc 1799 gcgcggtgtc atctatgtta ctagatcggg aattgcggcc 1839 20 321 PRT Artificial Expression cassette 20 Met Ser Thr Lys Thr Phe Ala Ser Ala Ala Asp Leu Glu Ile Lys Gln 1 5 10 15 Val Ser Phe Asp Lys Leu Ser Glu His Ala Tyr Ala Tyr Thr Ala Glu 20 25 30 Gly Asp Pro Asn Thr Gly Ile Ile Ile Gly Asp Asp Ala Val Met Val 35 40 45 Ile Asp Thr Gln Ala Thr Pro Val Met Ala Gln Asp Val Ile Arg Arg 50 55 60 Ile Arg Glu Val Thr Asp Lys Pro Ile Lys Tyr Val Thr Leu Ser His 65 70 75 80 Tyr His Ala Val Arg Val Leu Gly Ala Ser Ala Phe Phe Ala Glu Gly 85 90 95 Ala Glu His Ile Ile Ala Ser Gln Asp Thr Tyr Asp Leu Ile Val Glu 100 105 110 Arg Gly Glu Gln Asp Lys Ala Ser Glu Ile Gly Arg Phe Pro Arg Leu 115 120 125 Phe Gln Asn Val Glu Ser Val Pro Asp Gly Met Thr Trp Pro Thr Leu 130 135 140 Thr Phe Thr Gly Lys Met Thr Leu Trp Leu Gly Lys Leu Glu Val Gln 145 150 155 160 Ile Leu Gln Leu Gly Arg Gly His Thr Lys Gly Asp Thr Val Val Trp 165 170 175 Leu Pro Gln Asp Lys Val Leu Phe Ser Gly Asp Leu Val Glu Phe Gly 180 185 190 Ala Thr Pro Tyr Ala Gly Asp Ala Tyr Phe Gln Asp Trp Pro His Thr 195 200 205 Leu Asp Ala Ile Ala Ala Leu Gln Pro Glu Lys Leu Val Pro Gly Arg 210 215 220 Gly Ala Ala Leu Gln Thr Pro Ala Glu Val Gln Ala Gly Leu Ala Gly 225 230 235 240 Thr Arg Asp Phe Ile Ser Asp Leu Trp Thr Glu Val Lys Ala Gly Ala 245 250 255 Asp Ala Gln Gln Asp Leu Arg Lys Val Tyr Glu Ala Ala Phe Ala Lys 260 265 270 Leu Gln Pro Lys Tyr Gly Gln Trp Val Ile Phe Asn His Cys Met Pro 275 280 285 Phe Asp Val Thr Arg Ala Tyr Asp Glu Ala Ser Gly His Ala Asp Pro 290 295 300 Arg Ile Trp Thr Ala Glu Arg Asp Arg Gln Met Trp Leu Ala Leu Glu 305 310 315 320 Gly 21 4677 DNA Artificial Expression cassette 21 ccccctcgag gtcgacggta ttgatcagct tccagaaggt aattatccaa gatgtagcat 60 caagaatcca atgtttacgg gaaaaactat ggaagtatta tgtgagctca gcaagaagca 120 gatcaatatg cggcacatat gcaacctatg ttcaaaaatg aagaatgtac agatacaaga 180 tcctatactg ccagaatacg aagaagaata cgtagaaatt gaaaaagaag aaccaggcga 240 agaaaagaat cttgaagacg taagcactga cgacaacaat gaaaagaaga agataaggtc 300 ggtgattgtg aaagagacat agaggacaca tgtaaggtgg aaaatgtaag ggcggaaagt 360 aaccttatca caaaggaatc ttatccccca ctacttatcc ttttatattt ttccgtgtca 420 tttttgccct tgagttttcc tatataagga accaagttcg gcatttgtga aaacaagaaa 480 aaatttggtg taagctattt tctttgaagt actgaggata caacttcaga gaaatttgta 540 agtttgtaga tctgaattcg atgcaggatg cacatgtcca ccaagacctt tgcctccgcc 600 gccgacctcg aaatcaagca ggtcagcttc gacaagctct ccgagcacgc ctatgcctac 660 acggccgaag gcgaccccaa caccggcatc atcattggcg acgacgcggt gatggtgatc 720 gacacccagg ccacgcccgt catggcccag gacgtgatcc gccgcatccg tgaggtcacg 780 gacaagccca tcaagtacgt gacgctgtcg cactaccacg cggtgcgcgt gctgggcgcc 840 tcggccttct tcgcggaagg cgccgaacac atcattgcca gccaggacac ctacgacctc 900 atcgtggagc gcggcgagca ggacaaggcc agcgagatcg gccgctttcc ccgcctgttc 960 cagaacgtgg aaagcgtgcc cgatggcatg acctggccca ccctcacctt caccggcaag 1020 atgacgctgt ggctgggcaa gctggaagtg cagatcctgc agctgggccg cggccacacc 1080 aagggcgaca ccgtggtctg gctgccccag gacaaggtgc tgttcagcgg cgacctggtg 1140 gagttcggcg ccacgcccta tgcgggcgat gcctacttcc aggactggcc gcacacgctg 1200 gacgccatcg ccgccctgca gcccgaaaag ctcgtgcccg gccggggcgc cgcgctgcag 1260 acgccggccg aggtgcaggc cggcctggcc ggcacgcgcg acttcatcag cgacctgtgg 1320 accgaggtca aggccggcgc cgatgcccag caggacctgc gcaaggtcta cgaggccgcc 1380 ttcgccaagc tgcagcccaa gtacggccag tgggtgatct tcaaccactg catgcccttc 1440 gatgtgaccc gcgcctatga cgaggcatcg ggccacgccg acccacgcat ctggaccgcc 1500 gagcgcgacc gccagatgtg gctggcgctc gaaggctgat gcaagcttat cgataccgtc 1560 gacgaatttc cccgatcgtt caaacatttg gcaataaagt ttcttaagat tgaatcctgt 1620 tgccggtctt gcgatgatta tcatataatt tctgttgaat tacgttaagc atgtaataat 1680 taacatgtaa tgcatgacgt tatttatgag atgggttttt atgattagag tcccgcaatt 1740 atacatttaa tacgcgatag aaaacaaaat atagcgcgca aactaggata aattatcgcg 1800 cgcggtgtca tctatgttac tagatcggga attgcggccc cccctcgagc ccacagatgg 1860 ttagagaggc ttacgcagca ggtctcatca agacgatcta cccgagcaat aatctccagg 1920 aaatcaaata ccttcccaag aaggttaaag atgcagtcaa aagattcagg actaactgca 1980 tcaagaacac agagaaagat atatttctca agatcagaag tactattcca gtatggacga 2040 ttcaaggctt gcttcacaaa ccaaggcaag taatagagat tggagtctct aaaaaggtag 2100 ttcccactga atcaaaggcc atggagtcaa agattcaaat agaggaccta acagaactcg 2160 ccgtaaagac tggcgaacag ttcatacaga gtctcttacg actcaatgac aagaagaaaa 2220 tcttcgtcaa catggtggag cacgacacac ttgtctactc caaaaatatc aaagatacag 2280 tctcagaaga ccaaagggca attgagactt ttcaacaaag ggtaatatcc ggaaacctcc 2340 tcggattcca ttgcccagct atctgtcact ttattgtgaa gatagtggaa aaggaaggtg 2400 gctcctacaa atgccatcat tgcgataaag gaaaggccat cgttgaagat gcctctgccg 2460 acagtggtcc caaagatgga cccccaccca cgaggagcat cgtggaaaaa gaagacgttc 2520 caaccacgtc ttcaaagcaa gtggattgat gtgatatctc cactgacgta agggatgacg 2580 cacaatccca ctatccttcg caagaccctt cctctatata aggaagttca tttcatttgg 2640 agagaacacg ggggactcta gaggatcaga ggacgaacaa catgtcccac cccgccatct 2700 ccctgcaagc gctgcgcggc agcggcgcag acatacagtc catccacatc ccctacgagc 2760 gccatgccga ccaggacgcc ggtgcggaca cgcccgcccg gcatcccgtc gtcatcgtcg 2820 gcgccggccc cgtgggcctg tcgctggcca tcgacctggc ccagcgcggc cagcgcgtgg 2880 tgctgctgga caacgactgc cggctgtcca cgggctcgcg cgccatctgc ttttccaagc 2940 gcacgctgga gatctgggac cgcctgggcg tgggccagcc catggtggac aagggcgtgt 3000 cctggaacct gggcaaggtc ttcttcaagg accagccgct gtaccgcttc gacctgctgc 3060 ccgaggacgg ccacgagcgc ccggccttca tcaacctgca gcagtactac gccgaggcct 3120 atctggtcga gcgcgcactg cagctgccgc tgatcgacct gcgctggcac agcaaggtca 3180 cggcactgga gccgcaggcc gagggcgcgc tgctgaccgt ggagacgcct gacggcagct 3240 accgcatcga tgcgcaatgg gtcctggcct gcgatggctc gcgctcgccg ctgcgcggcc 3300 tgctgggcca ggaaagccat ggccgcatct tccgcgaccg cttcctgatc gccgacgtga 3360 agatgcacgc cgaattcccc accgagcgct ggttctggtt cgacccgccc ttccacccgg 3420 gccagagcgt gctgctgcac cgccagcccg acgatgtctg gcgcatcgac ttccagctgg 3480 gctgggacgc ggaccccgag gaagagaaaa agcccgagaa catcgtgccg cgcatccgcg 3540 ccctgctggg caaggacgcg cccttcgagc tggaatgggc cagcgtctac accttcgcct 3600 gcctgcgcat ggaccgcttc gtccatggcc gcgtggtctt tgcgggcgac agcgcccacg 3660 gcgtctcgcc gtttggcgca cgcggcgcca acagcggcgt gcaggatgcc gagaacctgg 3720 catggaagct ggaccgcgtg ctgcgcggcc aggccgatgc ctcgctgatc gccacctacg 3780 gcgccgagcg cgaatacgcg gccgacgaga acatccgcaa ctccacgcgc gccaccgact 3840 tcatcacgcc caagagcgag atcagccgcc tgtttcgcga cgccgtgctg gacctggcgc 3900 gcgaccatga attcgcgcgc cgcatcgtca acagcgggcg gctgtccgtg ccggccacgc 3960 tgcacggctc cgcgctcaac acgcctgaca ccgacacctt cgacggaacg cagctgcccg 4020 gcgccgtgct ggccgatgcg cccatgcgcc ggcccggcgc agacggcacg gcctggctgc 4080 tgcgcgcact gggaccggac ttcacgctgc tgcacttcga ccccacgccc gcctgggcgc 4140 aggcgctgcc cggcgtgctc aacctgtcca tcgcggccga gggcgaggcc catgcgccag 4200 acgccgacct catcgatgcg cgcggcctgg cggccaaacg cctggatgca cgccccggca 4260 ccagctacct gctgcggcct gaccagcatg tctgcgcgcg ctggcgccgc cccgacgaag 4320 ccagcgtgcg cgccgcgctg caaagagcct gcggcgccgc cgccacggcc tgaacctctt 4380 aagcttatcg ataccgtcga cgaatttccc cgatcgttca aacatttggc aataaagttt 4440 cttaagattg aatcctgttg ccggtcttgc gatgattatc atataatttc tgttgaatta 4500 cgttaagcat gtaataatta acatgtaatg catgacgtta tttatgagat gggtttttat 4560 gattagagtc ccgcaattat acatttaata cgcgatagaa aacaaaatat agcgcgcaaa 4620 ctaggataaa ttatcgcgcg cggtgtcatc tatgttccta ggtcgggaat tgcggcc 4677 22 8187 DNA Artificial Expression cassette 22 ccccctcgag gtcgacggta ttgatcagct tccagaaggt aattatccaa gatgtagcat 60 caagaatcca atgtttacgg gaaaaactat ggaagtatta tgtgagctca gcaagaagca 120 gatcaatatg cggcacatat gcaacctatg ttcaaaaatg aagaatgtac agatacaaga 180 tcctatactg ccagaatacg aagaagaata cgtagaaatt gaaaaagaag aaccaggcga 240 agaaaagaat cttgaagacg taagcactga cgacaacaat gaaaagaaga agataaggtc 300 ggtgattgtg aaagagacat agaggacaca tgtaaggtgg aaaatgtaag ggcggaaagt 360 aaccttatca caaaggaatc ttatccccca ctacttatcc ttttatattt ttccgtgtca 420 tttttgccct tgagttttcc tatataagga accaagttcg gcatttgtga aaacaagaaa 480 aaatttggtg taagctattt tctttgaagt actgaggata caacttcaga gaaatttgta 540 agtttgtaga tctgaattcg atgcaggatg cacatgtcca ccaagacctt tgcctccgcc 600 gccgacctcg aaatcaagca ggtcagcttc gacaagctct ccgagcacgc ctatgcctac 660 acggccgaag gcgaccccaa caccggcatc atcattggcg acgacgcggt gatggtgatc 720 gacacccagg ccacgcccgt catggcccag gacgtgatcc gccgcatccg tgaggtcacg 780 gacaagccca tcaagtacgt gacgctgtcg cactaccacg cggtgcgcgt gctgggcgcc 840 tcggccttct tcgcggaagg cgccgaacac atcattgcca gccaggacac ctacgacctc 900 atcgtggagc gcggcgagca ggacaaggcc agcgagatcg gccgctttcc ccgcctgttc 960 cagaacgtgg aaagcgtgcc cgatggcatg acctggccca ccctcacctt caccggcaag 1020 atgacgctgt ggctgggcaa gctggaagtg cagatcctgc agctgggccg cggccacacc 1080 aagggcgaca ccgtggtctg gctgccccag gacaaggtgc tgttcagcgg cgacctggtg 1140 gagttcggcg ccacgcccta tgcgggcgat gcctacttcc aggactggcc gcacacgctg 1200 gacgccatcg ccgccctgca gcccgaaaag ctcgtgcccg gccggggcgc cgcgctgcag 1260 acgccggccg aggtgcaggc cggcctggcc ggcacgcgcg acttcatcag cgacctgtgg 1320 accgaggtca aggccggcgc cgatgcccag caggacctgc gcaaggtcta cgaggccgcc 1380 ttcgccaagc tgcagcccaa gtacggccag tgggtgatct tcaaccactg catgcccttc 1440 gatgtgaccc gcgcctatga cgaggcatcg ggccacgccg acccacgcat ctggaccgcc 1500 gagcgcgacc gccagatgtg gctggcgctc gaaggctgat gcaagcttat cgataccgtc 1560 gacgaatttc cccgatcgtt caaacatttg gcaataaagt ttcttaagat tgaatcctgt 1620 tgccggtctt gcgatgatta tcatataatt tctgttgaat tacgttaagc atgtaataat 1680 taacatgtaa tgcatgacgt tatttatgag atgggttttt atgattagag tcccgcaatt 1740 atacatttaa tacgcgatag aaaacaaaat atagcgcgca aactaggata aattatcgcg 1800 cgcggtgtca tctatgttac tagatcggga attgcggccc cccctcgagc ccacagatgg 1860 ttagagaggc ttacgcagca ggtctcatca agacgatcta cccgagcaat aatctccagg 1920 aaatcaaata ccttcccaag aaggttaaag atgcagtcaa aagattcagg actaactgca 1980 tcaagaacac agagaaagat atatttctca agatcagaag tactattcca gtatggacga 2040 ttcaaggctt gcttcacaaa ccaaggcaag taatagagat tggagtctct aaaaaggtag 2100 ttcccactga atcaaaggcc atggagtcaa agattcaaat agaggaccta acagaactcg 2160 ccgtaaagac tggcgaacag ttcatacaga gtctcttacg actcaatgac aagaagaaaa 2220 tcttcgtcaa catggtggag cacgacacac ttgtctactc caaaaatatc aaagatacag 2280 tctcagaaga ccaaagggca attgagactt ttcaacaaag ggtaatatcc ggaaacctcc 2340 tcggattcca ttgcccagct atctgtcact ttattgtgaa gatagtggaa aaggaaggtg 2400 gctcctacaa atgccatcat tgcgataaag gaaaggccat cgttgaagat gcctctgccg 2460 acagtggtcc caaagatgga cccccaccca cgaggagcat cgtggaaaaa gaagacgttc 2520 caaccacgtc ttcaaagcaa gtggattgat gtgatatctc cactgacgta agggatgacg 2580 cacaatccca ctatccttcg caagaccctt cctctatata aggaagttca tttcatttgg 2640 agagaacacg ggggactcta gaggatcaga ggacgaacaa catgtcccac cccgccatct 2700 ccctgcaagc gctgcgcggc agcggcgcag acatacagtc catccacatc ccctacgagc 2760 gccatgccga ccaggacgcc ggtgcggaca cgcccgcccg gcatcccgtc gtcatcgtcg 2820 gcgccggccc cgtgggcctg tcgctggcca tcgacctggc ccagcgcggc cagcgcgtgg 2880 tgctgctgga caacgactgc cggctgtcca cgggctcgcg cgccatctgc ttttccaagc 2940 gcacgctgga gatctgggac cgcctgggcg tgggccagcc catggtggac aagggcgtgt 3000 cctggaacct gggcaaggtc ttcttcaagg accagccgct gtaccgcttc gacctgctgc 3060 ccgaggacgg ccacgagcgc ccggccttca tcaacctgca gcagtactac gccgaggcct 3120 atctggtcga gcgcgcactg cagctgccgc tgatcgacct gcgctggcac agcaaggtca 3180 cggcactgga gccgcaggcc gagggcgcgc tgctgaccgt ggagacgcct gacggcagct 3240 accgcatcga tgcgcaatgg gtcctggcct gcgatggctc gcgctcgccg ctgcgcggcc 3300 tgctgggcca ggaaagccat ggccgcatct tccgcgaccg cttcctgatc gccgacgtga 3360 agatgcacgc cgaattcccc accgagcgct ggttctggtt cgacccgccc ttccacccgg 3420 gccagagcgt gctgctgcac cgccagcccg acgatgtctg gcgcatcgac ttccagctgg 3480 gctgggacgc ggaccccgag gaagagaaaa agcccgagaa catcgtgccg cgcatccgcg 3540 ccctgctggg caaggacgcg cccttcgagc tggaatgggc cagcgtctac accttcgcct 3600 gcctgcgcat ggaccgcttc gtccatggcc gcgtggtctt tgcgggcgac agcgcccacg 3660 gcgtctcgcc gtttggcgca cgcggcgcca acagcggcgt gcaggatgcc gagaacctgg 3720 catggaagct ggaccgcgtg ctgcgcggcc aggccgatgc ctcgctgatc gccacctacg 3780 gcgccgagcg cgaatacgcg gccgacgaga acatccgcaa ctccacgcgc gccaccgact 3840 tcatcacgcc caagagcgag atcagccgcc tgtttcgcga cgccgtgctg gacctggcgc 3900 gcgaccatga attcgcgcgc cgcatcgtca acagcgggcg gctgtccgtg ccggccacgc 3960 tgcacggctc cgcgctcaac acgcctgaca ccgacacctt cgacggaacg cagctgcccg 4020 gcgccgtgct ggccgatgcg cccatgcgcc ggcccggcgc agacggcacg gcctggctgc 4080 tgcgcgcact gggaccggac ttcacgctgc tgcacttcga ccccacgccc gcctgggcgc 4140 aggcgctgcc cggcgtgctc aacctgtcca tcgcggccga gggcgaggcc catgcgccag 4200 acgccgacct catcgatgcg cgcggcctgg cggccaaacg cctggatgca cgccccggca 4260 ccagctacct gctgcggcct gaccagcatg tctgcgcgcg ctggcgccgc cccgacgaag 4320 ccagcgtgcg cgccgcgctg caaagagcct gcggcgccgc cgccacggcc tgaacctctt 4380 aagcttatcg ataccgtcga cgaatttccc cgatcgttca aacatttggc aataaagttt 4440 cttaagattg aatcctgttg ccggtcttgc gatgattatc atataatttc tgttgaatta 4500 cgttaagcat gtaataatta acatgtaatg catgacgtta tttatgagat gggtttttat 4560 gattagagtc ccgcaattat acatttaata cgcgatagaa aacaaaatat agcgcgcaaa 4620 ctaggataaa ttatcgcgcg cggtgtcatc tatgttccta ggtcgaggag aaatatgagt 4680 cgaggcatgg atacactaag ttcccctgaa gtgagcatga tctttgatgc tgagatgatt 4740 cccagagcaa gatagtttgt gctgcaagtg acacaattgt aatgaaacca ccactcaacg 4800 aatttacttg tggctttgac atgtcgtgtg ctctgtttgt atttgtgagt gccggttggt 4860 aattattttt gttaatgtga ttttaaaacc tcttatgtaa atagttactt tatctattga 4920 agtgtgttct tgtggtctat agtttctcaa agggaaatta aaatgttgac atcccattta 4980 caattgataa cttggtatac acaaactttg taaatttggt gatatttatg gtcgaaagaa 5040 ggcaataccc attgtatgtt ccaatatcaa tatcaatacg ataacttgat aatactaaca 5100 tatgattgtc attgtttttc cagtatcaat atacattaag ctactacaaa attagtataa 5160 atcactatat tataaatctt tttcggttgt aacttgtaat tcgtgggttt ttaaaataaa 5220 agcatgtgaa aattttcaaa taatgtgatg gcgcaatttt attttccgag ttccaaaata 5280 ttgccgcttc attaccctaa tttgtggcgc cacatgtaaa acaaaagacg attcttagtg 5340 gctatcactg ccatcacgcg gatcactaat atgaaccgtc gattaaaaca gatcgacggt 5400 ttatacatca ttttattgta cacacggatc gatatctcag ccgttagatt taatatgcga 5460 tctgattgct caaaaaatag actctccgtc tttgcctata aaaacaattt cacatctttc 5520 tcacccaaat ctactcttaa ccgttcttct tcttctacag acatcaattt ctctcgactc 5580 tagaggatcc aagcttatcg atttcgaacc cctcatgact tcacttacag tgtccggccg 5640 ggtggcgcag gtcctcagca gctatgtcag cgatgtgttc ggtgtgatgg gcaacggaaa 5700 cgtctacttc ctggacgccg ccgagaagga gggcctccgc ttcacggccg tacgccatga 5760 aggtgccgcc atcgcggcgg cggacgccta ctatcgggca tccgggcgcc tggcggcggg 5820 gaccaccacc tacggccccg gttacaccaa cgccctgacg gccctcgccg aggcggtcca 5880 ggcgcagatc cccgtggtgc tcgtcaccgg ggacgccccg agcagcggcg cccggccttg 5940 ggacgtggac caggccgcga tcgccgccgg gctgggggcg gcgaccttca cggtcacccg 6000 tgaagccgca ggctccatca cgcaggaagc ggtggagtac gcacttgccc ggcggaccgc 6060 cgtcgtgatc gccgttccat acgacctgtc ggcccttgag gcggcggagg aagatcttcc 6120 cgtgccgccg gcggcctcgg ttccggacgc catcggcggc ggactcggac gggcggccga 6180 agtgcgggcg gccgaattgc tggcgggcgc gaagcggccg ctcatccttg ccggccgcgg 6240 tgcgcacctc gcaggaaccg gccccgaact ccgggaactc gccgaccgcc tcggcgcgct 6300 cacggccggc accgcactgg cgctgaacct gctgcagggc gaggggtacc tcggcgtcgc 6360 gggcggcttc ggcacggata ccgccgccgg gctcatgggc gaggcggacg tggtgctcgt 6420 ggcgggagcc agcctgaccc ccttcaccat gcgcttcggc cacctgatcg gcccggacgc 6480 caccgtgatc cagatcgaca ccgccatgga gccgacggac ccgcgggtgg acctgtttgt 6540 cagtgcggac gcgaaggccg ctgccggccg gatcctccgg ctgctggatg acgccgccgg 6600 ggccaatgcg tcgaaggcct ggcgcgcgga agcactcaag cgtctggccg aaggaccctg 6660 ccaccacccc ggcaccgcag agaccacgga cggccgcctt gacccccggg cgcttgcttc 6720 ggcactggat gccgtcctgc cggaacgccg caccgtggtc caggacggcg ggcacttcct 6780 gggctgggca cccatgtact ggcgcatccc ccgtcctcag gacctggtca tggtggggac 6840 cgcgtaccag tcgatcgggc ttggcctggc cagcgccgtg ggggcgtccc gggccgtgga 6900 cgacggcaat atcctggtgc tggcggcggg cgacggcgga ttcctgatgg gcctgtccga 6960 cctggaatcg ctcgtgggcg cggcgagcag cgccgtcgtg gtgatctaca acgacgccgc 7020 ctacggggcc gagatccatc agtacggctc acgggggctc accgaaaagc ccatgctgat 7080 ccccgaagtg gacttcagcg ggattgcccg cgcgatcggg gcggaatccg caatcatccg 7140 caagctgtcg gacctctccg cgctcacgga ctggatcgag gccggcgcca ggggaacctt 7200 cgtggccgac tgccgcatca cctcaagcgt ccgggccccg tggctgagcg aatggatgag 7260 ggcctcgcaa gcggcgaagg aggcggtggc gggctagggc cggcctcgtc gaaatgccgc 7320 cctccaaccc aactcagtac cagctcaggg cgttctcagg gctgggaacg ccctgagctg 7380 ctactcattt gttcgaactc gaggtcgacg gtatcgataa gcttgatatc gaattcctgc 7440 agcccggggg atccactagg ggatcccccg atccgcgttt gtgttttctg ggtttctcac 7500 ttaagcgtct gcgttttact tttgtattgg gtttggcgtt tagtagtttg cggtagcgtt 7560 cttgttatgt gtaattacgc tttttcttct tgcttcagca gtttcggttg aaatataaat 7620 cgaatcaagt ttcactttat cagcgttgtt ttaaattttg gcattaaatt ggtgaaaatt 7680 gcttcaattt tgtatctaaa tagaagagac aacatgaaat tcgacttttg acctcaaatc 7740 ttcgaacatt tatttcctga tttcacgatg gatgaggata acgaaagggc ggttcctatg 7800 tccgggaaag ttcccgtaga agacaatgag caaagctact gaaacgcgga cacgacgtcg 7860 cattggtacg gatatgagtt aaaccgactc aattccttta ttaagacata aaccgatttt 7920 ggttaaagtg taacagtgag ctgatataaa accgaaacaa accggtacaa gtttgattga 7980 gcaacttgat gacaaacttc agaattttgg ttattgaatg aaaatcatag tctaatcgta 8040 aaaaatgtac agaagaaaag ctagagcaga acaaagattc tatattctgg ttccaattta 8100 tcatcgcttt aacgtccctc agatttgatc gggctgcagg aattcggcct gactgatcat 8160 ttaaacacta ggtcgggaat tgcggcc 8187 

1. A method for making plants tolerant to a herbicide, characterized in that at least one enzyme making it possible to bypass the metabolic pathway inhibited by said herbicide is expressed in said plants.
 2. The method as claimed in claim 1, characterized in that the herbicide is an HPPD inhibitor.
 3. The method as claimed in claim 2, characterized in that an HPP oxidase and/or an HPAH and/or an HPAC is expressed in the plant.
 4. A polypeptide, characterized in that it has HPP oxidase activity.
 5. The polypeptide as claimed in claim 4, characterized in that it is insensitive to HPPD inhibitors.
 6. The polypeptide as claimed in either of claims 4 and 5, characterized in that it comprises the amino acid sequence of SEQ ID No. 2, the fragments thereof and the sequences homologous thereto.
 7. The polypeptide as claimed in claim 6, characterized in that it comprises an amino acid sequence selected from the group comprising SEQ ID No. 4 and SEQ ID No. 6, the fragments thereof and the sequences homologous thereto.
 8. A polypeptide, characterized in that it has HPAH activity.
 9. The polypeptide as claimed in claim 8, characterized in that it is insensitive to HPPD inhibitors.
 10. The polypeptide as claimed in either of claims 8 and 9, characterized in that it comprises the amino acid sequence of SEQ ID No. 8, the fragments thereof and the sequences homologous thereto.
 11. A polypeptide, characterized in that it has HPAC activity.
 12. The polypeptide as claimed in claim 11, characterized in that it is insensitive to HPPD inhibitors.
 13. The polypeptide as claimed in either of claims 11 and 12, characterized in that it comprises the amino acid sequence of SEQ ID No. 10, the fragments thereof and the sequences homologous thereto.
 14. The polypeptide as claimed in claim 13, characterized in that it comprises an amino acid sequence selected from the group comprising SEQ ID No. 12 and SEQ ID No. 14, the fragments thereof and the sequences homologous thereof.
 15. A nucleic acid sequence, characterized in that it encodes a polypeptide as claimed in one of claims 4 to
 14. 16. A nucleic acid sequence encoding an HPP oxidase, characterized in that it comprises a nucleic acid sequence selected from the group comprising the coding sequences of. SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5 or SEQ ID No. 15, the sequences homologous thereto, the fragments thereof and the sequences capable of selectively hybridizing to said SEQ ID No. 1, 3, 5 or
 15. 17. A nucleic acid sequence encoding, an HPAH, characterized in that it comprises a nucleic acid sequence selected from the group comprising the coding sequences of SEQ ID No. 7 or SEQ ID No. 17, the sequences homologous thereto, the fragments thereof and the sequences capable of selectively hybridizing to said SEQ ID No. 7 or
 17. 18. A nucleic acid sequence encoding an HPAC, characterized in that it comprises a nucleic acid sequence selected from the group comprising the coding sequences of SEQ ID No. 9, SEQ ID No. 11, SEQ ID No. 13 or SEQ ID No. 19, the sequences homologous thereto, the fragments thereof and the sequences capable of selectively hybridizing to said SEQ ID No. 9, 11, 13 or
 19. 19. An expression cassette comprising a coding sequence, characterized in that the coding sequence comprises a nucleic acid sequence as claimed in one of claims 15 to
 18. 20. A cloning and/or expression vector, characterized in that it comprises at least one expression cassette as claimed in claim
 19. 21. A transformed plant cell, characterized in that it comprises at least one expression cassette as claimed in claim
 19. 22. A transformed plant, characterized in that it comprises at least one expression cassette as claimed in claim
 19. 23. A seed of a transformed plant as claimed in claim 22, characterized in that it comprises at least one expression cassette as claimed in claim
 19. 24. A method of transforming plants, characterized in that at least one expression cassette as claimed in claim 19 is introduced into their genome.
 25. A method for selective weeding of plants, in particular of crops, using an HPPD inhibitor, characterized in that this herbicide is applied to transformed plants as claimed in claim
 22. 26. A method of weed killing in an area of a field comprising seeds as claimed in claim 23 or transformed plants as claimed in claim 22, characterized in that it comprises the application, in said area of the field, of a dose, which is toxic for said weeds, of an HPPD-inhibiting herbicide, without however substantially affecting the seeds or transformed plants according to the invention.
 27. A method of growing transformed plants as claimed in claim 22, characterized in that it comprises sowing the seeds as claimed in claim 23 in an area of a field suitable for growing said plants, applying to said area of said field a dose, which is toxic for the weeds, of a herbicide having HPPD as the target, in the event of weeds being present, without substantially affecting said seeds or said transformed plants, then harvesting the plants grown when they reach the desired maturity and, optionally, separating the seeds from the harvested plants.
 28. The method as claimed in one of claims 25 to 27, characterized in that the herbicide is applied in pre-emergence and/or in post-emergence. 